No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 4r17D, 1.0000, 0.00, 1.000, 235, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2, 4r17R, 0.9999, 0.00, 1.000, 235, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3, 5bxlR, 0.9997, 0.10, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4, 5bxlD, 0.9997, 0.10, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT
5, 5fgaD, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
6, 5fg9R, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
7, 5fg9D, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
8, 5fg7D, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-T1A MUTANT
9, 5d0wR, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT
10, 5d0wD, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT
11, 5czaR, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT
12, 5czaD, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT
13, 4ya4R, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT
14, 4ya4D, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT
15, 4ya1R, 0.9996, 0.10, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT
16, 4ya1D, 0.9996, 0.10, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT
17, 4y9yR, 0.9996, 0.10, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT
18, 4y9yD, 0.9996, 0.10, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT
19, 4y8rR, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT
20, 4y8rD, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT
21, 4y8mR, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
22, 4y8mD, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
23, 4qvyR, 0.9996, 0.11, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
24, 4qvyD, 0.9996, 0.11, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
25, 5laiR, 0.9995, 0.12, 1.000, 235, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
26, 5laiD, 0.9995, 0.12, 1.000, 235, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
27, 5fgaR, 0.9995, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
28, 5cz6R, 0.9995, 0.12, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
29, 5cz6D, 0.9995, 0.12, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
30, 5cgfR, 0.9995, 0.12, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT
31, 5cgfD, 0.9995, 0.12, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT
32, 4y6vR, 0.9995, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
33, 4y6vD, 0.9995, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
34, 4qvlR, 0.9995, 0.12, 1.000, 235, 235, YCP IN COMPLEX WITH BORTEZOMIB
35, 4qvlD, 0.9995, 0.12, 1.000, 235, 235, YCP IN COMPLEX WITH BORTEZOMIB
36, 4quyR, 0.9995, 0.12, 1.000, 235, 235, YCP BETA5-A49S-MUTANT
37, 4quyD, 0.9995, 0.12, 1.000, 235, 235, YCP BETA5-A49S-MUTANT
38, 4quxR, 0.9995, 0.12, 1.000, 235, 235, YCP BETA5-A49T-MUTANT
39, 4quxD, 0.9995, 0.12, 1.000, 235, 235, YCP BETA5-A49T-MUTANT
40, 5l5rR, 0.9994, 0.14, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
41, 5l5rD, 0.9994, 0.14, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
42, 5l5bR, 0.9994, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
43, 5l5bD, 0.9994, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
44, 5l5aR, 0.9994, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
45, 5l5aD, 0.9994, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
46, 5bxnR, 0.9994, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
47, 5bxnD, 0.9994, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
48, 4z1lR, 0.9994, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
49, 4z1lD, 0.9994, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
50, 4qw1R, 0.9994, 0.14, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
51, 4qw1D, 0.9994, 0.14, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
52, 4qvwR, 0.9994, 0.14, 1.000, 235, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
53, 4qvwD, 0.9994, 0.14, 1.000, 235, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
54, 4qv7R, 0.9994, 0.14, 1.000, 235, 235, YCP BETA5-A50V MUTANT
55, 4qv7D, 0.9994, 0.14, 1.000, 235, 235, YCP BETA5-A50V MUTANT
56, 4qv1R, 0.9994, 0.13, 1.000, 235, 235, YCP BETA5-M45A MUTANT
57, 4qv1D, 0.9994, 0.13, 1.000, 235, 235, YCP BETA5-M45A MUTANT
58, 5l6bR, 0.9993, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
59, 5l6bD, 0.9993, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
60, 5l5uR, 0.9993, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
61, 5l5uD, 0.9993, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
62, 5bouR, 0.9993, 0.14, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
63, 5bouD, 0.9993, 0.14, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
64, 4rurR, 0.9993, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
65, 4rurD, 0.9993, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
66, 4qzzR, 0.9993, 0.14, 1.000, 235, 235, YCP IN COMPLEX WITH OMURALIDE
67, 4qzzD, 0.9993, 0.14, 1.000, 235, 235, YCP IN COMPLEX WITH OMURALIDE
68, 4qv8R, 0.9993, 0.14, 1.000, 235, 235, YCP BETA5-C52F MUTANT
69, 4qv8D, 0.9993, 0.14, 1.000, 235, 235, YCP BETA5-C52F MUTANT
70, 4qv6R, 0.9993, 0.15, 1.000, 235, 235, YCP BETA5-A49V MUTANT
71, 4qv6D, 0.9993, 0.15, 1.000, 235, 235, YCP BETA5-A49V MUTANT
72, 4qv4R, 0.9993, 0.14, 1.000, 235, 235, YCP BETA5-M45T MUTANT
73, 4qv4D, 0.9993, 0.14, 1.000, 235, 235, YCP BETA5-M45T MUTANT
74, 4qv0R, 0.9993, 0.14, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT
75, 4qv0D, 0.9993, 0.14, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT
76, 6gopR, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
77, 6gopD, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
78, 5lttR, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
79, 5lttD, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
80, 5l6aR, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
81, 5l6aD, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
82, 5l65R, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
83, 5l65D, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
84, 5l5wR, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
85, 5l5wD, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
86, 5l5fR, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
87, 5l5fD, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
88, 5l5eR, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
89, 5l5eD, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
90, 5l5dR, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
91, 5l5dD, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
92, 5cz7R, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
93, 5cz7D, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
94, 4y8nR, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
95, 4y8nD, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
96, 4y69R, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
97, 4y69D, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
98, 4r18R, 0.9992, 0.15, 1.000, 235, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
99, 4r18D, 0.9992, 0.15, 1.000, 235, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
100, 4qvpR, 0.9992, 0.16, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
101, 4qvpD, 0.9992, 0.16, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
102, 4qv9D, 0.9992, 0.16, 1.000, 235, 235, YCP BETA5-C63F MUTANT
103, 5lajR, 0.9991, 0.17, 1.000, 235, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
104, 5lajD, 0.9991, 0.17, 1.000, 235, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
105, 5l67R, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
106, 5l67D, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
107, 5l66R, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
108, 5l66D, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
109, 5l63R, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
110, 5l63D, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
111, 5l62R, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
112, 5l62D, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
113, 5l5zR, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
114, 5l5zD, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
115, 5l5xR, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
116, 5l5xD, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
117, 5l5pR, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
118, 5l5pD, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
119, 5l5oR, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
120, 5l5oD, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
121, 5l5iR, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
122, 5l5iD, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
123, 5l5hR, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
124, 5l5hD, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
125, 4ya5R, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
126, 4ya5D, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
127, 4y8tR, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
128, 4y8tD, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
129, 4r00D, 0.9991, 0.17, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
130, 4qwuR, 0.9991, 0.17, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
131, 4qwuD, 0.9991, 0.17, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
132, 4qvnR, 0.9991, 0.16, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
133, 4qvnD, 0.9991, 0.16, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
134, 4qv9R, 0.9991, 0.16, 1.000, 235, 235, YCP BETA5-C63F MUTANT
135, 4qv5R, 0.9991, 0.17, 1.000, 235, 235, YCP BETA5-M45I MUTANT
136, 4qv5D, 0.9991, 0.16, 1.000, 235, 235, YCP BETA5-M45I MUTANT
137, 4qv3R, 0.9991, 0.17, 1.000, 235, 235, YCP BETA5-M45V MUTANT
138, 4qv3D, 0.9991, 0.17, 1.000, 235, 235, YCP BETA5-M45V MUTANT
139, 5m2bR, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
140, 5m2bD, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
141, 5l6cR, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
142, 5l6cD, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
143, 5l68R, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
144, 5l68D, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
145, 5l64R, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
146, 5l64D, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
147, 5l61R, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
148, 5l61D, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
149, 5l5yR, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
150, 5l5yD, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
151, 5l5tR, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
152, 5l5tD, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
153, 5l5sR, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
154, 5l5sD, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
155, 5l5jR, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
156, 5l5jD, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
157, 5fg7R, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-T1A MUTANT
158, 5dkjR, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
159, 5dkjD, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
160, 5d0xR, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
161, 5d0xD, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
162, 5d0tR, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
163, 5d0tD, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
164, 4y8uR, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
165, 4y8uD, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
166, 4y6aR, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
167, 4y6aD, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
168, 4r00R, 0.9990, 0.17, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
169, 4qw0R, 0.9990, 0.17, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
170, 4qw0D, 0.9990, 0.17, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
171, 4qltR, 0.9990, 0.18, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
172, 4qltD, 0.9990, 0.18, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
173, 4no1R, 0.9990, 0.17, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
174, 4no1D, 0.9990, 0.17, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
175, 5l5qR, 0.9989, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
176, 5l5qD, 0.9989, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
177, 5l54R, 0.9989, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
178, 5l54D, 0.9989, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
179, 5cz4R, 0.9989, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
180, 5cz4D, 0.9989, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
181, 4qvqR, 0.9989, 0.19, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
182, 4qvqD, 0.9989, 0.19, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
183, 4qvmR, 0.9989, 0.19, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
184, 4qvmD, 0.9989, 0.19, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
185, 4qlsR, 0.9989, 0.18, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
186, 4qlsD, 0.9989, 0.18, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
187, 4qlqR, 0.9989, 0.19, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
188, 4qlqD, 0.9989, 0.19, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
189, 4no8R, 0.9989, 0.19, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
190, 4no8D, 0.9989, 0.19, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
191, 3nzjR, 0.9989, 0.19, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
192, 3nzjD, 0.9989, 0.19, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
193, 5l60R, 0.9988, 0.19, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
194, 5l60D, 0.9988, 0.19, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
195, 5l5vR, 0.9988, 0.19, 1.000, 235, 235,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
196, 5l5vD, 0.9988, 0.19, 1.000, 235, 235,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
197, 4ya7R, 0.9988, 0.19, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
198, 4ya7D, 0.9988, 0.19, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
199, 4ya3R, 0.9988, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
200, 4y9zR, 0.9988, 0.19, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
201, 4y9zD, 0.9988, 0.19, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
202, 4y8gR, 0.9988, 0.19, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
203, 4y8gD, 0.9988, 0.19, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
204, 4y77R, 0.9988, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
205, 4y77D, 0.9988, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
206, 4y75R, 0.9988, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
207, 4y75D, 0.9988, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
208, 4r02R, 0.9988, 0.19, 1.000, 235, 235, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
209, 4qz5D, 0.9988, 0.20, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
210, 3nzwR, 0.9988, 0.20, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
211, 3nzwD, 0.9988, 0.20, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
212, 3hyeR, 0.9988, 0.19, 1.000, 242, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
213, 3hyeD, 0.9988, 0.19, 1.000, 242, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
214, 3gptR, 0.9988, 0.20, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
215, 3gptD, 0.9988, 0.19, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
216, 5l69R, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
217, 5l69D, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
218, 5jhrR, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
219, 5jhrD, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
220, 5fghR, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
221, 5fghD, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
222, 4ya9R, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
223, 4ya9D, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
224, 4ya3D, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
225, 4ya2R, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
226, 4ya2D, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
227, 4y8sR, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
228, 4y8sD, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
229, 4y8pR, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
230, 4y8pD, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
231, 4y8jR, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
232, 4y8jD, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
233, 4y8hR, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
234, 4y8hD, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
235, 4y84R, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
236, 4y84D, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
237, 4y7wD, 0.9987, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
238, 4y70R, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
239, 4y70D, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
240, 4qz5R, 0.9987, 0.20, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
241, 4qz4R, 0.9987, 0.20, 1.000, 235, 235, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
242, 4qz4D, 0.9987, 0.20, 1.000, 235, 235, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
243, 4qvvR, 0.9987, 0.20, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
244, 4qvvD, 0.9987, 0.20, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
245, 3gpwR, 0.9987, 0.20, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
246, 3gpwD, 0.9987, 0.20, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
247, 5dkiR, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
248, 5dkiD, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
249, 4ya0R, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
250, 4ya0D, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
251, 4y8lR, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
252, 4y8lD, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
253, 4y7yD, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
254, 4y7wR, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
255, 4y74R, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
256, 4y74D, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
257, 4qz6R, 0.9986, 0.21, 1.000, 235, 235, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
258, 4qz6D, 0.9986, 0.21, 1.000, 235, 235, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
259, 4qz3R, 0.9986, 0.21, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
260, 4qz3D, 0.9986, 0.21, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
261, 4qwxR, 0.9986, 0.21, 1.000, 235, 235, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
262, 4qwxD, 0.9986, 0.21, 1.000, 235, 235, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
263, 4q1sR, 0.9986, 0.21, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
264, 4nnwR, 0.9986, 0.21, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
265, 4nnwD, 0.9986, 0.21, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
266, 4nnnR, 0.9986, 0.21, 1.000, 235, 235, YCP IN COMPLEX WITH MG132
267, 4nnnD, 0.9986, 0.21, 1.000, 235, 235, YCP IN COMPLEX WITH MG132
268, 4ltcD, 0.9986, 0.21, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
269, 4jsuR, 0.9986, 0.21, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
270, 4jsuD, 0.9986, 0.21, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
271, 3tddR, 0.9986, 0.21, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
272, 3tddD, 0.9986, 0.21, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
273, 5d0vR, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
274, 5d0vD, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
275, 5cgiR, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
276, 5cgiD, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
277, 5cggR, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
278, 5cggD, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
279, 4y8qR, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
280, 4y8qD, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
281, 4y8kR, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
282, 4y8kD, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
283, 4y8iR, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
284, 4y8iD, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
285, 4y82R, 0.9985, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
286, 4y82D, 0.9985, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
287, 4y80R, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
288, 4y80D, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
289, 4y7yR, 0.9985, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
290, 4qwlR, 0.9985, 0.22, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
291, 4qwlD, 0.9985, 0.22, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
292, 4qw6R, 0.9985, 0.22, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
293, 4qw6D, 0.9985, 0.22, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
294, 4qw5R, 0.9985, 0.22, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
295, 4qw5D, 0.9985, 0.22, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
296, 4qluR, 0.9985, 0.22, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
297, 4qluD, 0.9985, 0.22, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
298, 4no9R, 0.9985, 0.22, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
299, 4no9D, 0.9985, 0.22, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
300, 4no6R, 0.9985, 0.22, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
301, 4no6D, 0.9985, 0.22, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
302, 4lqiR, 0.9985, 0.21, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
303, 4lqiD, 0.9985, 0.21, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
304, 3shjR, 0.9985, 0.22, 1.000, 242, 235, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
305, 3shjD, 0.9985, 0.22, 1.000, 242, 235, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
306, 3nzxR, 0.9985, 0.22, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
307, 3nzxD, 0.9985, 0.22, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
308, 2gplD, 0.9985, 0.22, 1.000, 242, 235, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
309, 5l55D, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
310, 5l52R, 0.9984, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
311, 5l52D, 0.9984, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
312, 5jhsR, 0.9984, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
313, 5jhsD, 0.9984, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
314, 5fggR, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
315, 5d0zR, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
316, 5d0zD, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
317, 5d0sR, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
318, 5d0sD, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
319, 5cz9R, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
320, 5cz9D, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
321, 5cghR, 0.9984, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
322, 5cghD, 0.9984, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
323, 4y8oR, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
324, 4y8oD, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
325, 4r02D, 0.9984, 0.23, 1.000, 235, 235, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
326, 4qzwR, 0.9984, 0.22, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
327, 4qzwD, 0.9984, 0.22, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
328, 4qwrD, 0.9984, 0.23, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
329, 4qwiD, 0.9984, 0.23, 1.000, 235, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
330, 4qw7R, 0.9984, 0.22, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
331, 4qw7D, 0.9984, 0.22, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
332, 4qw4R, 0.9984, 0.23, 1.000, 235, 235, YCP IN COMPLEX WITH CARFILZOMIB
333, 4qw4D, 0.9984, 0.23, 1.000, 235, 235, YCP IN COMPLEX WITH CARFILZOMIB
334, 4qlvR, 0.9984, 0.22, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
335, 4qlvD, 0.9984, 0.22, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
336, 4q1sD, 0.9984, 0.22, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
337, 4ltcR, 0.9984, 0.23, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
338, 4jt0R, 0.9984, 0.22, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
339, 4jt0D, 0.9984, 0.22, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
340, 4jsqR, 0.9984, 0.22, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
341, 4jsqD, 0.9984, 0.22, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
342, 4j70R, 0.9984, 0.22, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
343, 4j70D, 0.9984, 0.22, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
344, 4intD, 0.9984, 0.23, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
345, 3un4R, 0.9984, 0.22, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
346, 3un4D, 0.9984, 0.22, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
347, 3mg0R, 0.9984, 0.22, 1.000, 242, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
348, 2gplR, 0.9984, 0.22, 1.000, 242, 235, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
349, 2fakR, 0.9984, 0.23, 1.000, 242, 235, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
350, 2fakD, 0.9984, 0.22, 1.000, 242, 235, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
351, 5l55R, 0.9983, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
352, 5fggD, 0.9983, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
353, 5fgfR, 0.9983, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
354, 5fgfD, 0.9983, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
355, 5ahjD, 0.9983, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
356, 4y81R, 0.9983, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
357, 4y81D, 0.9983, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
358, 4y7xR, 0.9983, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
359, 4y7xD, 0.9983, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
360, 4qz7R, 0.9983, 0.23, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
361, 4qz7D, 0.9983, 0.23, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
362, 4qz0R, 0.9983, 0.23, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
363, 4qz0D, 0.9983, 0.23, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
364, 4qwrR, 0.9983, 0.23, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
365, 4qwiR, 0.9983, 0.23, 1.000, 235, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
366, 4qwfR, 0.9983, 0.23, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
367, 4qwfD, 0.9983, 0.23, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
368, 4intR, 0.9983, 0.23, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
369, 4gk7R, 0.9983, 0.23, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
370, 4gk7D, 0.9983, 0.23, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
371, 5fhsR, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
372, 5fhsD, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
373, 5fgeR, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
374, 5fgeD, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
375, 5cz8R, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
376, 5cz8D, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
377, 5ahjR, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
378, 4y78R, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
379, 4y78D, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
380, 4y6zR, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
381, 4y6zD, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
382, 4qzxR, 0.9982, 0.24, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
383, 4qzxD, 0.9982, 0.24, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
384, 4qz2R, 0.9982, 0.24, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
385, 4qz2D, 0.9982, 0.24, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
386, 4qxjR, 0.9982, 0.24, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
387, 4qxjD, 0.9982, 0.24, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
388, 4qw3R, 0.9982, 0.24, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
389, 4qw3D, 0.9982, 0.24, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
390, 4inrD, 0.9982, 0.24, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
391, 4fzcR, 0.9982, 0.24, 1.000, 242, 235, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
392, 4fzcD, 0.9982, 0.24, 1.000, 242, 235, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
393, 3okjR, 0.9982, 0.24, 1.000, 242, 235, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
394, 3okjD, 0.9982, 0.24, 1.000, 242, 235, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
395, 3mg0D, 0.9982, 0.24, 1.000, 242, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
396, 3dy3R, 0.9982, 0.24, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
397, 3dy3D, 0.9982, 0.24, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
398, 5cz5R, 0.9981, 0.25, 1.000, 235, 235, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
399, 5cz5D, 0.9981, 0.25, 1.000, 235, 235, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
400, 4qwkR, 0.9981, 0.25, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
401, 4qwjR, 0.9981, 0.25, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
402, 4qwjD, 0.9981, 0.25, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
403, 3d29R, 0.9981, 0.25, 1.000, 242, 235, PROTEASOME INHIBITION BY FELLUTAMIDE B
404, 3d29D, 0.9981, 0.25, 1.000, 242, 235, PROTEASOME INHIBITION BY FELLUTAMIDE B
405, 2f16D, 0.9981, 0.25, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
406, 5fgiR, 0.9980, 0.25, 1.000, 235, 235, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
407, 5fgiD, 0.9980, 0.25, 1.000, 235, 235, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
408, 5fgdR, 0.9980, 0.25, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
409, 5fgdD, 0.9980, 0.25, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
410, 4qz1R, 0.9980, 0.25, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
411, 4qz1D, 0.9980, 0.25, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
412, 4qwkD, 0.9980, 0.25, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
413, 4qbyR, 0.9980, 0.25, 1.000, 235, 235, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
414, 4qbyD, 0.9980, 0.25, 1.000, 235, 235, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
415, 4inrR, 0.9980, 0.25, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
416, 3un8D, 0.9980, 0.25, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
417, 3e47R, 0.9980, 0.25, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
418, 3e47D, 0.9980, 0.25, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
419, 2f16R, 0.9980, 0.25, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
420, 4fzgR, 0.9979, 0.26, 1.000, 242, 235, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
421, 4fzgD, 0.9979, 0.26, 1.000, 242, 235, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
422, 3gpjR, 0.9979, 0.26, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
423, 3gpjD, 0.9979, 0.26, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
424, 3dy4R, 0.9979, 0.26, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
425, 3dy4D, 0.9979, 0.26, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
426, 1rypE, 0.9979, 0.26, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
427, 4hrdR, 0.9978, 0.26, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
428, 4hrdD, 0.9978, 0.27, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
429, 4qwsR, 0.9977, 0.27, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
430, 4qwsD, 0.9977, 0.27, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
431, 4hnpD, 0.9977, 0.27, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
432, 3un8R, 0.9977, 0.27, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
433, 2zcyR, 0.9977, 0.27, 1.000, 242, 235, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
434, 2zcyD, 0.9977, 0.27, 1.000, 242, 235, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
435, 1rypS, 0.9977, 0.27, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
436, 4inuD, 0.9976, 0.27, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
437, 3bdmR, 0.9975, 0.28, 1.000, 242, 235, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
438, 3bdmD, 0.9975, 0.28, 1.000, 242, 235, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
439, 4inuR, 0.9974, 0.29, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
440, 4qwgR, 0.9973, 0.30, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
441, 4qwgD, 0.9973, 0.30, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
442, 4eu2E, 0.9973, 0.30, 1.000, 242, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
443, 4hrcD, 0.9972, 0.30, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
444, 4hnpR, 0.9972, 0.30, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
445, 4x6zE, 0.9971, 0.31, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
446, 1g65D, 0.9971, 0.31, 1.000, 242, 235, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
447, 3wxrS, 0.9970, 0.31, 1.000, 238, 235, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
448, 4hrcR, 0.9968, 0.32, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
449, 3mg4R, 0.9968, 0.32, 1.000, 242, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
450, 1g65R, 0.9968, 0.32, 1.000, 242, 235, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
451, 5nifS, 0.9967, 0.33, 1.000, 236, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
452, 4eu2S, 0.9967, 0.33, 1.000, 242, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
453, 5nifE, 0.9966, 0.33, 1.000, 236, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
454, 4zzgS, 0.9966, 0.33, 1.000, 236, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
455, 4zzgE, 0.9965, 0.34, 1.000, 236, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
456, 3wxrE, 0.9963, 0.34, 0.996, 239, 235, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
457, 3mg4D, 0.9957, 0.41, 1.000, 242, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
458, 4x6zS, 0.9952, 0.41, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
459, 3mg6R, 0.9950, 0.43, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
460, 3oevR, 0.9948, 0.43, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
461, 3mg8R, 0.9946, 0.45, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
462, 3mg7R, 0.9942, 0.47, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
463, 1jd2D, 0.9940, 0.44, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
464, 3oeuD, 0.9938, 0.47, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
465, 3mg8D, 0.9938, 0.47, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
466, 3mg6D, 0.9934, 0.50, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
467, 1jd2Y, 0.9934, 0.47, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
468, 3oevD, 0.9933, 0.50, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
469, 3mg7D, 0.9933, 0.49, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
470, 3oeuR, 0.9922, 0.66, 0.996, 236, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
471, 3jcpNA, 0.9885, 0.62, 1.000, 242, 235, 
472, 3jcpN, 0.9885, 0.62, 1.000, 242, 235, 
473, 3sdkD, 0.9846, 0.62, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
474, 5mp9E, 0.9840, 0.55, 0.996, 233, 233, 26S PROTEASOME IN PRESENCE OF ATP (S1)
475, 3jcoNA, 0.9828, 0.73, 0.996, 242, 235, 
476, 3jcoN, 0.9828, 0.76, 1.000, 242, 235, 
477, 5mp9e, 0.9824, 0.76, 1.000, 242, 235, 26S PROTEASOME IN PRESENCE OF ATP (S1)
478, 3sdkR, 0.9820, 0.76, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
479, 5mpae, 0.9781, 0.77, 1.000, 242, 235, 26S PROTEASOME IN PRESENCE OF ATP (S2)
480, 5mpaE, 0.9752, 0.45, 1.000, 232, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
481, 5wvkS, 0.9740, 0.87, 0.996, 242, 235, 
482, 1g0uD, 0.9739, 0.93, 0.996, 242, 235, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
483, 1z7qS, 0.9737, 0.94, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
484, 1z7qE, 0.9737, 0.40, 0.983, 230, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
485, 1g0uR, 0.9735, 1.08, 0.996, 245, 235, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
486, 4g4sE, 0.9733, 1.08, 0.996, 245, 235, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
487, 5wvkZ, 0.9730, 0.42, 0.983, 230, 230, 
488, 3sdiR, 0.9714, 1.07, 0.987, 249, 234, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
489, 1fntE, 0.9711, 0.96, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
490, 1fntS, 0.9710, 0.32, 1.000, 229, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
491, 4cr2E, 0.9701, 1.14, 0.996, 244, 235, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
492, 3sdiD, 0.9666, 1.14, 0.996, 244, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
493, 4v7oMA, 0.9585, 1.04, 1.000, 243, 235, 
494, 4v7oE, 0.9585, 0.35, 1.000, 228, 228, 
495, 4v7oAB, 0.9585, 1.46, 1.000, 250, 235, 
496, 4v7oS, 0.9584, 1.46, 1.000, 250, 235, 
497, 5mpbE, 0.9572, 1.46, 1.000, 250, 235, 
498, 5le5R, 0.9557, 1.46, 1.000, 250, 235, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
499, 5lf4R, 0.9556, 1.24, 1.000, 242, 235, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
500, 5lezR, 0.9556, 0.60, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
501, 5leyR, 0.9556, 0.61, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
502, 5lf7R, 0.9555, 0.60, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
503, 5lf6R, 0.9555, 0.60, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
504, 5lf1R, 0.9554, 0.61, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
505, 5gjrKA, 0.9554, 0.61, 0.617, 233, 227, 
506, 5lf3R, 0.9553, 0.61, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
507, 5lexR, 0.9553, 0.60, 0.617, 234, 227, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
508, 5mpcE, 0.9552, 0.61, 0.617, 233, 227, 
509, 5lezD, 0.9552, 0.61, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
510, 5lf0R, 0.9551, 1.31, 1.000, 242, 235, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
511, 5gjrW, 0.9550, 0.61, 0.617, 233, 227, 
512, 5lexD, 0.9549, 0.62, 0.617, 233, 227, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
513, 5gjqF, 0.9548, 0.61, 0.617, 234, 227, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
514, 5lf6D, 0.9546, 0.62, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
515, 5le5D, 0.9546, 0.62, 0.617, 234, 227, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
516, 5leyD, 0.9545, 0.63, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
517, 5lf4D, 0.9544, 0.63, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
518, 5lf1D, 0.9544, 0.64, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
519, 5lf7D, 0.9543, 0.64, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
520, 5lf0D, 0.9543, 0.64, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
521, 5wviH, 0.9542, 0.64, 0.617, 233, 227, 
522, 5gjql, 0.9542, 0.64, 0.617, 233, 227, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
523, 4r67u, 0.9542, 1.29, 0.979, 243, 235, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
524, 4r67S, 0.9542, 0.64, 0.617, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
525, 4r67g, 0.9542, 0.64, 0.617, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
526, 4r67E, 0.9542, 0.64, 0.617, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
527, 5lf3D, 0.9541, 0.64, 0.617, 234, 227, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
528, 4r3oS, 0.9536, 0.64, 0.617, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME
529, 4r3oE, 0.9536, 0.65, 0.617, 233, 227, HUMAN CONSTITUTIVE 20S PROTEASOME
530, 5mpbS, 0.9535, 0.65, 0.617, 234, 227, 
531, 3unbf, 0.9535, 0.65, 0.617, 234, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
532, 3unbD, 0.9535, 1.32, 0.996, 242, 235, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
533, 1iruS, 0.9532, 0.66, 0.617, 233, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
534, 1iruE, 0.9532, 0.66, 0.617, 233, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
535, 4cr4E, 0.9531, 0.67, 0.617, 234, 227, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
536, 3unbR, 0.9531, 0.67, 0.617, 234, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
537, 6avoM, 0.9529, 1.31, 1.000, 243, 235, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
538, 6avoH, 0.9529, 0.67, 0.617, 233, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
539, 5wviBA, 0.9527, 0.68, 0.617, 233, 227, 
540, 3unbt, 0.9524, 0.68, 0.617, 233, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
541, 5l4gS, 0.9519, 1.31, 0.991, 243, 235, 
542, 5l4gE, 0.9508, 0.69, 0.617, 233, 227, 
543, 3uneR, 0.9492, 0.70, 0.617, 234, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
544, 3uneD, 0.9490, 0.72, 0.617, 234, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
545, 3unfR, 0.9485, 0.76, 0.617, 233, 227, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
546, 3unfD, 0.9485, 0.77, 0.617, 233, 227, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
547, 3unhR, 0.9482, 0.78, 0.617, 233, 227, MOUSE 20S IMMUNOPROTEASOME
548, 3unhD, 0.9482, 0.78, 0.617, 233, 227, MOUSE 20S IMMUNOPROTEASOME
549, 3unet, 0.9482, 0.79, 0.617, 233, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
550, 3unef, 0.9472, 0.79, 0.617, 233, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
551, 5mpcS, 0.9449, 0.79, 0.617, 233, 227, 
552, 5a5bE, 0.9401, 0.81, 0.617, 233, 227, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
553, 4cr3E, 0.9401, 1.45, 1.000, 242, 235, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
554, 3unfP, 0.9377, 1.57, 1.000, 243, 235, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
555, 3unfB, 0.9377, 1.57, 1.000, 243, 235, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
556, 5le5B, 0.9376, 1.73, 0.345, 248, 235, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
557, 5lf7B, 0.9375, 1.73, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
558, 5lf4B, 0.9373, 1.74, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
559, 3unhP, 0.9373, 1.74, 0.345, 248, 235, MOUSE 20S IMMUNOPROTEASOME
560, 3unhB, 0.9373, 1.75, 0.345, 248, 235, MOUSE 20S IMMUNOPROTEASOME
561, 5m32R, 0.9372, 1.74, 0.345, 248, 235, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
562, 5m32D, 0.9372, 1.74, 0.345, 248, 235, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
563, 5lf3B, 0.9368, 0.95, 0.562, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
564, 5leyB, 0.9368, 0.95, 0.562, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
565, 5lf1B, 0.9366, 1.75, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
566, 5lezB, 0.9366, 1.75, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
567, 5lexB, 0.9364, 1.76, 0.345, 248, 235, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
568, 3unbd, 0.9364, 1.76, 0.345, 248, 235, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
569, 5lf0B, 0.9362, 1.76, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
570, 5lf6B, 0.9361, 1.76, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
571, 5le5P, 0.9359, 1.76, 0.345, 248, 235, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
572, 3unbB, 0.9356, 1.76, 0.345, 248, 235, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
573, 5gjqD, 0.9353, 1.78, 0.345, 247, 235, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
574, 4r3oQ, 0.9350, 1.77, 0.345, 248, 235, HUMAN CONSTITUTIVE 20S PROTEASOME
575, 4r3oC, 0.9350, 1.76, 0.340, 250, 235, HUMAN CONSTITUTIVE 20S PROTEASOME
576, 4r67s, 0.9347, 1.79, 0.345, 250, 235, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
577, 4r67Q, 0.9347, 1.79, 0.345, 250, 235, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
578, 4r67e, 0.9347, 1.79, 0.345, 250, 235, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
579, 4r67C, 0.9347, 1.79, 0.345, 250, 235, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
580, 5lezP, 0.9346, 1.79, 0.345, 250, 235, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
581, 5lf7P, 0.9343, 1.79, 0.345, 250, 235, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
582, 5lf4P, 0.9342, 1.81, 0.345, 247, 235, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
583, 5lf1P, 0.9342, 1.80, 0.345, 247, 235, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
584, 3unbP, 0.9340, 1.81, 0.345, 248, 235, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
585, 5lf6P, 0.9339, 1.81, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
586, 3uneP, 0.9339, 1.79, 0.345, 248, 235, MOUSE CONSTITUTIVE 20S PROTEASOME
587, 3unbr, 0.9338, 1.81, 0.345, 248, 235, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
588, 5lf0P, 0.9337, 1.77, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
589, 5lf3P, 0.9336, 1.80, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
590, 5leyP, 0.9336, 1.82, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
591, 5lexP, 0.9334, 1.81, 0.345, 248, 235, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
592, 1iruQ, 0.9331, 1.82, 0.345, 247, 235, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
593, 3uner, 0.9330, 1.82, 0.345, 247, 235, MOUSE CONSTITUTIVE 20S PROTEASOME
594, 1iruC, 0.9330, 1.79, 0.340, 250, 235, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
595, 5gjqj, 0.9319, 1.80, 0.345, 248, 235, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
596, 3uned, 0.9318, 1.79, 0.340, 250, 235, MOUSE CONSTITUTIVE 20S PROTEASOME
597, 3uneB, 0.9313, 1.81, 0.345, 250, 235, MOUSE CONSTITUTIVE 20S PROTEASOME
598, 5vfsE, 0.9287, 1.81, 0.340, 248, 235, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
599, 4intP, 0.9284, 1.82, 0.345, 248, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
600, 4intB, 0.9282, 1.33, 0.612, 228, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
601, 4r02P, 0.9281, 1.84, 0.316, 238, 228, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
602, 4q1sP, 0.9281, 1.72, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
603, 4lqiP, 0.9278, 1.72, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
604, 4inrP, 0.9278, 1.72, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
605, 1g65P, 0.9278, 1.73, 0.359, 244, 231, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
606, 5vfsDA, 0.9277, 1.73, 0.359, 244, 231, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
607, 4lqiB, 0.9277, 1.72, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
608, 4inrB, 0.9276, 1.73, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
609, 1g65B, 0.9276, 1.34, 0.612, 228, 227, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
610, 4fzcP, 0.9275, 1.73, 0.359, 244, 231, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
611, 5t0cW, 0.9274, 1.72, 0.359, 244, 231, 
612, 5t0cCB, 0.9274, 1.74, 0.359, 244, 231, 
613, 4fzcB, 0.9274, 1.74, 0.359, 244, 231, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
614, 5vftK, 0.9273, 1.43, 0.612, 228, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
615, 4jsuP, 0.9273, 1.43, 0.612, 228, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
616, 4jsuB, 0.9273, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
617, 4jsqP, 0.9273, 1.40, 0.612, 228, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
618, 4inuP, 0.9273, 1.73, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
619, 3wxrQ, 0.9273, 1.73, 0.359, 244, 231, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
620, 3tddP, 0.9273, 1.73, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
621, 2gplP, 0.9273, 1.73, 0.359, 244, 231, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
622, 4jsqB, 0.9272, 1.77, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
623, 3nzjP, 0.9272, 1.73, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
624, 2gplB, 0.9272, 1.73, 0.359, 244, 231, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
625, 5lajP, 0.9271, 1.73, 0.359, 244, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
626, 4hnpP, 0.9271, 1.73, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
627, 4gk7P, 0.9271, 1.73, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
628, 3tddB, 0.9271, 1.73, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
629, 3hyeP, 0.9271, 1.77, 0.359, 244, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
630, 5lajB, 0.9270, 1.73, 0.359, 244, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
631, 4inuB, 0.9270, 1.73, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
632, 3nzwP, 0.9270, 1.73, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
633, 3nzjB, 0.9270, 1.73, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
634, 3hyeB, 0.9270, 1.73, 0.359, 244, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
635, 4gk7B, 0.9269, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
636, 3nzwB, 0.9269, 1.73, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
637, 5vfuV, 0.9268, 1.74, 0.359, 244, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
638, 4r18P, 0.9268, 1.73, 0.359, 244, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
639, 4nnwP, 0.9268, 1.74, 0.359, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
640, 4nnwB, 0.9268, 1.41, 0.612, 228, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
641, 4j70P, 0.9268, 1.73, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
642, 4fzgP, 0.9268, 1.74, 0.359, 244, 231, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
643, 4fzgB, 0.9268, 1.74, 0.359, 244, 231, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
644, 3e47P, 0.9268, 1.76, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
645, 4r18B, 0.9267, 1.74, 0.359, 244, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
646, 4hnpB, 0.9267, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
647, 3shjP, 0.9267, 1.74, 0.359, 244, 231, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
648, 3e47B, 0.9267, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
649, 1rypQ, 0.9267, 1.75, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
650, 4y9zP, 0.9266, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
651, 4y8iP, 0.9266, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
652, 4no9P, 0.9266, 1.74, 0.359, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
653, 4no9B, 0.9266, 1.74, 0.359, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
654, 4ltcP, 0.9266, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
655, 3shjB, 0.9266, 1.75, 0.359, 244, 231, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
656, 4y9zB, 0.9265, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
657, 4y8sP, 0.9265, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
658, 4y8sB, 0.9265, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
659, 4y8jP, 0.9265, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
660, 4y8jB, 0.9265, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
661, 4y8iB, 0.9265, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
662, 4y84P, 0.9265, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
663, 4y7yP, 0.9265, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
664, 4y7yB, 0.9265, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
665, 4qz6P, 0.9265, 1.74, 0.359, 244, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
666, 4qz6B, 0.9265, 1.74, 0.359, 244, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
667, 4qz5P, 0.9265, 1.74, 0.359, 244, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
668, 4eu2Q, 0.9265, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
669, 3dy4P, 0.9265, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
670, 3d29P, 0.9265, 1.74, 0.359, 244, 231, PROTEASOME INHIBITION BY FELLUTAMIDE B
671, 2fakP, 0.9265, 1.75, 0.359, 244, 231, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
672, 2fakB, 0.9265, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
673, 5cz8P, 0.9264, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
674, 5cz8B, 0.9264, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
675, 4y8lP, 0.9264, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
676, 4y8lB, 0.9264, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
677, 4y8hP, 0.9264, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
678, 4y8gP, 0.9264, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
679, 4y84B, 0.9264, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
680, 4y7wP, 0.9264, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
681, 4y70P, 0.9264, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
682, 4y70B, 0.9264, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
683, 4qzxP, 0.9264, 1.74, 0.359, 244, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
684, 4qz5B, 0.9264, 1.74, 0.359, 244, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
685, 4qz4P, 0.9264, 1.74, 0.359, 244, 231, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
686, 4qz4B, 0.9264, 1.74, 0.359, 244, 231, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
687, 4qz2P, 0.9264, 1.74, 0.359, 244, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
688, 4qz2B, 0.9264, 1.74, 0.359, 244, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
689, 4qw6P, 0.9264, 1.74, 0.359, 244, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
690, 4qlsP, 0.9264, 1.74, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
691, 4j70B, 0.9264, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
692, 4hrdP, 0.9264, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
693, 4hrcB, 0.9264, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
694, 3un4P, 0.9264, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
695, 3un4B, 0.9264, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
696, 3gpwP, 0.9264, 1.77, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
697, 3dy4B, 0.9264, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
698, 3dy3P, 0.9264, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
699, 3dy3B, 0.9264, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
700, 3d29B, 0.9264, 1.74, 0.359, 244, 231, PROTEASOME INHIBITION BY FELLUTAMIDE B
701, 5jhrP, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
702, 5fgfP, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
703, 5cgiP, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
704, 5cgiB, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
705, 5cgfP, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT
706, 4z1lP, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
707, 4ya9P, 0.9263, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
708, 4ya9B, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
709, 4ya7P, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
710, 4y8hB, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
711, 4y8gB, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
712, 4y80P, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
713, 4y80B, 0.9263, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
714, 4y7wB, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
715, 4qzxB, 0.9263, 1.74, 0.359, 244, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
716, 4qz0P, 0.9263, 1.74, 0.359, 244, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
717, 4qxjP, 0.9263, 1.74, 0.359, 244, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
718, 4qxjB, 0.9263, 1.74, 0.359, 244, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
719, 4qwfP, 0.9263, 1.75, 0.359, 244, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
720, 4qw7P, 0.9263, 1.74, 0.359, 244, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
721, 4qw7B, 0.9263, 1.74, 0.359, 244, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
722, 4qw6B, 0.9263, 1.74, 0.359, 244, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
723, 4qlsB, 0.9263, 1.74, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
724, 4qlqP, 0.9263, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
725, 4qlqB, 0.9263, 1.74, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
726, 4jt0P, 0.9263, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
727, 4jt0B, 0.9263, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
728, 3nzxP, 0.9263, 1.75, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
729, 3gpwB, 0.9263, 1.75, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
730, 2f16P, 0.9263, 1.75, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
731, 5jhsP, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
732, 5jhrB, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
733, 5fgfB, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
734, 5fgaP, 0.9262, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
735, 5cgfB, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT
736, 4z1lB, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
737, 4ya7B, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
738, 4y8pP, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
739, 4y78P, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
740, 4y78B, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
741, 4qzwP, 0.9262, 1.75, 0.359, 244, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
742, 4qzwB, 0.9262, 1.74, 0.359, 244, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
743, 4qz3P, 0.9262, 1.74, 0.359, 244, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
744, 4qz3B, 0.9262, 1.74, 0.359, 244, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
745, 4qz0B, 0.9262, 1.75, 0.359, 244, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
746, 4qwrP, 0.9262, 1.75, 0.359, 244, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
747, 4qwiP, 0.9262, 1.75, 0.359, 244, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
748, 4qwiB, 0.9262, 1.75, 0.359, 244, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
749, 4qwfB, 0.9262, 1.75, 0.359, 244, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
750, 4qw4P, 0.9262, 1.74, 0.359, 244, 231, YCP IN COMPLEX WITH CARFILZOMIB
751, 4qw4B, 0.9262, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH CARFILZOMIB
752, 4nnnP, 0.9262, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH MG132
753, 4nnnB, 0.9262, 1.74, 0.359, 244, 231, YCP IN COMPLEX WITH MG132
754, 3un8P, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
755, 3nzxB, 0.9262, 1.75, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
756, 2f16B, 0.9262, 1.75, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
757, 5lttP, 0.9261, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
758, 5l52P, 0.9261, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
759, 5l52B, 0.9261, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
760, 5jhsB, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
761, 5fgaB, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
762, 5d0vP, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
763, 5d0vB, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
764, 4y8uP, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
765, 4y8uB, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
766, 4y8pB, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
767, 4y8kP, 0.9261, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
768, 4y7xP, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
769, 4y7xB, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
770, 4y74P, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
771, 4y74B, 0.9261, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
772, 4y69P, 0.9261, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
773, 4qwxP, 0.9261, 1.74, 0.359, 244, 231, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
774, 4qwxB, 0.9261, 1.74, 0.359, 244, 231, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
775, 4qwrB, 0.9261, 1.74, 0.359, 244, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
776, 4qwjP, 0.9261, 1.75, 0.359, 244, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
777, 4qwjB, 0.9261, 1.75, 0.359, 244, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
778, 4qw5P, 0.9261, 1.75, 0.359, 244, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
779, 4qw5B, 0.9261, 1.75, 0.359, 244, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
780, 4hrcP, 0.9261, 1.75, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
781, 3okjP, 0.9261, 1.75, 0.359, 244, 231, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
782, 3okjB, 0.9261, 1.75, 0.359, 244, 231, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
783, 3bdmP, 0.9261, 1.61, 0.361, 244, 230, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
784, 3bdmB, 0.9261, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
785, 5lttB, 0.9260, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
786, 5l5tP, 0.9260, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
787, 5l5sP, 0.9260, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
788, 5fhsP, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
789, 5fgdP, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
790, 5fgdB, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
791, 5dkjP, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
792, 5dkjB, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
793, 5dkiP, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
794, 5d0zP, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
795, 5d0tP, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
796, 5cz9P, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
797, 5cz9B, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
798, 4ya0P, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
799, 4ya0B, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
800, 4y9yP, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT
801, 4y9yB, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT
802, 4y8qP, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
803, 4y8oP, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
804, 4y8kB, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
805, 4y77P, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
806, 4y77B, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
807, 4y6vP, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
808, 4y69B, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
809, 4qz1P, 0.9260, 1.75, 0.359, 244, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
810, 4qz1B, 0.9260, 1.75, 0.359, 244, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
811, 4qwlP, 0.9260, 1.74, 0.359, 244, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
812, 4qwlB, 0.9260, 1.75, 0.359, 244, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
813, 4qwkP, 0.9260, 1.75, 0.359, 244, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
814, 3mg0P, 0.9260, 1.75, 0.359, 244, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
815, 3gptP, 0.9260, 1.75, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
816, 2zcyP, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
817, 2zcyB, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
818, 5l68P, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
819, 5l60P, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
820, 5l60B, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
821, 5l5tB, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
822, 5l5sB, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
823, 5l5iP, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
824, 5l5iB, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
825, 5l5eP, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
826, 5l5eB, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
827, 5fhsB, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
828, 5fgiP, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
829, 5fgeP, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
830, 5fg9P, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
831, 5fg9B, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
832, 5dkiB, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
833, 5d0zB, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
834, 5d0xP, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
835, 5d0tB, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
836, 5cz7P, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
837, 5cz5P, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
838, 5bxlP, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT
839, 5bxlB, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT
840, 5bouP, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
841, 4ya5P, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
842, 4ya5B, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
843, 4y8tP, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
844, 4y8tB, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
845, 4y8qB, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
846, 4y8oB, 0.9259, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
847, 4y82P, 0.9259, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
848, 4y6vB, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
849, 4x6zQ, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
850, 4rurP, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
851, 4rurB, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
852, 4qz7P, 0.9259, 1.74, 0.359, 244, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
853, 4qwkB, 0.9259, 1.75, 0.359, 244, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
854, 4qw0P, 0.9259, 1.75, 0.359, 244, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
855, 4qw0B, 0.9259, 1.75, 0.359, 244, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
856, 4qvwP, 0.9259, 1.75, 0.359, 244, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
857, 4qvvP, 0.9259, 1.75, 0.359, 244, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
858, 4quxP, 0.9259, 1.75, 0.359, 244, 231, YCP BETA5-A49T-MUTANT
859, 3mg4P, 0.9259, 1.75, 0.359, 244, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
860, 3gptB, 0.9259, 1.75, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
861, 5l68B, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
862, 5l65P, 0.9258, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
863, 5l65B, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
864, 5l5xP, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
865, 5l5xB, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
866, 5l5jP, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
867, 5l5jB, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
868, 5l55P, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
869, 5l55B, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
870, 5l54P, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
871, 5l54B, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
872, 5fgiB, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
873, 5fggP, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
874, 5fggB, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
875, 5fgeB, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
876, 5fg7P, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
877, 5fg7B, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
878, 5d0xB, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
879, 5d0sP, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
880, 5cz7B, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
881, 5cz6P, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
882, 5cz5B, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
883, 5cz4P, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
884, 5cz4B, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
885, 5cggP, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
886, 5bouB, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
887, 4ya3P, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
888, 4ya3B, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
889, 4ya2P, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
890, 4ya1P, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT
891, 4y8nP, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
892, 4y8nB, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
893, 4y82B, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
894, 4y81P, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
895, 4y75P, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
896, 4r17P, 0.9258, 1.75, 0.359, 244, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
897, 4r00P, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
898, 4qz7B, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
899, 4qwuP, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
900, 4qwuB, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
901, 4qw1P, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
902, 4qvyP, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
903, 4qvyB, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
904, 4qvwB, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
905, 4qvvB, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
906, 4qvqP, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
907, 4qvqB, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
908, 4qvpP, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
909, 4qvpB, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
910, 4qv7P, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-A50V MUTANT
911, 4quxB, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-A49T-MUTANT
912, 4qltP, 0.9258, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
913, 5laiP, 0.9257, 1.75, 0.359, 244, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
914, 5laiB, 0.9257, 1.75, 0.359, 244, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
915, 5l5zP, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
916, 5l5zB, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
917, 5l5yP, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
918, 5l5yB, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
919, 5l5vP, 0.9257, 1.75, 0.359, 244, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
920, 5l5vB, 0.9257, 1.75, 0.359, 244, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
921, 5l5qP, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
922, 5l5qB, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
923, 5l5oP, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
924, 5l5hP, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
925, 5l5hB, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
926, 5fghP, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
927, 5d0sB, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
928, 5czaP, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT
929, 5cz6B, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
930, 5cggB, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
931, 4ya4P, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT
932, 4ya2B, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
933, 4ya1B, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT
934, 4y8rP, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT
935, 4y8rB, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT
936, 4y8mP, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
937, 4y8mB, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
938, 4y81B, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
939, 4y75B, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
940, 4y6zP, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
941, 4y6zB, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
942, 4y6aP, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
943, 4y6aB, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
944, 4r17B, 0.9257, 1.75, 0.359, 244, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
945, 4r00B, 0.9257, 1.75, 0.359, 244, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
946, 4qw1B, 0.9257, 1.75, 0.359, 244, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
947, 4qvmP, 0.9257, 1.75, 0.359, 244, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
948, 4qvlP, 0.9257, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH BORTEZOMIB
949, 4qv8P, 0.9257, 1.75, 0.359, 244, 231, YCP BETA5-C52F MUTANT
950, 4qv8B, 0.9257, 1.75, 0.359, 244, 231, YCP BETA5-C52F MUTANT
951, 4qv7B, 0.9257, 1.75, 0.359, 244, 231, YCP BETA5-A50V MUTANT
952, 4qv0P, 0.9257, 1.75, 0.359, 244, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
953, 4qluP, 0.9257, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
954, 4qltB, 0.9257, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
955, 5l6bP, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
956, 5l6bB, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
957, 5l67P, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
958, 5l67B, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
959, 5l5oB, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
960, 5l5fP, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
961, 5l5fB, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
962, 5l5aP, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
963, 5fghB, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
964, 5d0wP, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT
965, 5czaB, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT
966, 4ya4B, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT
967, 4qzzP, 0.9256, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH OMURALIDE
968, 4qwsP, 0.9256, 1.75, 0.359, 244, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
969, 4qwsB, 0.9256, 1.75, 0.359, 244, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
970, 4qvmB, 0.9256, 1.75, 0.359, 244, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
971, 4qvlB, 0.9256, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH BORTEZOMIB
972, 4qv3P, 0.9256, 1.75, 0.359, 244, 231, YCP BETA5-M45V MUTANT
973, 4qv3B, 0.9256, 1.75, 0.359, 244, 231, YCP BETA5-M45V MUTANT
974, 4qv0B, 0.9256, 1.75, 0.359, 244, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
975, 4quyP, 0.9256, 1.75, 0.359, 244, 231, YCP BETA5-A49S-MUTANT
976, 4qluB, 0.9256, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
977, 6gopP, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
978, 6gopB, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
979, 5vftk, 0.9255, 1.75, 0.359, 244, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
980, 5l6cP, 0.9255, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
981, 5l6cB, 0.9255, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
982, 5l69P, 0.9255, 1.46, 0.612, 228, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
983, 5l69B, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
984, 5l64P, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
985, 5l64B, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
986, 5l63P, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
987, 5l63B, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
988, 5l62P, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
989, 5l62B, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
990, 5l5uP, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
991, 5l5pP, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
992, 5l5pB, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
993, 5l5dP, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
994, 5l5aB, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
995, 5d0wB, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT
996, 5cghP, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
997, 5cghB, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
998, 4qzzB, 0.9255, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH OMURALIDE
999, 4qvnP, 0.9255, 1.75, 0.359, 244, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1000, 4qv9P, 0.9255, 1.75, 0.359, 244, 231, YCP BETA5-C63F MUTANT
1001, 4quyB, 0.9255, 1.75, 0.359, 244, 231, YCP BETA5-A49S-MUTANT
1002, 4no6P, 0.9255, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1003, 4no6B, 0.9255, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1004, 3un8B, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1005, 5l66P, 0.9254, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1006, 5l66B, 0.9254, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1007, 5l61P, 0.9254, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1008, 5l5wP, 0.9254, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1009, 5l5wB, 0.9254, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1010, 5l5uB, 0.9254, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1011, 5l5dB, 0.9254, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1012, 4qvnB, 0.9254, 1.75, 0.359, 244, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1013, 4qv9B, 0.9254, 1.75, 0.359, 244, 231, YCP BETA5-C63F MUTANT
1014, 4qv4P, 0.9254, 1.75, 0.359, 244, 231, YCP BETA5-M45T MUTANT
1015, 5m2bP, 0.9253, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1016, 5m2bB, 0.9253, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1017, 5l61B, 0.9253, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1018, 5ahjP, 0.9253, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1019, 5ahjB, 0.9253, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1020, 4qw3P, 0.9253, 1.75, 0.359, 244, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1021, 4qw3B, 0.9253, 1.76, 0.359, 244, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1022, 4qv5P, 0.9253, 1.76, 0.359, 244, 231, YCP BETA5-M45I MUTANT
1023, 4qv4B, 0.9253, 1.76, 0.359, 244, 231, YCP BETA5-M45T MUTANT
1024, 4qv1P, 0.9253, 1.76, 0.359, 244, 231, YCP BETA5-M45A MUTANT
1025, 4qv1B, 0.9253, 1.75, 0.359, 244, 231, YCP BETA5-M45A MUTANT
1026, 4hrdB, 0.9253, 1.75, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1027, 4qv5B, 0.9252, 1.75, 0.359, 244, 231, YCP BETA5-M45I MUTANT
1028, 5bxnP, 0.9251, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1029, 5bxnB, 0.9251, 1.77, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1030, 4qwgP, 0.9251, 1.75, 0.359, 244, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1031, 4qwgB, 0.9251, 1.76, 0.359, 244, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1032, 4qv6P, 0.9251, 1.76, 0.359, 244, 231, YCP BETA5-A49V MUTANT
1033, 4ltcB, 0.9251, 1.75, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1034, 3gpjP, 0.9251, 1.75, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1035, 3gpjB, 0.9251, 1.76, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1036, 1rypC, 0.9251, 1.77, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1037, 5l6aP, 0.9250, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1038, 5l6aB, 0.9250, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1039, 5l5rP, 0.9250, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1040, 5l5bP, 0.9250, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1041, 5l5bB, 0.9250, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1042, 4r02B, 0.9250, 1.76, 0.359, 244, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1043, 4qv6B, 0.9250, 1.76, 0.359, 244, 231, YCP BETA5-A49V MUTANT
1044, 4q1sB, 0.9250, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1045, 5l5rB, 0.9249, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1046, 4zzgQ, 0.9249, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1047, 3wxrC, 0.9249, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1048, 3mg0B, 0.9249, 1.76, 0.359, 244, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1049, 5nifQ, 0.9248, 1.77, 0.359, 242, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1050, 4qlvP, 0.9247, 1.75, 0.351, 242, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1051, 4no8P, 0.9247, 1.76, 0.359, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1052, 4zzgC, 0.9246, 1.77, 0.359, 242, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1053, 4qlvB, 0.9246, 1.77, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1054, 4no8B, 0.9246, 1.76, 0.359, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1055, 4no1P, 0.9246, 1.77, 0.359, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1056, 4qbyP, 0.9245, 1.77, 0.359, 244, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1057, 4no1B, 0.9245, 1.76, 0.359, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1058, 5nifC, 0.9244, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1059, 4x6zC, 0.9244, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1060, 4qbyB, 0.9244, 1.76, 0.359, 244, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1061, 4eu2C, 0.9243, 1.78, 0.359, 241, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1062, 5vfuJA, 0.9236, 1.76, 0.359, 244, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1063, 1jd2W, 0.9236, 1.77, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1064, 1jd2B, 0.9235, 1.77, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1065, 3mg4B, 0.9234, 1.51, 0.612, 228, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1066, 5mp9c, 0.9221, 1.77, 0.359, 244, 231, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1067, 3jcpLA, 0.9220, 1.77, 0.359, 244, 231, 
1068, 3jcpL, 0.9220, 1.78, 0.359, 244, 231, 
1069, 1g0uA, 0.9213, 1.75, 0.359, 244, 231, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1070, 5mp9C, 0.9212, 1.80, 0.359, 244, 231, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1071, 1g0uO, 0.9212, 1.80, 0.359, 244, 231, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1072, 1j2qB, 0.9204, 1.80, 0.359, 244, 231, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1073, 1jd2V, 0.9202, 1.54, 0.330, 246, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1074, 1rypP, 0.9201, 1.76, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1075, 3sdiO, 0.9200, 1.55, 0.330, 246, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1076, 1z7qQ, 0.9200, 1.83, 0.411, 237, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1077, 1z7qC, 0.9200, 1.56, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1078, 1j2qF, 0.9199, 1.57, 0.330, 250, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1079, 1j2qD, 0.9199, 1.56, 0.330, 246, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1080, 5mpac, 0.9198, 1.74, 0.361, 243, 230, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1081, 1j2qG, 0.9198, 1.74, 0.361, 243, 230, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1082, 1rypB, 0.9197, 1.84, 0.411, 237, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1083, 1j2qE, 0.9196, 1.84, 0.411, 237, 231, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1084, 1j2qA, 0.9196, 1.78, 0.359, 244, 231, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1085, 3mg7O, 0.9195, 1.84, 0.411, 237, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1086, 1j2qC, 0.9195, 1.57, 0.330, 250, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1087, 1g65O, 0.9194, 1.85, 0.411, 237, 231, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1088, 3oeuO, 0.9193, 1.84, 0.411, 237, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1089, 5mpaC, 0.9192, 1.57, 0.330, 250, 227, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1090, 3sdkO, 0.9192, 1.85, 0.411, 237, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1091, 3mg8O, 0.9192, 1.57, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1092, 1jd2A, 0.9192, 1.57, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1093, 4intO, 0.9191, 1.81, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1094, 3e47O, 0.9191, 1.57, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1095, 2gplO, 0.9191, 1.57, 0.330, 250, 227, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1096, 1g65A, 0.9191, 1.57, 0.330, 250, 227, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1097, 5vfok, 0.9190, 1.57, 0.330, 250, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1098, 4qv5O, 0.9190, 1.58, 0.330, 250, 227, YCP BETA5-M45I MUTANT
1099, 4qv5A, 0.9190, 1.58, 0.330, 250, 227, YCP BETA5-M45I MUTANT
1100, 3mg4O, 0.9190, 1.58, 0.330, 250, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1101, 3e47A, 0.9190, 1.56, 0.608, 228, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1102, 2gplA, 0.9190, 1.58, 0.330, 250, 227, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1103, 3mg0O, 0.9189, 1.58, 0.330, 250, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1104, 3jcoLA, 0.9189, 1.58, 0.330, 250, 227, 
1105, 3jcoL, 0.9189, 1.58, 0.330, 250, 227, 
1106, 5vfpCA, 0.9188, 1.58, 0.330, 250, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1107, 3wxrP, 0.9188, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1108, 4inuO, 0.9187, 1.84, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1109, 4intA, 0.9187, 1.84, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1110, 4inrO, 0.9187, 1.84, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1111, 2f16O, 0.9187, 1.49, 0.606, 228, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1112, 5l5rO, 0.9186, 1.58, 0.330, 249, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1113, 5l5rA, 0.9186, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1114, 4qv3O, 0.9186, 1.58, 0.330, 250, 227, YCP BETA5-M45V MUTANT
1115, 4jsqO, 0.9186, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1116, 4jsqA, 0.9186, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1117, 4fzcO, 0.9186, 1.59, 0.330, 250, 227, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1118, 4fzcA, 0.9186, 1.59, 0.330, 250, 227, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1119, 3oevO, 0.9186, 1.59, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1120, 2fakO, 0.9186, 1.58, 0.330, 250, 227, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1121, 2f16A, 0.9186, 1.58, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1122, 5l5bO, 0.9185, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1123, 5l5bA, 0.9185, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1124, 4qv4O, 0.9185, 1.58, 0.330, 250, 227, YCP BETA5-M45T MUTANT
1125, 4qv3A, 0.9185, 1.59, 0.330, 250, 227, YCP BETA5-M45V MUTANT
1126, 4inuA, 0.9185, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1127, 4hnpO, 0.9185, 1.59, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1128, 3un4O, 0.9185, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1129, 3un4A, 0.9185, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1130, 3sdiA, 0.9185, 1.59, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1131, 3mg6A, 0.9185, 1.58, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1132, 2fakA, 0.9185, 1.59, 0.330, 250, 227, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1133, 5vfrk, 0.9184, 1.59, 0.330, 250, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1134, 4qv4A, 0.9184, 1.59, 0.330, 250, 227, YCP BETA5-M45T MUTANT
1135, 4ltcO, 0.9184, 1.58, 0.330, 246, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1136, 4inrA, 0.9184, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1137, 3un8O, 0.9184, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1138, 3mg7A, 0.9184, 1.49, 0.606, 228, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1139, 3mg6O, 0.9184, 1.59, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1140, 5t0gK, 0.9183, 1.59, 0.330, 250, 227, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1141, 5l6aO, 0.9183, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1142, 5l6aA, 0.9183, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1143, 5d0wO, 0.9183, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1144, 5d0wA, 0.9183, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1145, 5ahjO, 0.9183, 1.55, 0.612, 228, 227, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1146, 5ahjA, 0.9183, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1147, 4qv1O, 0.9183, 1.59, 0.330, 250, 227, YCP BETA5-M45A MUTANT
1148, 4qv1A, 0.9183, 1.59, 0.330, 250, 227, YCP BETA5-M45A MUTANT
1149, 4no1O, 0.9183, 1.59, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1150, 4no1A, 0.9183, 1.59, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1151, 3okjO, 0.9183, 1.59, 0.330, 250, 227, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1152, 1fntC, 0.9183, 1.59, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1153, 6gopO, 0.9182, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1154, 6gopA, 0.9182, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1155, 5l5uO, 0.9182, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1156, 5l5uA, 0.9182, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1157, 5l55O, 0.9182, 1.75, 0.361, 241, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1158, 5fggO, 0.9182, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1159, 5fggA, 0.9182, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1160, 4qv9O, 0.9182, 1.59, 0.330, 250, 227, YCP BETA5-C63F MUTANT
1161, 4qv9A, 0.9182, 1.59, 0.330, 250, 227, YCP BETA5-C63F MUTANT
1162, 4qv0O, 0.9182, 1.59, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1163, 4qv0A, 0.9182, 1.59, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1164, 4quyO, 0.9182, 1.59, 0.330, 250, 227, YCP BETA5-A49S-MUTANT
1165, 4quyA, 0.9182, 1.59, 0.330, 250, 227, YCP BETA5-A49S-MUTANT
1166, 4jsuO, 0.9182, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1167, 4jsuA, 0.9182, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1168, 3wxrB, 0.9182, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1169, 3sdkA, 0.9182, 1.59, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1170, 3okjA, 0.9182, 1.59, 0.330, 250, 227, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1171, 3mg8A, 0.9182, 1.59, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1172, 1fntQ, 0.9182, 1.59, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1173, 5l5dO, 0.9181, 1.60, 0.330, 249, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1174, 5l5dA, 0.9181, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1175, 5l55A, 0.9181, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1176, 5bxnO, 0.9181, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1177, 5bxnA, 0.9181, 1.75, 0.361, 241, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1178, 4zzgB, 0.9181, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1179, 4ya4O, 0.9181, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1180, 4ya4A, 0.9181, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1181, 4y8sO, 0.9181, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1182, 4y8sA, 0.9181, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1183, 4qv7O, 0.9181, 1.60, 0.330, 250, 227, YCP BETA5-A50V MUTANT
1184, 4no8O, 0.9181, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1185, 4no8A, 0.9181, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1186, 4fzgO, 0.9181, 1.59, 0.330, 250, 227, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1187, 3shjO, 0.9181, 1.59, 0.330, 250, 227, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1188, 3shjA, 0.9181, 1.60, 0.330, 250, 227, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1189, 3oevA, 0.9181, 1.59, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1190, 3oeuA, 0.9181, 1.59, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1191, 3hyeO, 0.9181, 1.59, 0.330, 250, 227, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1192, 5l5hO, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1193, 5l5hA, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1194, 5czaO, 0.9180, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1195, 5czaA, 0.9180, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1196, 5cggO, 0.9180, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1197, 5cggA, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1198, 5bxlO, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1199, 5bxlA, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1200, 4ya9O, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1201, 4ya9A, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1202, 4r02O, 0.9180, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1203, 4qz7O, 0.9180, 1.60, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1204, 4qz7A, 0.9180, 1.60, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1205, 4qz4O, 0.9180, 1.60, 0.330, 250, 227, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1206, 4qz4A, 0.9180, 1.60, 0.330, 250, 227, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1207, 4qvnO, 0.9180, 1.59, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1208, 4qv8O, 0.9180, 1.59, 0.330, 250, 227, YCP BETA5-C52F MUTANT
1209, 4qv8A, 0.9180, 1.59, 0.330, 250, 227, YCP BETA5-C52F MUTANT
1210, 4qv7A, 0.9180, 1.59, 0.330, 250, 227, YCP BETA5-A50V MUTANT
1211, 4qv6O, 0.9180, 1.60, 0.330, 250, 227, YCP BETA5-A49V MUTANT
1212, 4qv6A, 0.9180, 1.60, 0.330, 250, 227, YCP BETA5-A49V MUTANT
1213, 4no6O, 0.9180, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1214, 4jt0O, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1215, 4jt0A, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1216, 4g4sB, 0.9180, 1.60, 0.330, 250, 227, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1217, 4fzgA, 0.9180, 1.60, 0.330, 250, 227, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1218, 3un8A, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1219, 3tddO, 0.9180, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1220, 3mg4A, 0.9180, 1.60, 0.330, 250, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1221, 3hyeA, 0.9180, 1.58, 0.330, 246, 227, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1222, 5l63O, 0.9179, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1223, 5l5wO, 0.9179, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1224, 5l5wA, 0.9179, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1225, 4zzgP, 0.9179, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1226, 4ya1O, 0.9179, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1227, 4ya1A, 0.9179, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1228, 4y8rO, 0.9179, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1229, 4qwuO, 0.9179, 1.60, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1230, 4qvnA, 0.9179, 1.60, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1231, 4qlsO, 0.9179, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1232, 4qlsA, 0.9179, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1233, 4no6A, 0.9179, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1234, 4nnnO, 0.9179, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH MG132
1235, 4nnnA, 0.9179, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH MG132
1236, 4ltcA, 0.9179, 1.59, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1237, 3tddA, 0.9179, 1.59, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1238, 3nzxO, 0.9179, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1239, 3nzxA, 0.9179, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1240, 3nzwO, 0.9179, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1241, 3gptO, 0.9179, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1242, 2zcyO, 0.9179, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1243, 5vfqC, 0.9178, 1.60, 0.330, 250, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1244, 5vfoI, 0.9178, 1.60, 0.330, 250, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1245, 5nifP, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1246, 5nifB, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1247, 5m2bO, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1248, 5m2bA, 0.9178, 1.84, 0.342, 248, 234, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1249, 5l6bO, 0.9178, 2.12, 0.342, 239, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1250, 5l6bA, 0.9178, 1.85, 0.342, 248, 234, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1251, 5l63A, 0.9178, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1252, 5l61O, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1253, 5jhrO, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1254, 5jhrA, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1255, 4ya2O, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1256, 4ya2A, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1257, 4y9yO, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1258, 4y9yA, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1259, 4y8tO, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1260, 4y8tA, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1261, 4y8rA, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1262, 4y8pO, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1263, 4y8pA, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1264, 4y75O, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1265, 4y75A, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1266, 4qz0O, 0.9178, 1.60, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1267, 4qz0A, 0.9178, 1.60, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1268, 4qwuA, 0.9178, 1.60, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1269, 4qluO, 0.9178, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1270, 4qluA, 0.9178, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1271, 4g4sC, 0.9178, 1.60, 0.330, 250, 227, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1272, 3nzwA, 0.9178, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1273, 3gptA, 0.9178, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1274, 2zcyA, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1275, 5vfrI, 0.9177, 1.60, 0.330, 250, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1276, 5l65O, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1277, 5l61A, 0.9177, 1.74, 0.358, 237, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1278, 5l5sO, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1279, 5l5sA, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1280, 5l5pO, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1281, 5l5pA, 0.9177, 1.84, 0.342, 248, 234, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1282, 5l5oO, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1283, 5l5oA, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1284, 5cghO, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1285, 5cghA, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1286, 4ya7O, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1287, 4ya7A, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1288, 4x6zP, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1289, 4qzzO, 0.9177, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH OMURALIDE
1290, 4qzzA, 0.9177, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH OMURALIDE
1291, 4nnwO, 0.9177, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1292, 4nnwA, 0.9177, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1293, 4lqiO, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1294, 4gk7O, 0.9177, 1.60, 0.330, 249, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1295, 4gk7A, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1296, 3dy3O, 0.9177, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1297, 3dy3A, 0.9177, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1298, 5l69O, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1299, 5l69A, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1300, 5l66O, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1301, 5l65A, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1302, 5l64O, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1303, 5l64A, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1304, 5l62O, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1305, 5l5tO, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1306, 5l5tA, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1307, 5l5qO, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1308, 5l5qA, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1309, 5l5aO, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1310, 5l5aA, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1311, 5l52O, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1312, 5l52A, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1313, 4y9zO, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1314, 4y9zA, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1315, 4y8gO, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1316, 4y8gA, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1317, 4qz6O, 0.9176, 1.60, 0.330, 250, 227, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1318, 4qz6A, 0.9176, 1.60, 0.330, 250, 227, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1319, 4qwxO, 0.9176, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1320, 4qwlO, 0.9176, 1.60, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1321, 4qwlA, 0.9176, 1.60, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1322, 4qvlO, 0.9176, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH BORTEZOMIB
1323, 4qvlA, 0.9176, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH BORTEZOMIB
1324, 4qltO, 0.9176, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1325, 4no9O, 0.9176, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1326, 4lqiA, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1327, 4hrcO, 0.9176, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1328, 3nzjO, 0.9176, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1329, 3nzjA, 0.9176, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1330, 3gpwO, 0.9176, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1331, 3gpwA, 0.9176, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1332, 3gpjO, 0.9176, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1333, 3bdmO, 0.9176, 1.59, 0.330, 249, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1334, 5vfqDA, 0.9175, 1.60, 0.330, 250, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1335, 5l6cO, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1336, 5l6cA, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1337, 5l67O, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1338, 5l67A, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1339, 5l66A, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1340, 5l62A, 0.9175, 1.30, 0.609, 228, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1341, 5l5xO, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1342, 5l5jO, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1343, 5l5jA, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1344, 5fgaO, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1345, 5fgaA, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1346, 5d0vO, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1347, 5cz6O, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1348, 5cz6A, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1349, 4y8hO, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1350, 4y8hA, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1351, 4r17O, 0.9175, 1.60, 0.330, 250, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1352, 4qwxA, 0.9175, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1353, 4qw6O, 0.9175, 1.60, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1354, 4qw6A, 0.9175, 1.60, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1355, 4qw1O, 0.9175, 1.60, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1356, 4qw1A, 0.9175, 1.60, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1357, 4qltA, 0.9175, 1.60, 0.330, 249, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1358, 4no9A, 0.9175, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1359, 3mg0A, 0.9175, 1.60, 0.330, 250, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1360, 3gpjA, 0.9175, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1361, 3bdmA, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1362, 5lttO, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1363, 5lttA, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1364, 5l68O, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1365, 5l5xA, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1366, 5l5iO, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1367, 5l5iA, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1368, 5fg7O, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1369, 5fg7A, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1370, 5d0vA, 0.9174, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1371, 5d0sO, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1372, 5d0sA, 0.9174, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1373, 4y8kO, 0.9174, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1374, 4y8kA, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1375, 4y77O, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1376, 4y77A, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1377, 4r18O, 0.9174, 1.60, 0.330, 250, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1378, 4r18A, 0.9174, 1.60, 0.330, 250, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1379, 4r17A, 0.9174, 1.60, 0.330, 250, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1380, 4qz3O, 0.9174, 1.60, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1381, 4qz3A, 0.9174, 1.60, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1382, 4qlqO, 0.9174, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1383, 4qlqA, 0.9174, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1384, 4q1sO, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1385, 3d29O, 0.9174, 1.60, 0.330, 249, 227, PROTEASOME INHIBITION BY FELLUTAMIDE B
1386, 5l68A, 0.9173, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1387, 5l5fO, 0.9173, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1388, 5cgfO, 0.9173, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1389, 5cgfA, 0.9173, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1390, 4r00O, 0.9173, 1.61, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1391, 4r00A, 0.9173, 1.60, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1392, 4qwfO, 0.9173, 1.61, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1393, 4qwfA, 0.9173, 1.61, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1394, 4qvyO, 0.9173, 1.61, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1395, 4qvyA, 0.9173, 1.61, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1396, 4quxO, 0.9173, 1.60, 0.330, 250, 227, YCP BETA5-A49T-MUTANT
1397, 4quxA, 0.9173, 1.60, 0.330, 250, 227, YCP BETA5-A49T-MUTANT
1398, 3dy4O, 0.9173, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1399, 3dy4A, 0.9173, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1400, 3d29A, 0.9173, 1.61, 0.330, 250, 227, PROTEASOME INHIBITION BY FELLUTAMIDE B
1401, 5l5zO, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1402, 5l5zA, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1403, 5l5vO, 0.9172, 1.61, 0.330, 250, 227,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1404, 5l5vA, 0.9172, 1.61, 0.330, 250, 227,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1405, 5l5fA, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1406, 5fg9O, 0.9172, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1407, 5fg9A, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1408, 5d0zO, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1409, 5d0zA, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1410, 5cz9O, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1411, 5cz9A, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1412, 5cgiO, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1413, 5cgiA, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1414, 4y8mO, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1415, 4y8mA, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1416, 4qzwO, 0.9172, 1.61, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1417, 4qzwA, 0.9172, 1.61, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1418, 4qz2O, 0.9172, 1.60, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1419, 4qz2A, 0.9172, 1.60, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1420, 4qw7O, 0.9172, 1.61, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1421, 4qw7A, 0.9172, 1.61, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1422, 4qw5O, 0.9172, 1.61, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1423, 4qw5A, 0.9172, 1.61, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1424, 4qvwO, 0.9172, 1.61, 0.330, 250, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1425, 4qvwA, 0.9172, 1.61, 0.330, 250, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1426, 4qbyO, 0.9172, 1.61, 0.330, 250, 227, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1427, 4qbyA, 0.9172, 1.61, 0.330, 250, 227, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1428, 5l60O, 0.9171, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1429, 5l60A, 0.9171, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1430, 5l5yO, 0.9171, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1431, 5l5yA, 0.9171, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1432, 5l5eO, 0.9171, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1433, 5l54O, 0.9171, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1434, 5l54A, 0.9171, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1435, 4qz5O, 0.9171, 1.61, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1436, 4qz5A, 0.9171, 1.61, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1437, 4qvpO, 0.9171, 1.61, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1438, 4q1sA, 0.9171, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1439, 4hnpA, 0.9171, 1.61, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1440, 5lajA, 0.9170, 1.61, 0.330, 250, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1441, 5l5eA, 0.9170, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1442, 5jhsO, 0.9170, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1443, 5cz7O, 0.9170, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1444, 5cz7A, 0.9170, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1445, 4y74O, 0.9170, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1446, 4y74A, 0.9170, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1447, 4qvpA, 0.9170, 1.61, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1448, 4hrdO, 0.9170, 1.61, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1449, 5lajO, 0.9169, 1.61, 0.330, 250, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1450, 5jhsA, 0.9169, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1451, 5fgfO, 0.9169, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1452, 5fgfA, 0.9169, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1453, 5bouO, 0.9169, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1454, 5bouA, 0.9169, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1455, 4z1lO, 0.9169, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1456, 4z1lA, 0.9169, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1457, 4y84O, 0.9169, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1458, 4y84A, 0.9169, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1459, 5mpbQ, 0.9168, 1.61, 0.330, 250, 227, 
1460, 4y70O, 0.9168, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1461, 4y70A, 0.9168, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1462, 4y6vO, 0.9168, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1463, 4y6vA, 0.9168, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1464, 4qvqO, 0.9168, 1.61, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1465, 4qvqA, 0.9168, 1.83, 0.359, 244, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1466, 5fgeO, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1467, 5dkjO, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1468, 5dkjA, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1469, 4y8lO, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1470, 4y8lA, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1471, 4y8jO, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1472, 4y8jA, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1473, 4y82O, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1474, 4y82A, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1475, 4rurO, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1476, 4rurA, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1477, 4r02A, 0.9167, 1.61, 0.330, 250, 227, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1478, 4qwrO, 0.9167, 1.61, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1479, 4qwrA, 0.9167, 1.61, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1480, 5ln3E, 0.9166, 1.61, 0.330, 250, 227, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
1481, 5fgeA, 0.9166, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1482, 5cz8O, 0.9166, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1483, 4y7wO, 0.9166, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1484, 4y7wA, 0.9166, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1485, 4qw4O, 0.9166, 1.61, 0.330, 250, 227, YCP IN COMPLEX WITH CARFILZOMIB
1486, 4qw4A, 0.9166, 1.29, 0.602, 232, 226, YCP IN COMPLEX WITH CARFILZOMIB
1487, 4qlvO, 0.9166, 1.61, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1488, 4qlvA, 0.9166, 1.62, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1489, 1z7qP, 0.9166, 1.61, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1490, 5cz8A, 0.9165, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1491, 4y8uO, 0.9165, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1492, 4y8uA, 0.9165, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1493, 4y8qO, 0.9165, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1494, 4y8qA, 0.9165, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1495, 4y6aO, 0.9165, 1.46, 0.330, 249, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1496, 4y6aA, 0.9165, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1497, 4y69O, 0.9165, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1498, 4y69A, 0.9165, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1499, 1z7qB, 0.9165, 1.62, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1500, 5fhsO, 0.9164, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1501, 5fhsA, 0.9164, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1502, 5fgiO, 0.9164, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1503, 5fgiA, 0.9164, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1504, 4y8oA, 0.9164, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1505, 4y8nO, 0.9164, 1.46, 0.330, 249, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1506, 4y8nA, 0.9164, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1507, 4y8iO, 0.9164, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1508, 4y8iA, 0.9164, 1.62, 0.330, 249, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1509, 4y81A, 0.9164, 1.62, 0.330, 249, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1510, 4y80O, 0.9164, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1511, 4y80A, 0.9164, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1512, 4y7xO, 0.9164, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1513, 4y7xA, 0.9164, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1514, 4y6zO, 0.9164, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1515, 4qzxO, 0.9164, 1.62, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1516, 4qz1O, 0.9164, 1.61, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1517, 4qz1A, 0.9164, 1.61, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1518, 5d0tO, 0.9163, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1519, 5d0tA, 0.9163, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1520, 4y8oO, 0.9163, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1521, 4y81O, 0.9163, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1522, 4y7yO, 0.9163, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1523, 4y7yA, 0.9163, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1524, 4y6zA, 0.9163, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1525, 4qzxA, 0.9163, 1.62, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1526, 4qxjO, 0.9163, 1.62, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1527, 4qw0O, 0.9163, 1.62, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1528, 4qw0A, 0.9163, 1.62, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1529, 4hrdA, 0.9163, 1.62, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1530, 5vfpC, 0.9162, 1.61, 0.330, 250, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1531, 5laiO, 0.9162, 1.62, 0.330, 250, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1532, 5laiA, 0.9162, 1.62, 0.330, 250, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1533, 5fgdO, 0.9162, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1534, 5fgdA, 0.9162, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1535, 4ya5A, 0.9162, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1536, 4qxjA, 0.9162, 1.49, 0.606, 228, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1537, 4qwiO, 0.9162, 1.86, 0.342, 248, 234, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1538, 4qwiA, 0.9162, 1.62, 0.330, 250, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1539, 5d0xO, 0.9161, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1540, 5d0xA, 0.9161, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1541, 4ya5O, 0.9161, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1542, 4qvmO, 0.9161, 1.62, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1543, 4qvmA, 0.9161, 1.62, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1544, 4j70O, 0.9161, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1545, 4j70A, 0.9161, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1546, 6epfC, 0.9160, 1.62, 0.330, 250, 227, GROUND STATE 26S PROTEASOME (GS1)
1547, 5fghO, 0.9160, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1548, 5fghA, 0.9160, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1549, 5cz5O, 0.9160, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1550, 5cz5A, 0.9160, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1551, 3mg7P, 0.9160, 1.62, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1552, 4eu2P, 0.9159, 1.62, 0.330, 250, 227, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1553, 4y78O, 0.9158, 1.88, 0.339, 249, 233, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1554, 4y78A, 0.9158, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1555, 4qwkO, 0.9158, 1.62, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1556, 4qwkA, 0.9158, 1.62, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1557, 3jcpKA, 0.9158, 1.62, 0.330, 250, 227, 
1558, 3jcpK, 0.9158, 1.66, 0.361, 235, 227, 
1559, 4hrcA, 0.9157, 1.57, 0.327, 249, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1560, 5dkiO, 0.9156, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1561, 5dkiA, 0.9156, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1562, 3oeuP, 0.9156, 1.62, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1563, 3sdiP, 0.9155, 1.62, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1564, 3oevP, 0.9155, 1.61, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1565, 5cz4O, 0.9154, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1566, 5cz4A, 0.9154, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1567, 4qwjO, 0.9154, 1.62, 0.330, 249, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1568, 4qwjA, 0.9154, 1.63, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1569, 3mg6P, 0.9154, 1.63, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1570, 4qvvO, 0.9153, 1.67, 0.361, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1571, 4qvvA, 0.9153, 1.65, 0.361, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1572, 3mg8P, 0.9153, 1.67, 0.361, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1573, 4ya3O, 0.9152, 1.63, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1574, 4ya3A, 0.9152, 1.63, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1575, 4qwsO, 0.9152, 1.63, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1576, 4qwsA, 0.9152, 1.63, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1577, 1g0uP, 0.9152, 1.67, 0.361, 235, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1578, 4ya0O, 0.9151, 1.63, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1579, 4ya0A, 0.9151, 1.63, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1580, 4qw3O, 0.9151, 1.67, 0.361, 235, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1581, 4qw3A, 0.9151, 1.63, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1582, 5vfoi, 0.9149, 1.63, 0.330, 250, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1583, 4qwgO, 0.9147, 1.63, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1584, 4qwgA, 0.9147, 1.63, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1585, 3sdkP, 0.9146, 1.65, 0.361, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1586, 5vfsC, 0.9145, 1.63, 0.330, 250, 227, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1587, 5vfpAA, 0.9145, 1.63, 0.330, 250, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1588, 5mp9B, 0.9145, 1.64, 0.330, 250, 227, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1589, 3unbe, 0.9144, 1.64, 0.330, 250, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1590, 5vfqBA, 0.9142, 1.97, 0.340, 250, 235, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1591, 5t0hK, 0.9142, 1.64, 0.330, 250, 227, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1592, 1g0uB, 0.9141, 1.64, 0.330, 250, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1593, 3unhQ, 0.9140, 1.68, 0.361, 235, 227, MOUSE 20S IMMUNOPROTEASOME
1594, 3unhC, 0.9140, 1.92, 0.338, 250, 234, MOUSE 20S IMMUNOPROTEASOME
1595, 3unfQ, 0.9139, 2.03, 0.342, 239, 231, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1596, 3unfC, 0.9139, 1.96, 0.340, 250, 235, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1597, 5gjqE, 0.9138, 1.62, 0.330, 250, 227, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1598, 5gjrV, 0.9136, 1.79, 0.346, 239, 231, 
1599, 4r3oR, 0.9136, 1.97, 0.340, 250, 235, HUMAN CONSTITUTIVE 20S PROTEASOME
1600, 4r3oD, 0.9136, 1.53, 0.612, 228, 227, HUMAN CONSTITUTIVE 20S PROTEASOME
1601, 5vfri, 0.9135, 1.67, 0.361, 235, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1602, 5gjrJA, 0.9135, 1.80, 0.351, 238, 231, 
1603, 5lf3O, 0.9133, 1.80, 0.351, 238, 231, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1604, 3mg8B, 0.9132, 1.80, 0.351, 238, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1605, 5lf0O, 0.9131, 1.80, 0.351, 238, 231, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1606, 5lezO, 0.9131, 1.82, 0.342, 243, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1607, 5leyO, 0.9131, 1.81, 0.346, 243, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1608, 5mpbC, 0.9130, 1.80, 0.346, 243, 231, 
1609, 4eu2B, 0.9130, 1.80, 0.346, 243, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1610, 1g0uC, 0.9130, 1.97, 0.340, 250, 235, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1611, 5lf1O, 0.9129, 1.81, 0.346, 243, 231, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1612, 5lezA, 0.9129, 1.55, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1613, 5lexO, 0.9129, 1.68, 0.361, 235, 227, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1614, 4q1sC, 0.9129, 1.56, 0.311, 230, 225, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1615, 3unbQ, 0.9129, 1.56, 0.311, 230, 225, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1616, 3unbC, 0.9129, 1.56, 0.311, 230, 225, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1617, 3jcoKA, 0.9129, 1.86, 0.351, 244, 231, 
1618, 3jcoK, 0.9129, 1.60, 0.327, 249, 226, 
1619, 5lf6O, 0.9128, 1.81, 0.338, 238, 231, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1620, 3mg6B, 0.9128, 1.56, 0.311, 230, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1621, 5lf7O, 0.9127, 1.56, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1622, 3sdiC, 0.9127, 1.56, 0.311, 230, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1623, 5lf0A, 0.9126, 1.82, 0.338, 241, 231, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1624, 5lexA, 0.9126, 1.81, 0.346, 239, 231, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1625, 4r67t, 0.9126, 1.82, 0.346, 239, 231, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1626, 5vfpE, 0.9125, 1.63, 0.330, 250, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1627, 4x6zB, 0.9125, 1.63, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1628, 4r67f, 0.9125, 1.63, 0.330, 250, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1629, 4r67D, 0.9125, 1.56, 0.311, 230, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1630, 5lf4O, 0.9124, 1.69, 0.361, 235, 227, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1631, 4r67R, 0.9124, 1.56, 0.311, 230, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1632, 3unbs, 0.9124, 1.83, 0.338, 238, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1633, 3uneQ, 0.9123, 1.56, 0.311, 230, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
1634, 5vfrK, 0.9122, 1.56, 0.311, 230, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1635, 3sdkB, 0.9122, 1.82, 0.346, 243, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1636, 3sdiB, 0.9122, 1.60, 0.606, 228, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1637, 5vfsBA, 0.9121, 2.33, 0.333, 240, 231, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1638, 5lf7C, 0.9121, 1.62, 0.327, 248, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1639, 5lf3A, 0.9121, 1.82, 0.346, 243, 231, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1640, 5leyA, 0.9121, 1.82, 0.346, 243, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1641, 5le5O, 0.9121, 1.56, 0.311, 230, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1642, 3oevB, 0.9121, 1.82, 0.346, 243, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1643, 3oeuC, 0.9121, 1.82, 0.346, 239, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1644, 5lf1A, 0.9120, 1.81, 0.351, 239, 231, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1645, 5gjqm, 0.9120, 1.67, 0.608, 228, 227, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1646, 5lf6A, 0.9119, 1.69, 0.361, 235, 227, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1647, 5lf4A, 0.9119, 1.69, 0.361, 235, 227, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1648, 5le5C, 0.9119, 1.94, 0.338, 250, 234, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1649, 3uneq, 0.9119, 1.72, 0.354, 236, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
1650, 3sdkC, 0.9119, 1.57, 0.311, 230, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1651, 5lf3C, 0.9118, 1.57, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1652, 3oeuB, 0.9118, 1.57, 0.311, 230, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1653, 3dy4C, 0.9118, 1.70, 0.361, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1654, 2zcyC, 0.9118, 1.86, 0.338, 241, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1655, 1g0uQ, 0.9118, 1.57, 0.311, 230, 225, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1656, 5vfqE, 0.9117, 1.68, 0.316, 238, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1657, 5vfoK, 0.9117, 1.57, 0.311, 230, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1658, 3uneO, 0.9117, 1.57, 0.311, 230, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
1659, 3mg7B, 0.9117, 1.72, 0.354, 236, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1660, 3dy4Q, 0.9117, 1.68, 0.310, 233, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1661, 2zcyQ, 0.9117, 1.86, 0.338, 241, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1662, 5lf7A, 0.9116, 1.72, 0.354, 236, 229, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1663, 5le5A, 0.9116, 1.69, 0.361, 235, 227, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1664, 4r3oP, 0.9116, 1.82, 0.338, 241, 231, HUMAN CONSTITUTIVE 20S PROTEASOME
1665, 4r3oB, 0.9116, 1.82, 0.338, 241, 231, HUMAN CONSTITUTIVE 20S PROTEASOME
1666, 4eu2D, 0.9116, 1.82, 0.338, 238, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1667, 6avoP, 0.9115, 1.41, 0.609, 228, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1668, 6avob, 0.9115, 1.78, 0.316, 238, 228, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1669, 5mp9b, 0.9115, 1.60, 0.606, 228, 226, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1670, 4r67r, 0.9115, 1.69, 0.310, 233, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1671, 4r67P, 0.9115, 1.70, 0.361, 235, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1672, 5lf4C, 0.9114, 1.82, 0.338, 241, 231, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1673, 4r67d, 0.9114, 1.82, 0.338, 241, 231, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1674, 3d29C, 0.9114, 1.57, 0.311, 230, 225, PROTEASOME INHIBITION BY FELLUTAMIDE B
1675, 5leyC, 0.9113, 1.57, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1676, 5gjqG, 0.9113, 1.70, 0.310, 233, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1677, 4r67B, 0.9113, 1.70, 0.310, 233, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1678, 3uneC, 0.9113, 1.83, 0.338, 241, 231, MOUSE CONSTITUTIVE 20S PROTEASOME
1679, 3dy3Q, 0.9113, 1.59, 0.311, 230, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1680, 3dy3C, 0.9113, 1.59, 0.311, 230, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1681, 3d29Q, 0.9113, 1.67, 0.330, 250, 227, PROTEASOME INHIBITION BY FELLUTAMIDE B
1682, 5vfuT, 0.9111, 1.70, 0.310, 233, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1683, 5vftI, 0.9111, 1.70, 0.310, 233, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1684, 1rypD, 0.9111, 1.73, 0.354, 236, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1685, 5mpab, 0.9110, 1.70, 0.310, 233, 226, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1686, 5lf0C, 0.9110, 1.83, 0.338, 241, 231, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1687, 5lezC, 0.9110, 1.73, 0.354, 236, 229, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1688, 1g65C, 0.9110, 1.66, 0.316, 238, 228, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1689, 1fntP, 0.9110, 1.71, 0.310, 233, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1690, 4zzgD, 0.9109, 1.82, 0.351, 239, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1691, 3un8Q, 0.9109, 1.83, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1692, 3mg6C, 0.9109, 1.83, 0.338, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1693, 3bdmC, 0.9109, 1.83, 0.338, 241, 231, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1694, 1iruP, 0.9109, 2.05, 0.336, 250, 235, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1695, 1fntB, 0.9109, 2.05, 0.336, 250, 235, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1696, 5lf1C, 0.9108, 1.83, 0.338, 241, 231, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1697, 3un8C, 0.9108, 1.67, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1698, 3mg8C, 0.9108, 1.73, 0.354, 236, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1699, 3gpjQ, 0.9108, 1.74, 0.354, 236, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1700, 3gpjC, 0.9108, 1.83, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1701, 3bdmQ, 0.9108, 1.61, 0.330, 247, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1702, 6avoZ, 0.9106, 1.85, 0.338, 241, 231, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1703, 6avoO, 0.9106, 1.84, 0.338, 241, 231, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1704, 5wvkX, 0.9106, 1.87, 0.338, 241, 231, 
1705, 4inrC, 0.9106, 1.83, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1706, 3shjC, 0.9106, 1.72, 0.310, 233, 226, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1707, 1rypR, 0.9106, 1.61, 0.330, 247, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1708, 5nifD, 0.9105, 1.74, 0.354, 236, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1709, 5lf6C, 0.9105, 1.85, 0.338, 241, 231, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1710, 4q1sQ, 0.9105, 1.88, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1711, 3shjQ, 0.9105, 1.83, 0.338, 241, 231, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1712, 5lexC, 0.9104, 1.83, 0.338, 241, 231, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1713, 5l4gP, 0.9104, 1.83, 0.338, 241, 231, 
1714, 4lqiC, 0.9104, 1.77, 0.341, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1715, 4lqiQ, 0.9103, 1.77, 0.341, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1716, 4hnpC, 0.9103, 1.86, 0.355, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1717, 4eu2R, 0.9103, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1718, 3nzwC, 0.9103, 1.84, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1719, 5wvkY, 0.9102, 1.83, 0.338, 241, 231, 
1720, 4inuC, 0.9102, 1.86, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1721, 4inrQ, 0.9102, 1.74, 0.354, 236, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1722, 3unec, 0.9102, 1.84, 0.338, 241, 231, MOUSE CONSTITUTIVE 20S PROTEASOME
1723, 3uneA, 0.9102, 1.84, 0.338, 241, 231, MOUSE CONSTITUTIVE 20S PROTEASOME
1724, 3nzwQ, 0.9102, 1.74, 0.354, 236, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1725, 3gptC, 0.9102, 1.68, 0.310, 233, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1726, 4intC, 0.9101, 1.84, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1727, 4gk7Q, 0.9101, 1.84, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1728, 4gk7C, 0.9101, 1.86, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1729, 4fzcC, 0.9101, 1.85, 0.338, 241, 231, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1730, 3un4Q, 0.9101, 1.84, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1731, 3un4C, 0.9101, 1.83, 0.342, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1732, 3tddC, 0.9101, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1733, 3nzxC, 0.9101, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1734, 3hyeC, 0.9101, 1.69, 0.310, 233, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1735, 3gpwC, 0.9101, 1.70, 0.310, 233, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1736, 3gptQ, 0.9101, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1737, 4jsuQ, 0.9100, 1.84, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1738, 4jsuC, 0.9100, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1739, 4jsqQ, 0.9100, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1740, 4jsqC, 0.9100, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1741, 4fzcQ, 0.9100, 1.85, 0.342, 241, 231, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1742, 3tddQ, 0.9100, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1743, 3okjC, 0.9100, 1.85, 0.338, 241, 231, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1744, 3nzxQ, 0.9100, 1.84, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1745, 3gpwQ, 0.9100, 1.84, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1746, 4x6zD, 0.9099, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1747, 4inuQ, 0.9099, 1.84, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1748, 4intQ, 0.9099, 1.84, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1749, 3okjQ, 0.9099, 1.85, 0.338, 241, 231, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1750, 3hyeQ, 0.9099, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1751, 1g65Q, 0.9099, 1.86, 0.338, 241, 231, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1752, 4zzgR, 0.9098, 1.86, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1753, 4jt0Q, 0.9098, 1.85, 0.342, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1754, 4jt0C, 0.9098, 1.84, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1755, 3unes, 0.9098, 1.84, 0.338, 241, 231, MOUSE CONSTITUTIVE 20S PROTEASOME
1756, 3unbq, 0.9098, 1.84, 0.338, 241, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1757, 3e47C, 0.9098, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1758, 4hrcC, 0.9097, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1759, 3nzjQ, 0.9097, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1760, 3nzjC, 0.9097, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1761, 3mg7C, 0.9097, 1.85, 0.338, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1762, 3e47Q, 0.9097, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1763, 5nifR, 0.9096, 1.84, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1764, 5l4gD, 0.9096, 1.87, 0.338, 241, 231, 
1765, 5vfqB, 0.9095, 1.86, 0.338, 241, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1766, 5m32P, 0.9095, 1.86, 0.338, 241, 231, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1767, 4j70C, 0.9095, 1.83, 0.351, 239, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1768, 2fakC, 0.9095, 1.55, 0.312, 231, 224, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1769, 2f16C, 0.9095, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1770, 3wxrD, 0.9094, 1.86, 0.338, 241, 231, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1771, 2fakQ, 0.9094, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1772, 1z7qR, 0.9094, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1773, 1z7qD, 0.9094, 1.90, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1774, 4fzgQ, 0.9093, 1.85, 0.338, 241, 231, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1775, 4fzgC, 0.9093, 1.88, 0.338, 241, 231, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1776, 3mg0C, 0.9093, 1.88, 0.346, 243, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1777, 2f16Q, 0.9093, 1.97, 0.340, 250, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1778, 4j70Q, 0.9092, 1.52, 0.310, 230, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1779, 3unbc, 0.9092, 2.05, 0.339, 244, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1780, 3sdiQ, 0.9092, 1.86, 0.338, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1781, 3oevC, 0.9092, 1.86, 0.338, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1782, 3mg0Q, 0.9092, 1.85, 0.338, 241, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1783, 5gjqC, 0.9091, 1.88, 0.338, 241, 231, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1784, 4ltcC, 0.9091, 1.86, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1785, 4hrdC, 0.9091, 1.92, 0.345, 241, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1786, 3unee, 0.9091, 1.92, 0.345, 241, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
1787, 4hnpQ, 0.9090, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1788, 3unbO, 0.9090, 1.85, 0.338, 241, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1789, 3unbA, 0.9090, 1.87, 0.338, 241, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1790, 1iruR, 0.9089, 1.86, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1791, 1iruD, 0.9089, 1.86, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1792, 5l4gR, 0.9087, 1.57, 0.312, 231, 224, 
1793, 5l4gB, 0.9087, 1.86, 0.338, 238, 231, 
1794, 1j2pF, 0.9087, 1.90, 0.338, 241, 231, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1795, 1j2pG, 0.9086, 1.87, 0.342, 241, 231, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1796, 1j2pA, 0.9086, 1.75, 0.310, 233, 226, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1797, 5gjrGA, 0.9085, 1.87, 0.338, 241, 231, 
1798, 4ltcQ, 0.9085, 1.87, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1799, 2gplC, 0.9085, 1.85, 0.351, 239, 231, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1800, 1j2pE, 0.9085, 1.87, 0.338, 241, 231, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1801, 1j2pC, 0.9085, 1.56, 0.312, 231, 224, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1802, 1iruT, 0.9085, 1.57, 0.312, 231, 224, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1803, 2gplQ, 0.9084, 1.85, 0.346, 243, 231, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1804, 1j2pD, 0.9084, 1.85, 0.346, 243, 231, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1805, 1j2pB, 0.9084, 1.89, 0.346, 243, 231, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1806, 4r3oF, 0.9083, 1.82, 0.310, 233, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
1807, 5wvkW, 0.9082, 2.06, 0.405, 243, 232, 
1808, 5t0gI, 0.9082, 2.06, 0.405, 243, 232, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1809, 4r67v, 0.9082, 2.07, 0.405, 243, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1810, 4r67T, 0.9082, 1.79, 0.265, 244, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1811, 5gjqk, 0.9081, 1.87, 0.338, 241, 231, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1812, 6gopC, 0.9080, 1.86, 0.342, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1813, 4x6zR, 0.9080, 2.07, 0.405, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1814, 3mg4C, 0.9080, 2.07, 0.405, 243, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1815, 6gopQ, 0.9079, 1.86, 0.314, 238, 229, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1816, 5gjrHA, 0.9079, 1.86, 0.342, 241, 231, 
1817, 4hrcQ, 0.9079, 2.07, 0.405, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1818, 5gjrT, 0.9078, 2.07, 0.405, 243, 232, 
1819, 5gjrS, 0.9078, 1.69, 0.316, 238, 228, 
1820, 3unhS, 0.9078, 1.70, 0.330, 250, 227, MOUSE 20S IMMUNOPROTEASOME
1821, 1iruB, 0.9078, 1.96, 0.338, 250, 234, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1822, 1fntD, 0.9078, 1.86, 0.314, 238, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1823, 4r67h, 0.9077, 1.86, 0.314, 238, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1824, 3unhE, 0.9077, 1.88, 0.351, 243, 231, MOUSE 20S IMMUNOPROTEASOME
1825, 1fntR, 0.9077, 1.83, 0.343, 240, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1826, 5vfoH, 0.9076, 1.89, 0.338, 241, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1827, 4r67F, 0.9076, 1.89, 0.338, 241, 231, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1828, 3unfS, 0.9076, 1.83, 0.343, 240, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1829, 3unfE, 0.9076, 1.57, 0.312, 231, 224, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1830, 1jd2C, 0.9076, 1.88, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1831, 5wvkP, 0.9075, 1.57, 0.312, 231, 224, 
1832, 5mpcC, 0.9075, 1.81, 0.265, 244, 230, 
1833, 5gjqh, 0.9075, 1.77, 0.316, 238, 228, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1834, 4r3oT, 0.9075, 1.79, 0.310, 233, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
1835, 4qv9Q, 0.9075, 1.95, 0.345, 239, 232, YCP BETA5-C63F MUTANT
1836, 4qv9C, 0.9075, 1.72, 0.316, 238, 228, YCP BETA5-C63F MUTANT
1837, 4qv6Q, 0.9075, 1.77, 0.316, 238, 228, YCP BETA5-A49V MUTANT
1838, 4qv6C, 0.9075, 1.95, 0.345, 239, 232, YCP BETA5-A49V MUTANT
1839, 4qv0Q, 0.9075, 1.56, 0.310, 230, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1840, 4qv0C, 0.9075, 1.73, 0.316, 238, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1841, 5d0tC, 0.9074, 1.77, 0.316, 238, 228, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1842, 3unbS, 0.9074, 1.77, 0.316, 238, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1843, 5vfrH, 0.9073, 1.87, 0.338, 241, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1844, 5d0tQ, 0.9073, 1.69, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1845, 5cz8Q, 0.9073, 1.97, 0.355, 244, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1846, 5cz8C, 0.9073, 1.80, 0.265, 244, 230, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1847, 4qz5Q, 0.9073, 1.73, 0.316, 238, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1848, 4qz5C, 0.9073, 1.83, 0.343, 240, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1849, 4qw1C, 0.9073, 1.83, 0.343, 240, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1850, 4qv7Q, 0.9073, 1.84, 0.343, 240, 230, YCP BETA5-A50V MUTANT
1851, 4qv7C, 0.9073, 1.84, 0.343, 240, 230, YCP BETA5-A50V MUTANT
1852, 4cr4C, 0.9073, 1.83, 0.343, 240, 230, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1853, 5gjqB, 0.9072, 1.83, 0.343, 240, 230, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1854, 5a5bC, 0.9072, 1.83, 0.343, 240, 230, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
1855, 4qzzQ, 0.9072, 1.73, 0.316, 238, 228, YCP IN COMPLEX WITH OMURALIDE
1856, 4qzzC, 0.9072, 1.56, 0.310, 230, 226, YCP IN COMPLEX WITH OMURALIDE
1857, 4qz3Q, 0.9072, 1.83, 0.343, 240, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1858, 4qz3C, 0.9072, 1.83, 0.343, 240, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1859, 4qwlQ, 0.9072, 1.83, 0.343, 240, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1860, 4qwlC, 0.9072, 1.84, 0.343, 240, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1861, 4qw1Q, 0.9072, 1.84, 0.343, 240, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1862, 4qvvQ, 0.9072, 1.83, 0.343, 240, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1863, 4qv3Q, 0.9072, 1.83, 0.343, 240, 230, YCP BETA5-M45V MUTANT
1864, 4qv3C, 0.9072, 1.83, 0.343, 240, 230, YCP BETA5-M45V MUTANT
1865, 4cr3C, 0.9072, 2.03, 0.353, 245, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1866, 5l54C, 0.9071, 1.83, 0.265, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1867, 5fgaQ, 0.9071, 2.09, 0.353, 245, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1868, 5fgaC, 0.9071, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1869, 5dkjC, 0.9071, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1870, 5cgfQ, 0.9071, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1871, 5cgfC, 0.9071, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1872, 4ya2Q, 0.9071, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1873, 4ya2C, 0.9071, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1874, 4y8sQ, 0.9071, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1875, 4y8sC, 0.9071, 1.83, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1876, 4r00Q, 0.9071, 1.84, 0.343, 240, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1877, 4r00C, 0.9071, 1.84, 0.343, 240, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1878, 4qz6Q, 0.9071, 2.09, 0.353, 245, 232, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1879, 4qz6C, 0.9071, 1.84, 0.343, 240, 230, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1880, 4qwuC, 0.9071, 1.84, 0.343, 240, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1881, 4qwjQ, 0.9071, 1.84, 0.343, 240, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1882, 4qwjC, 0.9071, 1.84, 0.343, 240, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1883, 4qvvC, 0.9071, 1.83, 0.343, 240, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1884, 4qvpQ, 0.9071, 1.83, 0.343, 240, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1885, 4qvpC, 0.9071, 1.83, 0.343, 240, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1886, 4qv8Q, 0.9071, 1.83, 0.343, 240, 230, YCP BETA5-C52F MUTANT
1887, 4qv8C, 0.9071, 1.84, 0.343, 240, 230, YCP BETA5-C52F MUTANT
1888, 1jd2X, 0.9071, 1.84, 0.343, 240, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1889, 5l54Q, 0.9070, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1890, 5l4gO, 0.9070, 1.84, 0.343, 240, 230, 
1891, 5fg7Q, 0.9070, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1892, 5fg7C, 0.9070, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1893, 5dkjQ, 0.9070, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1894, 5d0sQ, 0.9070, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1895, 5d0sC, 0.9070, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1896, 4qwuQ, 0.9070, 1.83, 0.343, 240, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1897, 4quyQ, 0.9070, 1.84, 0.343, 240, 230, YCP BETA5-A49S-MUTANT
1898, 4quyC, 0.9070, 1.84, 0.343, 240, 230, YCP BETA5-A49S-MUTANT
1899, 4hrdQ, 0.9070, 1.84, 0.343, 240, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1900, 1iruO, 0.9070, 1.84, 0.343, 240, 230, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1901, 1iruA, 0.9070, 1.87, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1902, 5dkiC, 0.9069, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1903, 5d0zC, 0.9069, 1.78, 0.265, 244, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1904, 5d0xC, 0.9069, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1905, 5d0wC, 0.9069, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1906, 4z1lC, 0.9069, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1907, 4y8rQ, 0.9069, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1908, 4y8rC, 0.9069, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1909, 4qzwQ, 0.9069, 1.84, 0.343, 240, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1910, 4qzwC, 0.9069, 1.84, 0.343, 240, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1911, 4qz7Q, 0.9069, 1.84, 0.343, 240, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1912, 4qz7C, 0.9069, 1.89, 0.338, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1913, 4qw7Q, 0.9069, 1.82, 0.265, 244, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1914, 4qw7C, 0.9069, 1.83, 0.265, 244, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1915, 4qvlQ, 0.9069, 1.84, 0.343, 240, 230, YCP IN COMPLEX WITH BORTEZOMIB
1916, 4qvlC, 0.9069, 1.84, 0.343, 240, 230, YCP IN COMPLEX WITH BORTEZOMIB
1917, 4qv1Q, 0.9069, 1.84, 0.343, 240, 230, YCP BETA5-M45A MUTANT
1918, 4qv1C, 0.9069, 1.84, 0.343, 240, 230, YCP BETA5-M45A MUTANT
1919, 3unbu, 0.9069, 1.84, 0.343, 240, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1920, 3mg8Q, 0.9069, 1.84, 0.343, 240, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1921, 5lajQ, 0.9068, 1.84, 0.343, 240, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1922, 5lajC, 0.9068, 1.84, 0.343, 240, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1923, 5l52C, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1924, 5jhsQ, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1925, 5jhsC, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1926, 5fhsQ, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1927, 5fhsC, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1928, 5dkiQ, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1929, 5d0zQ, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1930, 5d0xQ, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1931, 5d0wQ, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1932, 4z1lQ, 0.9068, 1.74, 0.316, 238, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1933, 4y9yC, 0.9068, 1.92, 0.338, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1934, 4y7yQ, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1935, 4y7yC, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1936, 4qwkC, 0.9068, 1.84, 0.343, 240, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1937, 4qw6Q, 0.9068, 1.84, 0.343, 240, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1938, 4qw6C, 0.9068, 1.84, 0.343, 240, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1939, 4qv5C, 0.9068, 1.84, 0.343, 240, 230, YCP BETA5-M45I MUTANT
1940, 4qv4Q, 0.9068, 1.84, 0.343, 240, 230, YCP BETA5-M45T MUTANT
1941, 4qv4C, 0.9068, 1.84, 0.343, 240, 230, YCP BETA5-M45T MUTANT
1942, 4qltQ, 0.9068, 1.84, 0.343, 240, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1943, 4qltC, 0.9068, 1.84, 0.343, 240, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1944, 3uneG, 0.9068, 1.84, 0.343, 240, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
1945, 5l55Q, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1946, 5l55C, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1947, 5l52Q, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1948, 5fggQ, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1949, 5fggC, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1950, 5czaQ, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1951, 5czaC, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1952, 5cz5Q, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1953, 5cz5C, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1954, 5bxnQ, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1955, 5bxnC, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1956, 4y9yQ, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1957, 4y8lC, 0.9067, 1.80, 0.265, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1958, 4y8jQ, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1959, 4y8jC, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1960, 4qzxC, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1961, 4qxjQ, 0.9067, 1.85, 0.343, 240, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1962, 4qxjC, 0.9067, 1.85, 0.343, 240, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1963, 4qwkQ, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1964, 4qwiQ, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1965, 4qwiC, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1966, 4qw5Q, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1967, 4qw5C, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1968, 4qw0Q, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1969, 4qw0C, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1970, 4qvqQ, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1971, 4qvqC, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1972, 4qv5Q, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-M45I MUTANT
1973, 3uneS, 0.9067, 1.84, 0.343, 240, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
1974, 5lf0S, 0.9066, 1.84, 0.343, 240, 230, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1975, 5fg9Q, 0.9066, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1976, 5fg9C, 0.9066, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1977, 5cz9C, 0.9066, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1978, 5cgiQ, 0.9066, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1979, 5cgiC, 0.9066, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1980, 5cggQ, 0.9066, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1981, 5cggC, 0.9066, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1982, 4y9zQ, 0.9066, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1983, 4y9zC, 0.9066, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1984, 4y8lQ, 0.9066, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1985, 4r3oO, 0.9066, 1.84, 0.343, 240, 230, HUMAN CONSTITUTIVE 20S PROTEASOME
1986, 4qzxQ, 0.9066, 1.81, 0.316, 238, 228, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1987, 4qw4C, 0.9066, 1.55, 0.319, 237, 226, YCP IN COMPLEX WITH CARFILZOMIB
1988, 4qvyQ, 0.9066, 1.84, 0.343, 240, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1989, 4qvyC, 0.9066, 1.84, 0.343, 240, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1990, 4qvwQ, 0.9066, 1.85, 0.343, 240, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1991, 4qvwC, 0.9066, 1.84, 0.343, 240, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1992, 5vfpB, 0.9065, 1.84, 0.343, 240, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1993, 5fgiQ, 0.9065, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1994, 5fgiC, 0.9065, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1995, 5fghC, 0.9065, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1996, 5cz9Q, 0.9065, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1997, 4ya7Q, 0.9065, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1998, 4ya7C, 0.9065, 1.82, 0.265, 244, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1999, 4ya4Q, 0.9065, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2000, 4ya4C, 0.9065, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2001, 4y8iQ, 0.9065, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2002, 4y8iC, 0.9065, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2003, 4y7wC, 0.9065, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2004, 4y70C, 0.9065, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2005, 4qz4C, 0.9065, 1.57, 0.310, 230, 226, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2006, 4qz2Q, 0.9065, 2.13, 0.342, 239, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2007, 4qz2C, 0.9065, 1.85, 0.343, 240, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2008, 4qwrQ, 0.9065, 1.85, 0.343, 240, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2009, 4qwrC, 0.9065, 1.84, 0.343, 240, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2010, 4qw4Q, 0.9065, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH CARFILZOMIB
2011, 4qvnC, 0.9065, 1.85, 0.343, 240, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2012, 4nnnQ, 0.9065, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH MG132
2013, 4nnnC, 0.9065, 1.84, 0.343, 240, 230, YCP IN COMPLEX WITH MG132
2014, 5fghQ, 0.9064, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2015, 5d0vQ, 0.9064, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2016, 5d0vC, 0.9064, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2017, 5bxlQ, 0.9064, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2018, 5bxlC, 0.9064, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2019, 4ya1C, 0.9064, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2020, 4y7wQ, 0.9064, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2021, 4y78C, 0.9064, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2022, 4y70Q, 0.9064, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2023, 4r02C, 0.9064, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2024, 4qz4Q, 0.9064, 1.85, 0.343, 240, 230, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2025, 4qwfQ, 0.9064, 1.85, 0.343, 240, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2026, 4qwfC, 0.9064, 1.85, 0.343, 240, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2027, 4qvnQ, 0.9064, 1.85, 0.343, 240, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2028, 4qlsQ, 0.9064, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2029, 4qlsC, 0.9064, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2030, 4no8Q, 0.9064, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2031, 4no8C, 0.9064, 1.84, 0.343, 240, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2032, 5m32O, 0.9063, 1.84, 0.343, 240, 230, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2033, 5m32A, 0.9063, 1.84, 0.343, 240, 230, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2034, 5l4gA, 0.9063, 1.85, 0.343, 240, 230, 
2035, 5jhrQ, 0.9063, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2036, 5jhrC, 0.9063, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2037, 5fgdC, 0.9063, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2038, 4ya1Q, 0.9063, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2039, 4y8qQ, 0.9063, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2040, 4y8qC, 0.9063, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2041, 4y8hQ, 0.9063, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2042, 4y8hC, 0.9063, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2043, 4y80C, 0.9063, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2044, 4y78Q, 0.9063, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2045, 4r3oA, 0.9063, 1.84, 0.343, 240, 230, HUMAN CONSTITUTIVE 20S PROTEASOME
2046, 4r18Q, 0.9063, 1.63, 0.311, 230, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2047, 4r18C, 0.9063, 1.63, 0.311, 230, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2048, 4qz0C, 0.9063, 1.82, 0.265, 244, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2049, 4quxQ, 0.9063, 1.85, 0.343, 240, 230, YCP BETA5-A49T-MUTANT
2050, 4quxC, 0.9063, 1.85, 0.343, 240, 230, YCP BETA5-A49T-MUTANT
2051, 4no1Q, 0.9063, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2052, 4no1C, 0.9063, 1.84, 0.343, 240, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2053, 5fgfQ, 0.9062, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2054, 5fgfC, 0.9062, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2055, 5fgdQ, 0.9062, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2056, 5ahjQ, 0.9062, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2057, 5ahjC, 0.9062, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2058, 4y8uQ, 0.9062, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2059, 4y8uC, 0.9062, 1.83, 0.265, 244, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2060, 4y80Q, 0.9062, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2061, 4qz0Q, 0.9062, 1.84, 0.343, 240, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2062, 4qvmQ, 0.9062, 1.85, 0.343, 240, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2063, 4qvmC, 0.9062, 1.84, 0.343, 240, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2064, 5fgeQ, 0.9061, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2065, 5fgeC, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2066, 5cz7Q, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2067, 5cz7C, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2068, 5cz6Q, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2069, 5cz6C, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2070, 4ya9C, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2071, 4ya0C, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2072, 4y8pC, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2073, 4y8mQ, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2074, 4y8mC, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2075, 4y84Q, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2076, 4qlqQ, 0.9061, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2077, 4qlqC, 0.9061, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2078, 4no6C, 0.9061, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2079, 5cghQ, 0.9060, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2080, 5cghC, 0.9060, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2081, 4ya9Q, 0.9060, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2082, 4ya0Q, 0.9060, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2083, 4y8pQ, 0.9060, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2084, 4y84C, 0.9060, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2085, 4y77Q, 0.9060, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2086, 4y77C, 0.9060, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2087, 4r67q, 0.9060, 1.85, 0.343, 240, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2088, 4r67O, 0.9060, 1.85, 0.343, 240, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2089, 4r67c, 0.9060, 1.85, 0.343, 240, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2090, 4r67A, 0.9060, 1.85, 0.343, 240, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2091, 4qwxQ, 0.9060, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2092, 4qwxC, 0.9060, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2093, 4no6Q, 0.9060, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2094, 3mg6Q, 0.9060, 1.85, 0.343, 240, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2095, 1iruF, 0.9060, 1.85, 0.343, 240, 230, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2096, 5lf7S, 0.9059, 1.85, 0.343, 240, 230, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2097, 5lf4S, 0.9059, 1.85, 0.343, 240, 230, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2098, 5gjqi, 0.9059, 1.85, 0.343, 240, 230, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2099, 4ya3Q, 0.9059, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2100, 4ya3C, 0.9059, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2101, 4y8gQ, 0.9059, 1.82, 0.265, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2102, 4y8gC, 0.9059, 1.82, 0.265, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2103, 4y82C, 0.9059, 1.82, 0.265, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2104, 4y7xC, 0.9059, 1.82, 0.265, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2105, 4y69Q, 0.9059, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2106, 4y69C, 0.9059, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2107, 4qwsC, 0.9059, 1.85, 0.343, 240, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2108, 5lexS, 0.9058, 1.93, 0.338, 241, 231, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2109, 5cz4Q, 0.9058, 1.64, 0.317, 238, 227, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2110, 5cz4C, 0.9058, 1.56, 0.314, 237, 226, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2111, 4ya5C, 0.9058, 1.56, 0.314, 237, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2112, 4y82Q, 0.9058, 1.59, 0.312, 231, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2113, 4y7xQ, 0.9058, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2114, 4y75Q, 0.9058, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2115, 4y75C, 0.9058, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2116, 4y74C, 0.9058, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2117, 4qwsQ, 0.9058, 1.85, 0.343, 240, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2118, 4no9Q, 0.9058, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2119, 4no9C, 0.9058, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2120, 4cr2C, 0.9058, 1.85, 0.343, 240, 230, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2121, 5lf6S, 0.9057, 1.85, 0.343, 240, 230, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2122, 4ya5Q, 0.9057, 1.56, 0.314, 235, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2123, 4y8oC, 0.9057, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2124, 4y74Q, 0.9057, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2125, 4y6vQ, 0.9057, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2126, 4y6vC, 0.9057, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2127, 4qw3Q, 0.9057, 1.85, 0.343, 240, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2128, 4qw3C, 0.9057, 1.86, 0.343, 240, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2129, 3oevQ, 0.9057, 1.86, 0.343, 240, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2130, 3mg4Q, 0.9057, 1.86, 0.343, 240, 230, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2131, 6epdC, 0.9056, 1.85, 0.343, 240, 230, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
2132, 4y8tQ, 0.9056, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2133, 4y8tC, 0.9056, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2134, 4y8oQ, 0.9056, 2.03, 0.353, 245, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2135, 4y8nQ, 0.9056, 1.56, 0.319, 237, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2136, 4y8nC, 0.9056, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2137, 4y81C, 0.9056, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2138, 4rurQ, 0.9056, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2139, 4rurC, 0.9056, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2140, 4qlvC, 0.9056, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2141, 3unfO, 0.9056, 1.85, 0.343, 240, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2142, 3unfA, 0.9056, 1.85, 0.343, 240, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2143, 5lf3S, 0.9055, 1.93, 0.338, 241, 231, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2144, 5lf1S, 0.9055, 1.91, 0.338, 241, 231, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2145, 5bouQ, 0.9055, 2.08, 0.340, 249, 235, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2146, 5bouC, 0.9055, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2147, 4y8kQ, 0.9055, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2148, 4y8kC, 0.9055, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2149, 4y81Q, 0.9055, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2150, 4y6aQ, 0.9055, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2151, 4y6aC, 0.9055, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2152, 4qlvQ, 0.9055, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2153, 3uneU, 0.9055, 1.85, 0.343, 240, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2154, 3sdkQ, 0.9055, 1.86, 0.343, 240, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2155, 5mp9d, 0.9054, 1.55, 0.314, 230, 223, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2156, 5leyS, 0.9054, 1.55, 0.314, 230, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2157, 5gjqX, 0.9054, 1.56, 0.314, 237, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2158, 4qz1Q, 0.9054, 1.56, 0.319, 237, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2159, 4qz1C, 0.9054, 1.86, 0.343, 240, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2160, 3unhO, 0.9054, 1.86, 0.343, 240, 230, MOUSE 20S IMMUNOPROTEASOME
2161, 3unhA, 0.9054, 1.86, 0.343, 240, 230, MOUSE 20S IMMUNOPROTEASOME
2162, 3uneu, 0.9054, 1.86, 0.343, 240, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2163, 5gjqn, 0.9053, 1.86, 0.343, 240, 230, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2164, 4qbyC, 0.9053, 1.86, 0.343, 240, 230, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2165, 3uneg, 0.9053, 1.86, 0.343, 240, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2166, 3unbG, 0.9053, 1.86, 0.343, 240, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2167, 3jcpMA, 0.9053, 1.82, 0.265, 244, 230, 
2168, 3jcpM, 0.9053, 1.93, 0.338, 241, 231, 
2169, 5lezS, 0.9052, 1.85, 0.343, 240, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2170, 4y6zC, 0.9052, 1.56, 0.319, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2171, 4r17Q, 0.9052, 2.25, 0.349, 243, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2172, 4r17C, 0.9052, 1.86, 0.343, 240, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2173, 4qbyQ, 0.9052, 1.86, 0.343, 240, 230, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2174, 4nnwQ, 0.9052, 1.55, 0.314, 230, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2175, 4nnwC, 0.9052, 1.55, 0.314, 230, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2176, 3uneE, 0.9052, 1.66, 0.317, 238, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
2177, 5vfsAA, 0.9051, 2.20, 0.349, 243, 232, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2178, 5l5wQ, 0.9051, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2179, 5l5wC, 0.9051, 1.82, 0.316, 238, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2180, 4y6zQ, 0.9051, 1.77, 0.262, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2181, 5t0iI, 0.9050, 1.91, 0.338, 241, 231, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2182, 4qluQ, 0.9050, 1.91, 0.338, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2183, 4qluC, 0.9050, 1.91, 0.338, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2184, 3unbi, 0.9050, 1.57, 0.319, 237, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2185, 5laiQ, 0.9049, 1.86, 0.343, 240, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2186, 5laiC, 0.9049, 1.86, 0.343, 240, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2187, 5l5zQ, 0.9049, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2188, 5l5zC, 0.9048, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2189, 5l5xQ, 0.9048, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2190, 5l5xC, 0.9048, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2191, 3unew, 0.9048, 1.66, 0.317, 238, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
2192, 3unbg, 0.9048, 1.74, 0.310, 232, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2193, 5vfsB, 0.9047, 1.86, 0.343, 240, 230, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2194, 5vfoL, 0.9047, 1.86, 0.343, 240, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2195, 5lttQ, 0.9047, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2196, 5lttC, 0.9047, 2.06, 0.340, 250, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2197, 5l60Q, 0.9047, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2198, 5l60C, 0.9047, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2199, 5l5uQ, 0.9047, 1.78, 0.262, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2200, 5l5uC, 0.9047, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2201, 5l4gG, 0.9047, 1.86, 0.343, 240, 230, 
2202, 4qwgQ, 0.9047, 1.86, 0.343, 240, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2203, 4qwgC, 0.9047, 1.86, 0.343, 240, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2204, 3unbE, 0.9047, 1.86, 0.343, 240, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2205, 5le5S, 0.9046, 1.86, 0.343, 240, 230, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2206, 5l64Q, 0.9046, 1.83, 0.261, 244, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2207, 5l64C, 0.9046, 1.78, 0.316, 238, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2208, 5l5yQ, 0.9046, 1.94, 0.338, 250, 234, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2209, 5l5yC, 0.9046, 1.76, 0.310, 232, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2210, 4r02Q, 0.9046, 1.74, 0.316, 238, 228, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2211, 5l62Q, 0.9045, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2212, 5l62C, 0.9045, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2213, 5l5fQ, 0.9045, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2214, 5l5fC, 0.9045, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2215, 5l5eQ, 0.9045, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2216, 5l5eC, 0.9045, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2217, 5l65Q, 0.9044, 2.20, 0.349, 242, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2218, 5l65C, 0.9044, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2219, 5l61Q, 0.9044, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2220, 5l61C, 0.9044, 1.84, 0.316, 238, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2221, 5l5sQ, 0.9044, 1.62, 0.319, 237, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2222, 5l5sC, 0.9044, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2223, 5mp9D, 0.9043, 1.87, 0.343, 240, 230, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2224, 5l63Q, 0.9043, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2225, 5l63C, 0.9043, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2226, 5l5bQ, 0.9043, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2227, 5l5aQ, 0.9043, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2228, 5l5aC, 0.9043, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2229, 5gjrMA, 0.9043, 1.87, 0.343, 240, 230, 
2230, 5vfuHA, 0.9042, 1.87, 0.343, 240, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2231, 5vfti, 0.9042, 1.87, 0.343, 240, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2232, 5vfrl, 0.9042, 1.87, 0.343, 240, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2233, 5l6bQ, 0.9042, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2234, 5l6bC, 0.9042, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2235, 5l5bC, 0.9042, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2236, 5a0qQ, 0.9042, 1.87, 0.343, 240, 230, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2237, 5a0qC, 0.9042, 1.87, 0.343, 240, 230, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2238, 5vfol, 0.9041, 1.87, 0.343, 240, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2239, 5l67Q, 0.9041, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2240, 5l67C, 0.9041, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2241, 5l66Q, 0.9041, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2242, 5l66C, 0.9041, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2243, 5l5vQ, 0.9041, 1.87, 0.343, 240, 230,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2244, 5l5vC, 0.9041, 1.87, 0.343, 240, 230,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2245, 5l5rQ, 0.9041, 2.21, 0.349, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2246, 5l5rC, 0.9041, 2.02, 0.338, 250, 234, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2247, 5l5hQ, 0.9041, 2.02, 0.338, 250, 234, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2248, 5l5hC, 0.9041, 1.77, 0.316, 238, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2249, 5gjrY, 0.9041, 1.87, 0.343, 240, 230, 
2250, 3mg7Q, 0.9041, 1.87, 0.343, 240, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2251, 5vfqAA, 0.9040, 1.87, 0.343, 240, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2252, 5mpaB, 0.9040, 1.73, 0.344, 237, 227, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2253, 5l5qQ, 0.9040, 1.73, 0.344, 237, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2254, 5l5qC, 0.9040, 1.78, 0.316, 238, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2255, 5l5pQ, 0.9040, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2256, 5l5pC, 0.9040, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2257, 5l5iQ, 0.9040, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2258, 5l5iC, 0.9040, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2259, 3unei, 0.9040, 1.87, 0.343, 240, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2260, 5vfuS, 0.9039, 1.87, 0.343, 240, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2261, 5vftH, 0.9039, 1.87, 0.343, 240, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2262, 5l6cQ, 0.9039, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2263, 5l6cC, 0.9039, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2264, 5l6aQ, 0.9039, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2265, 5l6aC, 0.9039, 2.21, 0.349, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2266, 5l5tQ, 0.9039, 1.96, 0.342, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2267, 5l5tC, 0.9039, 1.75, 0.310, 232, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2268, 6avoG, 0.9038, 1.77, 0.330, 250, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2269, 5t0jI, 0.9038, 1.87, 0.343, 240, 230, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2270, 5l5oQ, 0.9038, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2271, 3unbw, 0.9038, 1.88, 0.343, 240, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2272, 3oeuQ, 0.9038, 1.88, 0.343, 240, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2273, 5vfsF, 0.9037, 1.87, 0.343, 240, 230, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2274, 5l5oC, 0.9037, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2275, 5l5jC, 0.9037, 1.85, 0.265, 244, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2276, 5l5dQ, 0.9037, 1.73, 0.310, 232, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2277, 5l5dC, 0.9037, 1.73, 0.310, 232, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2278, 6avoL, 0.9036, 1.88, 0.343, 240, 230, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2279, 5vfqEA, 0.9036, 1.88, 0.343, 240, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2280, 5vfoh, 0.9036, 1.88, 0.343, 240, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2281, 5m2bQ, 0.9036, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2282, 5l5jQ, 0.9036, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2283, 3unbU, 0.9036, 1.88, 0.343, 240, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2284, 5m2bC, 0.9035, 1.51, 0.320, 234, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2285, 5l68Q, 0.9035, 2.07, 0.336, 250, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2286, 5l68C, 0.9035, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2287, 5l4gU, 0.9035, 1.80, 0.262, 243, 229, 
2288, 5vfuGA, 0.9034, 1.96, 0.338, 241, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2289, 5vfth, 0.9034, 1.84, 0.316, 238, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2290, 5vfrL, 0.9034, 2.47, 0.332, 240, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2291, 5vfrh, 0.9034, 1.88, 0.343, 240, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2292, 5vfpZ, 0.9034, 1.88, 0.343, 240, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2293, 5t0hI, 0.9034, 1.88, 0.343, 240, 230, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2294, 5l69Q, 0.9034, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2295, 5l69C, 0.9034, 1.51, 0.320, 234, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2296, 5wvkQ, 0.9033, 1.78, 0.316, 238, 228, 
2297, 5vfpDA, 0.9031, 1.75, 0.310, 232, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2298, 3jcoMA, 0.9031, 1.88, 0.343, 240, 230, 
2299, 3jcoM, 0.9031, 1.88, 0.343, 240, 230, 
2300, 6avoQ, 0.9030, 1.80, 0.262, 243, 229, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2301, 6avoJ, 0.9030, 1.88, 0.343, 240, 230, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2302, 5vftL, 0.9030, 1.88, 0.343, 240, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2303, 5vfsEA, 0.9030, 1.88, 0.343, 240, 230, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2304, 4r3oG, 0.9030, 2.23, 0.349, 241, 232, HUMAN CONSTITUTIVE 20S PROTEASOME
2305, 5t0cZA, 0.9029, 1.73, 0.310, 232, 226, 
2306, 5t0cT, 0.9029, 1.73, 0.310, 232, 226, 
2307, 5mpad, 0.9029, 1.77, 0.316, 238, 228, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2308, 5vfuW, 0.9028, 1.75, 0.310, 232, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2309, 5vfpF, 0.9028, 1.76, 0.310, 232, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2310, 4r3oU, 0.9027, 2.02, 0.338, 250, 234, HUMAN CONSTITUTIVE 20S PROTEASOME
2311, 3wxrR, 0.9027, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2312, 3unbv, 0.9027, 1.88, 0.343, 240, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2313, 5vfqF, 0.9026, 1.98, 0.355, 244, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2314, 3unbT, 0.9025, 1.78, 0.316, 238, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2315, 5lf4E, 0.9021, 1.93, 0.338, 241, 231, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2316, 3unbh, 0.9021, 1.93, 0.338, 241, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2317, 5mpcQ, 0.9020, 1.93, 0.338, 241, 231, 
2318, 5lf0E, 0.9020, 2.16, 0.346, 239, 231, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2319, 4r67U, 0.9020, 2.16, 0.346, 239, 231, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2320, 4r67G, 0.9020, 1.85, 0.316, 238, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2321, 5lf6E, 0.9019, 1.84, 0.316, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2322, 4r67w, 0.9019, 2.25, 0.349, 245, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2323, 4r67i, 0.9019, 1.76, 0.310, 232, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2324, 3unhU, 0.9019, 1.76, 0.310, 232, 226, MOUSE 20S IMMUNOPROTEASOME
2325, 3unhG, 0.9019, 1.88, 0.343, 240, 230, MOUSE 20S IMMUNOPROTEASOME
2326, 5lexT, 0.9018, 1.85, 0.316, 238, 228, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2327, 5lf7E, 0.9017, 1.78, 0.316, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2328, 5leyE, 0.9017, 2.25, 0.349, 245, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2329, 5lf1E, 0.9016, 1.97, 0.338, 241, 231, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2330, 5lezT, 0.9015, 2.17, 0.351, 244, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2331, 3unfU, 0.9015, 1.79, 0.316, 238, 228, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2332, 3unfG, 0.9015, 2.34, 0.333, 240, 231, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2333, 5lf3E, 0.9014, 2.17, 0.351, 244, 231, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2334, 5le5E, 0.9014, 1.47, 0.317, 233, 224, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2335, 5lexE, 0.9013, 2.18, 0.351, 244, 231, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2336, 5lexF, 0.9011, 1.98, 0.351, 244, 231, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2337, 5l63T, 0.9011, 1.47, 0.317, 233, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2338, 5l63F, 0.9011, 2.25, 0.349, 245, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2339, 3uneF, 0.9011, 2.25, 0.349, 245, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
2340, 5vfuKA, 0.9010, 1.47, 0.317, 233, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2341, 5vftl, 0.9009, 2.25, 0.349, 245, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2342, 5m2bT, 0.9009, 2.25, 0.349, 245, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2343, 5m2bF, 0.9009, 1.83, 0.266, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2344, 5l6aT, 0.9009, 1.83, 0.266, 243, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2345, 5l6aF, 0.9009, 2.31, 0.345, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2346, 5l64T, 0.9009, 1.48, 0.317, 233, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2347, 5l64F, 0.9009, 1.48, 0.317, 233, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2348, 5l61T, 0.9009, 1.48, 0.317, 233, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2349, 5l61F, 0.9009, 2.31, 0.345, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2350, 5l5wT, 0.9009, 1.83, 0.266, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2351, 5l5wF, 0.9009, 1.83, 0.266, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2352, 5l5dT, 0.9009, 1.48, 0.317, 233, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2353, 5l5dF, 0.9009, 1.49, 0.317, 233, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2354, 4r18T, 0.9009, 1.48, 0.317, 233, 224, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2355, 4r18F, 0.9009, 2.18, 0.346, 239, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2356, 4r02F, 0.9009, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2357, 3unbF, 0.9009, 2.10, 0.330, 243, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2358, 3sdiT, 0.9009, 2.07, 0.352, 244, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2359, 5l69T, 0.9008, 1.71, 0.317, 238, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2360, 5l69F, 0.9008, 1.71, 0.317, 238, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2361, 5l66T, 0.9008, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2362, 5l62T, 0.9008, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2363, 5l62F, 0.9008, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2364, 5l5yT, 0.9008, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2365, 5l5pT, 0.9008, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2366, 5l5pF, 0.9008, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2367, 5l5hT, 0.9008, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2368, 5l5hF, 0.9008, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2369, 5lezF, 0.9007, 2.10, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2370, 5l6cT, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2371, 5l6cF, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2372, 5l66F, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2373, 5l65T, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2374, 5l65F, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2375, 5l60T, 0.9007, 2.09, 0.326, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2376, 5l60F, 0.9007, 2.11, 0.352, 244, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2377, 5l5zT, 0.9007, 2.09, 0.330, 242, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2378, 5l5zF, 0.9007, 2.09, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2379, 5l5yF, 0.9007, 2.09, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2380, 5l5uT, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2381, 5l5uF, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2382, 5l5tT, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2383, 5l5tF, 0.9007, 2.09, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2384, 5l5sT, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2385, 5l5sF, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2386, 5l5rT, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2387, 5l5rF, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2388, 5l5qT, 0.9007, 2.19, 0.346, 239, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2389, 5l5qF, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2390, 5l5oT, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2391, 5l5oF, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2392, 5l5jT, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2393, 4qvnT, 0.9007, 2.10, 0.330, 243, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2394, 4qvnF, 0.9007, 2.09, 0.330, 243, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2395, 3unev, 0.9007, 2.09, 0.330, 243, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2396, 5t0gH, 0.9006, 2.10, 0.330, 243, 230, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2397, 5lf3F, 0.9006, 2.10, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2398, 5lezE, 0.9006, 2.09, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2399, 5le5T, 0.9006, 2.10, 0.330, 243, 230, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2400, 5l6bT, 0.9006, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2401, 5l6bF, 0.9006, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2402, 5l67T, 0.9006, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2403, 5l5jF, 0.9006, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2404, 5l5iT, 0.9006, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2405, 5l5iF, 0.9006, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2406, 4zzgG, 0.9006, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2407, 4eu2G, 0.9006, 2.10, 0.330, 243, 230, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2408, 5lf1T, 0.9005, 2.10, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2409, 5lajT, 0.9005, 2.10, 0.330, 243, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2410, 5lajF, 0.9005, 2.10, 0.330, 243, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2411, 5l68T, 0.9005, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2412, 5l68F, 0.9005, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2413, 5l67F, 0.9005, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2414, 5l5xT, 0.9005, 2.13, 0.352, 244, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2415, 5l5xF, 0.9005, 1.80, 0.310, 233, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2416, 5l5vT, 0.9005, 2.31, 0.345, 239, 232,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2417, 5l5vF, 0.9005, 1.49, 0.317, 233, 224,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2418, 5l5fT, 0.9005, 2.32, 0.345, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2419, 5l5fF, 0.9005, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2420, 4r02T, 0.9005, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2421, 5l5eT, 0.9004, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2422, 5l5eF, 0.9004, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2423, 5l5bT, 0.9004, 2.09, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2424, 5l5bF, 0.9004, 2.09, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2425, 5fggT, 0.9004, 2.08, 0.326, 244, 230, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2426, 5fggF, 0.9004, 2.09, 0.330, 244, 230, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2427, 5cghT, 0.9004, 2.33, 0.345, 240, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2428, 5cghF, 0.9004, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2429, 5bxnT, 0.9004, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2430, 5bxnF, 0.9004, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2431, 5ahjT, 0.9004, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2432, 5ahjF, 0.9004, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2433, 4zzgU, 0.9004, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2434, 4qvwT, 0.9004, 2.10, 0.330, 243, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2435, 4qv6T, 0.9004, 2.10, 0.330, 243, 230, YCP BETA5-A49V MUTANT
2436, 4qv6F, 0.9004, 2.10, 0.330, 243, 230, YCP BETA5-A49V MUTANT
2437, 5nifG, 0.9003, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2438, 5lttT, 0.9003, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2439, 5lttF, 0.9003, 2.11, 0.326, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2440, 5lf7T, 0.9003, 2.10, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2441, 5l5aT, 0.9003, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2442, 5l5aF, 0.9003, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2443, 4ya9T, 0.9003, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2444, 4ya9F, 0.9003, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2445, 4qz7T, 0.9003, 2.11, 0.330, 243, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2446, 4qz7F, 0.9003, 2.11, 0.330, 243, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2447, 4qw1T, 0.9003, 2.11, 0.330, 243, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2448, 4qw1F, 0.9003, 2.10, 0.330, 243, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2449, 4qvyT, 0.9003, 2.10, 0.330, 243, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2450, 4qvyF, 0.9003, 2.12, 0.330, 243, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2451, 4qvwF, 0.9003, 2.12, 0.330, 243, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2452, 3sdiF, 0.9003, 2.08, 0.326, 244, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2453, 5lf1Q, 0.9002, 2.10, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2454, 5cz9T, 0.9002, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2455, 5bxlT, 0.9002, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2456, 5bxlF, 0.9002, 2.09, 0.326, 244, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2457, 5bouT, 0.9002, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2458, 5bouF, 0.9002, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2459, 4ya4T, 0.9002, 2.33, 0.345, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2460, 4ya4F, 0.9002, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2461, 4y8tT, 0.9002, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2462, 4y8tF, 0.9002, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2463, 4y8pT, 0.9002, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2464, 4y8pF, 0.9002, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2465, 4y8gT, 0.9002, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2466, 4y8gF, 0.9002, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2467, 4y75T, 0.9002, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2468, 4y75F, 0.9002, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2469, 4qzzT, 0.9002, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH OMURALIDE
2470, 4qzzF, 0.9002, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH OMURALIDE
2471, 4qz4T, 0.9002, 2.08, 0.330, 242, 230, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2472, 4qz4F, 0.9002, 1.93, 0.348, 238, 230, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2473, 4qwfT, 0.9002, 2.11, 0.330, 243, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2474, 4qwfF, 0.9002, 2.11, 0.330, 243, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2475, 4qw6T, 0.9002, 2.10, 0.330, 243, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2476, 4qw6F, 0.9002, 2.10, 0.330, 243, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2477, 4qvqT, 0.9002, 2.10, 0.330, 243, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2478, 4qvqF, 0.9002, 2.11, 0.330, 243, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2479, 4qvpT, 0.9002, 2.11, 0.330, 243, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2480, 4qvpF, 0.9002, 2.12, 0.330, 243, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2481, 4qvlT, 0.9002, 2.12, 0.330, 243, 230, YCP IN COMPLEX WITH BORTEZOMIB
2482, 4qvlF, 0.9002, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH BORTEZOMIB
2483, 4hnpF, 0.9002, 2.11, 0.330, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2484, 6gopT, 0.9001, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2485, 6gopF, 0.9001, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2486, 5nifU, 0.9001, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2487, 5lf6Q, 0.9001, 2.11, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2488, 5fgiT, 0.9001, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2489, 5d0vT, 0.9001, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2490, 5d0vF, 0.9001, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2491, 5cz9F, 0.9001, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2492, 5cz7T, 0.9001, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2493, 5cz7F, 0.9001, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2494, 5cz6T, 0.9001, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2495, 5cz6F, 0.9001, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2496, 5cggT, 0.9001, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2497, 5cggF, 0.9001, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2498, 4qz6T, 0.9001, 2.10, 0.330, 243, 230, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2499, 4qz0T, 0.9001, 2.10, 0.330, 243, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2500, 4qz0F, 0.9001, 2.10, 0.330, 243, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2501, 4qwxT, 0.9001, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2502, 4qwxF, 0.9001, 2.14, 0.335, 244, 230, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2503, 4qwlT, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2504, 4qw7T, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2505, 4qw7F, 0.9001, 2.09, 0.326, 244, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2506, 4qw5T, 0.9001, 1.93, 0.348, 238, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2507, 4qw5F, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2508, 4qv1T, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-M45A MUTANT
2509, 4qv1F, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-M45A MUTANT
2510, 4qv0F, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2511, 4quxT, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-A49T-MUTANT
2512, 4quxF, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-A49T-MUTANT
2513, 4qlsT, 0.9001, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2514, 4qlsF, 0.9001, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2515, 5fgiF, 0.9000, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2516, 5fgeT, 0.9000, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2517, 5fgeF, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2518, 5d0zT, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2519, 5d0wT, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2520, 5d0wF, 0.9000, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2521, 5d0sT, 0.9000, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2522, 5d0sF, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2523, 5czaT, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2524, 5czaF, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2525, 4y9yT, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2526, 4y8kT, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2527, 4y77T, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2528, 4y77F, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2529, 4y6aT, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2530, 4y6aF, 0.9000, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2531, 4rurT, 0.9000, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2532, 4rurF, 0.9000, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2533, 4qz6F, 0.9000, 2.12, 0.330, 243, 230, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2534, 4qwuT, 0.9000, 2.11, 0.330, 243, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2535, 4qwuF, 0.9000, 2.12, 0.330, 243, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2536, 4qwlF, 0.9000, 2.12, 0.330, 243, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2537, 4qw4T, 0.9000, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH CARFILZOMIB
2538, 4qw4F, 0.9000, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH CARFILZOMIB
2539, 4qvmT, 0.9000, 2.11, 0.330, 243, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2540, 4qvmF, 0.9000, 2.12, 0.330, 243, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2541, 4qv5T, 0.9000, 2.12, 0.330, 243, 230, YCP BETA5-M45I MUTANT
2542, 4qv5F, 0.9000, 2.11, 0.330, 243, 230, YCP BETA5-M45I MUTANT
2543, 4qv4T, 0.9000, 2.11, 0.330, 243, 230, YCP BETA5-M45T MUTANT
2544, 4qv4F, 0.9000, 2.10, 0.330, 243, 230, YCP BETA5-M45T MUTANT
2545, 4qv0T, 0.9000, 2.11, 0.330, 243, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2546, 4quyT, 0.9000, 2.11, 0.330, 243, 230, YCP BETA5-A49S-MUTANT
2547, 4quyF, 0.9000, 2.11, 0.330, 243, 230, YCP BETA5-A49S-MUTANT
2548, 4hrcF, 0.9000, 2.11, 0.330, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2549, 4cr4B, 0.9000, 2.11, 0.330, 243, 230, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2550, 6epcC, 0.8999, 2.10, 0.330, 243, 230, GROUND STATE 26S PROTEASOME (GS2)
2551, 5lf6T, 0.8999, 2.10, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2552, 5l55T, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2553, 5l55F, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2554, 5jhsT, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2555, 5jhsF, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2556, 5jhrT, 0.8999, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2557, 5jhrF, 0.8999, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2558, 5fgaF, 0.8999, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2559, 5d0zF, 0.8999, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2560, 4ya1T, 0.8999, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2561, 4ya1F, 0.8999, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2562, 4y9yF, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2563, 4y8uT, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2564, 4y8uF, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2565, 4y8sT, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2566, 4y8sF, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2567, 4y8mT, 0.8999, 2.08, 0.330, 244, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2568, 4y8mF, 0.8999, 1.83, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2569, 4y8kF, 0.8999, 2.20, 0.340, 249, 235, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2570, 4y84T, 0.8999, 2.34, 0.345, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2571, 4y84F, 0.8999, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2572, 4y6vT, 0.8999, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2573, 4y6vF, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2574, 4y69T, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2575, 4y69F, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2576, 4qz3T, 0.8999, 2.11, 0.330, 243, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2577, 4qz3F, 0.8999, 2.11, 0.330, 243, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2578, 4qv8T, 0.8999, 2.11, 0.330, 243, 230, YCP BETA5-C52F MUTANT
2579, 4qv8F, 0.8999, 2.11, 0.330, 243, 230, YCP BETA5-C52F MUTANT
2580, 4qv7F, 0.8999, 2.11, 0.330, 243, 230, YCP BETA5-A50V MUTANT
2581, 4qlvT, 0.8999, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2582, 3uneh, 0.8999, 2.10, 0.330, 243, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2583, 5lf4Q, 0.8998, 2.10, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2584, 5lf0T, 0.8998, 2.11, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2585, 5leyT, 0.8998, 2.11, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2586, 5fgfT, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2587, 5fgfF, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2588, 5fgaT, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2589, 5fg9T, 0.8998, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2590, 5fg9F, 0.8998, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2591, 4ya7T, 0.8998, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2592, 4ya7F, 0.8998, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2593, 4ya5T, 0.8998, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2594, 4y8rT, 0.8998, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2595, 4y8rF, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2596, 4y8nT, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2597, 4y8nF, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2598, 4y8hT, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2599, 4y81T, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2600, 4y81F, 0.8998, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2601, 4y7xT, 0.8998, 2.14, 0.352, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2602, 4r17T, 0.8998, 1.94, 0.348, 238, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2603, 4r17F, 0.8998, 2.34, 0.345, 240, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2604, 4qz2T, 0.8998, 2.35, 0.345, 240, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2605, 4qz2F, 0.8998, 2.12, 0.330, 243, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2606, 4qwkT, 0.8998, 2.12, 0.330, 243, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2607, 4qw0T, 0.8998, 2.11, 0.330, 243, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2608, 4qw0F, 0.8998, 2.11, 0.330, 243, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2609, 4qv7T, 0.8998, 2.11, 0.330, 243, 230, YCP BETA5-A50V MUTANT
2610, 4qlvF, 0.8998, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2611, 4nnwT, 0.8998, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2612, 4nnwF, 0.8998, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2613, 4hrdF, 0.8998, 2.11, 0.330, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2614, 5lf7F, 0.8997, 2.11, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2615, 5lf3T, 0.8997, 2.11, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2616, 5lf0F, 0.8997, 2.11, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2617, 5fghT, 0.8997, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2618, 5fghF, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2619, 5fgdT, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2620, 5fgdF, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2621, 5fg7T, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2622, 5fg7F, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2623, 5dkjT, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2624, 5dkjF, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2625, 5d0tT, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2626, 5d0tF, 0.8997, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2627, 4ya5F, 0.8997, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2628, 4ya2T, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2629, 4ya2F, 0.8997, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2630, 4y9zT, 0.8997, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2631, 4y8oT, 0.8997, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2632, 4y8oF, 0.8997, 2.09, 0.330, 244, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2633, 4y8hF, 0.8997, 2.20, 0.346, 239, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2634, 4y82T, 0.8997, 2.34, 0.345, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2635, 4y82F, 0.8997, 2.21, 0.346, 239, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2636, 4y7xF, 0.8997, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2637, 4y74T, 0.8997, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2638, 4y74F, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2639, 4y6zT, 0.8997, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2640, 4y6zF, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2641, 4x6zU, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2642, 4qzwT, 0.8997, 2.10, 0.330, 243, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2643, 4qzwF, 0.8997, 2.10, 0.330, 243, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2644, 4qz1T, 0.8997, 2.10, 0.330, 243, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2645, 4qz1F, 0.8997, 2.10, 0.330, 243, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2646, 4qwkF, 0.8997, 2.10, 0.330, 243, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2647, 5lf4T, 0.8996, 2.13, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2648, 5laiT, 0.8996, 2.13, 0.330, 243, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2649, 5laiF, 0.8996, 2.11, 0.330, 243, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2650, 5l52T, 0.8996, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2651, 5l52F, 0.8996, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2652, 5d0xT, 0.8996, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2653, 5d0xF, 0.8996, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2654, 5cgiT, 0.8996, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2655, 5cgiF, 0.8996, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2656, 5cgfT, 0.8996, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2657, 4y9zF, 0.8996, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2658, 4r00T, 0.8996, 2.11, 0.330, 243, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2659, 4r00F, 0.8996, 2.11, 0.330, 243, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2660, 4qz5T, 0.8996, 2.10, 0.330, 244, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2661, 4qz5F, 0.8996, 2.11, 0.330, 243, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2662, 4qwrT, 0.8996, 2.11, 0.330, 243, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2663, 4qwrF, 0.8996, 2.11, 0.330, 243, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2664, 4qwiT, 0.8996, 2.11, 0.330, 243, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2665, 4qwiF, 0.8996, 2.11, 0.330, 243, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2666, 4qv9F, 0.8996, 2.34, 0.345, 240, 232, YCP BETA5-C63F MUTANT
2667, 4no9T, 0.8996, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2668, 4no9F, 0.8996, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2669, 3unhT, 0.8996, 2.12, 0.330, 243, 230, MOUSE 20S IMMUNOPROTEASOME
2670, 3unhF, 0.8996, 2.12, 0.330, 243, 230, MOUSE 20S IMMUNOPROTEASOME
2671, 3unfT, 0.8996, 2.10, 0.330, 243, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2672, 3unfF, 0.8996, 2.10, 0.330, 243, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2673, 5fhsT, 0.8995, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2674, 5fhsF, 0.8995, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2675, 5cgfF, 0.8995, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2676, 4y8qT, 0.8995, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2677, 4y8qF, 0.8995, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2678, 4y8lT, 0.8995, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2679, 4y8lF, 0.8995, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2680, 4y8iT, 0.8995, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2681, 4y8iF, 0.8995, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2682, 4x6zG, 0.8995, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2683, 4qw3T, 0.8995, 2.11, 0.330, 243, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2684, 4qw3F, 0.8995, 2.11, 0.330, 243, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2685, 4qv9T, 0.8995, 2.12, 0.330, 243, 230, YCP BETA5-C63F MUTANT
2686, 4qv3T, 0.8995, 2.12, 0.330, 243, 230, YCP BETA5-M45V MUTANT
2687, 4qv3F, 0.8995, 2.12, 0.330, 243, 230, YCP BETA5-M45V MUTANT
2688, 4no1T, 0.8995, 2.00, 0.354, 244, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2689, 4no1F, 0.8995, 2.00, 0.354, 244, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2690, 4nnnT, 0.8995, 2.00, 0.354, 244, 229, YCP IN COMPLEX WITH MG132
2691, 4nnnF, 0.8995, 2.00, 0.354, 244, 229, YCP IN COMPLEX WITH MG132
2692, 5t0gL, 0.8994, 2.12, 0.330, 243, 230, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2693, 5lf1F, 0.8994, 2.12, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2694, 5cz5T, 0.8994, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2695, 5cz5F, 0.8994, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2696, 4z1lT, 0.8994, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2697, 4z1lF, 0.8994, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2698, 4qwsT, 0.8994, 2.11, 0.330, 243, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2699, 4qwsF, 0.8994, 2.11, 0.330, 243, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2700, 4qluT, 0.8994, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2701, 4qluF, 0.8994, 2.10, 0.326, 244, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2702, 4qltT, 0.8994, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2703, 4qltF, 0.8994, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2704, 4q1sF, 0.8994, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2705, 3uneT, 0.8994, 2.12, 0.330, 243, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2706, 5leyF, 0.8993, 2.12, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2707, 5le5F, 0.8993, 2.12, 0.330, 243, 230, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2708, 4y8jT, 0.8993, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2709, 4y8jF, 0.8993, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2710, 4y80T, 0.8993, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2711, 4y80F, 0.8993, 1.81, 0.316, 238, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2712, 4qxjT, 0.8993, 2.21, 0.346, 239, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2713, 4qxjF, 0.8993, 2.11, 0.330, 243, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2714, 4qlqT, 0.8993, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2715, 4qlqF, 0.8993, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2716, 4no6T, 0.8993, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2717, 4no6F, 0.8993, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2718, 3un8F, 0.8993, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2719, 5lf7Q, 0.8992, 2.13, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2720, 5lf3Q, 0.8992, 2.13, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2721, 5leyQ, 0.8992, 2.12, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2722, 5l54T, 0.8992, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2723, 5l54F, 0.8992, 2.11, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2724, 5dkiT, 0.8992, 2.17, 0.352, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2725, 5dkiF, 0.8992, 2.21, 0.346, 239, 231, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2726, 5cz8T, 0.8992, 2.20, 0.346, 239, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2727, 5cz8F, 0.8992, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2728, 5cz4T, 0.8992, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2729, 5cz4F, 0.8992, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2730, 4y7wT, 0.8992, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2731, 4y7wF, 0.8992, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2732, 4y70T, 0.8992, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2733, 4y70F, 0.8992, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2734, 4qzxT, 0.8992, 2.12, 0.330, 243, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2735, 4qzxF, 0.8992, 2.11, 0.330, 243, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2736, 4qwjT, 0.8992, 2.11, 0.330, 243, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2737, 4qwjF, 0.8992, 2.17, 0.335, 244, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2738, 4qwgT, 0.8992, 1.95, 0.348, 238, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2739, 4qwgF, 0.8992, 1.95, 0.348, 238, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2740, 4qvvT, 0.8992, 1.95, 0.348, 239, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2741, 4qvvF, 0.8992, 2.12, 0.330, 243, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2742, 4no8T, 0.8992, 2.12, 0.330, 243, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2743, 4no8F, 0.8992, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2744, 4ltcT, 0.8992, 2.10, 0.330, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2745, 4ltcF, 0.8992, 2.12, 0.330, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2746, 5lf6F, 0.8991, 2.12, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2747, 4ya3T, 0.8991, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2748, 4ya3F, 0.8991, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2749, 4qbyT, 0.8991, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2750, 4qbyF, 0.8991, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2751, 3un8T, 0.8991, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2752, 5lf4F, 0.8990, 2.11, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2753, 4ya0T, 0.8990, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2754, 4ya0F, 0.8990, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2755, 4y7yT, 0.8990, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2756, 4y78T, 0.8990, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2757, 4y78F, 0.8990, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2758, 6epfE, 0.8989, 2.11, 0.330, 243, 230, GROUND STATE 26S PROTEASOME (GS1)
2759, 4y7yF, 0.8989, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2760, 4hnpT, 0.8989, 2.10, 0.330, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2761, 5lf0Q, 0.8988, 2.12, 0.330, 243, 230, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2762, 4j70F, 0.8988, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2763, 4intT, 0.8988, 2.11, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2764, 4inrT, 0.8988, 2.11, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2765, 4inrF, 0.8988, 2.21, 0.346, 239, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2766, 4hrcT, 0.8988, 2.11, 0.330, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2767, 3nzjT, 0.8988, 2.11, 0.330, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2768, 3nzjF, 0.8988, 2.13, 0.326, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2769, 4q1sT, 0.8987, 2.13, 0.326, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2770, 4intF, 0.8987, 2.18, 0.335, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2771, 5vfsD, 0.8986, 2.21, 0.346, 239, 231, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2772, 3mg4F, 0.8986, 2.11, 0.330, 243, 230, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2773, 3mg0T, 0.8986, 2.11, 0.330, 243, 230, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2774, 5mp9G, 0.8985, 2.11, 0.330, 243, 230, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2775, 4j70T, 0.8985, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2776, 4inuF, 0.8985, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2777, 4hrdT, 0.8985, 1.64, 0.608, 233, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2778, 3gptT, 0.8985, 2.11, 0.330, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2779, 3gptF, 0.8985, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2780, 5mpaD, 0.8984, 1.96, 0.348, 238, 230, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2781, 4inuT, 0.8984, 2.12, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2782, 3nzwT, 0.8984, 2.18, 0.335, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2783, 3nzwF, 0.8984, 2.18, 0.335, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2784, 3hyeT, 0.8984, 2.18, 0.335, 244, 230, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2785, 3hyeF, 0.8984, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2786, 1rypG, 0.8984, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2787, 5mp9g, 0.8983, 2.12, 0.330, 244, 230, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2788, 4lqiT, 0.8983, 2.14, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2789, 4lqiF, 0.8983, 2.18, 0.335, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2790, 1iruG, 0.8983, 1.34, 0.612, 228, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2791, 3mg7U, 0.8982, 2.00, 0.342, 239, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2792, 1rypU, 0.8982, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2793, 1jd2F, 0.8982, 2.13, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2794, 1iruU, 0.8982, 2.11, 0.330, 243, 230, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2795, 4jsqT, 0.8981, 2.12, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2796, 4jsqF, 0.8981, 2.19, 0.335, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2797, 4fzgF, 0.8981, 2.12, 0.330, 244, 230, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2798, 4fzgT, 0.8980, 2.12, 0.330, 244, 230, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2799, 3tddT, 0.8980, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2800, 3tddF, 0.8980, 1.94, 0.343, 240, 230, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2801, 3nzxT, 0.8980, 2.19, 0.335, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2802, 3nzxF, 0.8980, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2803, 3mg4T, 0.8980, 2.12, 0.330, 244, 230, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2804, 3gpwT, 0.8980, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2805, 3gpwF, 0.8980, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2806, 3d29T, 0.8980, 2.17, 0.335, 244, 230, PROTEASOME INHIBITION BY FELLUTAMIDE B
2807, 2fakT, 0.8980, 2.16, 0.335, 243, 230, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2808, 4gk7T, 0.8979, 2.13, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2809, 4gk7F, 0.8979, 2.13, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2810, 4eu2U, 0.8979, 2.28, 0.349, 245, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2811, 3e47T, 0.8979, 1.91, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2812, 3e47F, 0.8979, 2.17, 0.335, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2813, 3d29F, 0.8979, 2.18, 0.335, 244, 230, PROTEASOME INHIBITION BY FELLUTAMIDE B
2814, 2fakF, 0.8979, 2.28, 0.349, 245, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2815, 1jd21, 0.8979, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2816, 1g0uF, 0.8979, 2.12, 0.330, 244, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2817, 4jt0T, 0.8978, 2.12, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2818, 4jt0F, 0.8978, 2.12, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2819, 4jsuT, 0.8978, 2.13, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2820, 4jsuF, 0.8978, 2.13, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2821, 3mg6U, 0.8978, 2.12, 0.330, 244, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2822, 3mg0F, 0.8978, 2.12, 0.330, 244, 230, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2823, 2gplT, 0.8978, 2.13, 0.330, 244, 230, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2824, 2gplF, 0.8978, 2.13, 0.330, 244, 230, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2825, 1z7qG, 0.8978, 2.13, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2826, 4v7oU, 0.8977, 2.13, 0.330, 244, 230, 
2827, 4v7oG, 0.8977, 2.12, 0.330, 244, 230, 
2828, 3okjT, 0.8977, 2.13, 0.330, 244, 230, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2829, 3okjF, 0.8977, 2.13, 0.330, 244, 230, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2830, 3mg8U, 0.8977, 2.20, 0.335, 244, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2831, 1z7qU, 0.8977, 2.13, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2832, 3sdkU, 0.8976, 2.13, 0.330, 244, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2833, 5mpbB, 0.8975, 2.13, 0.330, 244, 230, 
2834, 4v7oOA, 0.8975, 2.12, 0.330, 244, 230, 
2835, 4v7oCB, 0.8975, 2.18, 0.335, 244, 230, 
2836, 3dy3T, 0.8975, 2.17, 0.335, 242, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2837, 3dy3F, 0.8975, 2.13, 0.330, 244, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2838, 1g0uT, 0.8975, 2.13, 0.330, 244, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2839, 3un4T, 0.8974, 2.13, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2840, 3un4F, 0.8974, 2.13, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2841, 3oeuU, 0.8974, 1.91, 0.239, 243, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2842, 1g65T, 0.8974, 2.13, 0.330, 244, 230, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2843, 3gpjT, 0.8973, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2844, 3bdmT, 0.8973, 2.12, 0.330, 244, 230, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2845, 3bdmF, 0.8973, 2.09, 0.330, 243, 230, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2846, 2f16T, 0.8973, 2.15, 0.326, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2847, 2f16F, 0.8973, 2.15, 0.326, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2848, 3gpjF, 0.8972, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2849, 1g65F, 0.8972, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2850, 4fzcT, 0.8971, 1.92, 0.239, 243, 230, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2851, 4fzcF, 0.8971, 2.09, 0.330, 243, 230, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2852, 4cr2B, 0.8971, 1.92, 0.239, 243, 230, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2853, 3shjT, 0.8971, 1.75, 0.332, 250, 226, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2854, 3shjF, 0.8971, 2.15, 0.326, 244, 230, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2855, 3dy4T, 0.8971, 2.15, 0.326, 244, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2856, 5mpcP, 0.8970, 2.14, 0.330, 244, 230, 
2857, 3mg4U, 0.8970, 2.14, 0.330, 244, 230, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2858, 3dy4F, 0.8970, 2.17, 0.335, 242, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2859, 2zcyT, 0.8970, 2.14, 0.330, 244, 230, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2860, 2zcyF, 0.8970, 2.13, 0.330, 244, 230, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2861, 6avoR, 0.8969, 1.92, 0.239, 243, 230, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2862, 1rypO, 0.8969, 2.17, 0.335, 244, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2863, 3un8U, 0.8968, 2.14, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2864, 3oevU, 0.8968, 2.20, 0.335, 244, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2865, 4v7oQ, 0.8966, 2.20, 0.335, 244, 230, 
2866, 4v7oYA, 0.8965, 2.13, 0.330, 244, 230, 
2867, 4v7oKA, 0.8965, 2.13, 0.330, 244, 230, 
2868, 4v7oC, 0.8965, 2.14, 0.330, 244, 230, 
2869, 3wxrO, 0.8963, 2.17, 0.335, 244, 230, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2870, 1rypA, 0.8961, 2.19, 0.335, 244, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2871, 5vfuU, 0.8960, 2.19, 0.335, 244, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2872, 5vftJ, 0.8960, 1.81, 0.330, 250, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2873, 5dsvF, 0.8960, 2.13, 0.330, 244, 230, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2874, 3h4pA, 0.8960, 2.13, 0.330, 244, 230, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2875, 6avoK, 0.8958, 2.14, 0.330, 244, 230, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2876, 5wviDA, 0.8958, 1.73, 0.339, 250, 227, 
2877, 5dsvL, 0.8958, 1.92, 0.239, 243, 230, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2878, 4q1sU, 0.8958, 2.14, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2879, 4ltcU, 0.8958, 2.14, 0.330, 244, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2880, 4g4sG, 0.8958, 2.14, 0.330, 244, 230, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2881, 3mg7G, 0.8958, 1.93, 0.263, 240, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2882, 5dsvN, 0.8957, 1.94, 0.239, 243, 230, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2883, 4j70U, 0.8957, 1.93, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2884, 3h4pE, 0.8957, 1.93, 0.239, 243, 230, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2885, 3h4pD, 0.8957, 1.80, 0.344, 232, 224, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2886, 1g65U, 0.8957, 1.80, 0.344, 232, 224, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2887, 5mpcB, 0.8956, 1.80, 0.344, 232, 224, 
2888, 5dsvB, 0.8956, 2.15, 0.326, 244, 230, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2889, 3un8G, 0.8956, 1.80, 0.344, 232, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2890, 3mg6G, 0.8956, 1.93, 0.239, 243, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2891, 5dsvA, 0.8955, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2892, 4hnpU, 0.8955, 2.02, 0.342, 239, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2893, 3h4pH, 0.8955, 2.02, 0.342, 239, 231, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2894, 3h4pN, 0.8954, 2.40, 0.349, 244, 232, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2895, 5wvkR, 0.8953, 2.08, 0.434, 232, 228, 
2896, 5wvkBA, 0.8953, 1.94, 0.263, 240, 228, 
2897, 5wviOA, 0.8953, 1.86, 0.326, 250, 227, 
2898, 3mg0U, 0.8953, 2.40, 0.349, 245, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2899, 3jcpPA, 0.8953, 1.94, 0.239, 243, 230, 
2900, 3h4pL, 0.8953, 1.94, 0.239, 243, 230, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2901, 4jsuU, 0.8952, 2.03, 0.338, 246, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2902, 4jsuG, 0.8952, 1.95, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2903, 3oevG, 0.8952, 2.40, 0.349, 244, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2904, 3h4pC, 0.8952, 1.95, 0.239, 243, 230, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2905, 5vfsCA, 0.8951, 2.11, 0.434, 232, 228, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2906, 5dsvD, 0.8951, 2.09, 0.434, 232, 228, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2907, 4jsqU, 0.8951, 1.96, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2908, 4jsqG, 0.8951, 1.72, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2909, 4j70G, 0.8951, 2.40, 0.349, 245, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2910, 4hrcU, 0.8951, 1.95, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2911, 3wxrA, 0.8951, 1.95, 0.239, 243, 230, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2912, 3tddU, 0.8951, 2.40, 0.349, 244, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2913, 3tddG, 0.8951, 1.94, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2914, 3sdkG, 0.8951, 2.09, 0.434, 232, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2915, 3jcpP, 0.8951, 2.09, 0.434, 232, 228, 
2916, 5dsvE, 0.8950, 2.06, 0.342, 241, 231, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2917, 4inrU, 0.8950, 2.09, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2918, 3oeuG, 0.8950, 1.87, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2919, 5mpbP, 0.8949, 1.95, 0.239, 243, 230, 
2920, 3un4U, 0.8949, 2.12, 0.326, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2921, 3nzjU, 0.8949, 2.09, 0.434, 232, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2922, 5a5bD, 0.8948, 1.96, 0.239, 243, 230, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2923, 4intU, 0.8948, 1.96, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2924, 4hrdU, 0.8948, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2925, 4cr3D, 0.8948, 2.10, 0.434, 232, 228, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2926, 3un4G, 0.8948, 2.03, 0.342, 239, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2927, 3nzxU, 0.8948, 2.41, 0.349, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2928, 1jd22, 0.8948, 1.95, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2929, 4v7oO, 0.8947, 1.96, 0.239, 243, 230, 
2930, 4v7oIA, 0.8947, 1.97, 0.239, 243, 230, 
2931, 4v7oA, 0.8947, 1.94, 0.239, 243, 230, 
2932, 3nzjG, 0.8947, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2933, 3h4pJ, 0.8947, 1.96, 0.239, 243, 230, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2934, 4v7oWA, 0.8946, 1.96, 0.239, 243, 230, 
2935, 4lqiU, 0.8946, 1.96, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2936, 4jt0U, 0.8946, 2.12, 0.326, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2937, 4jt0G, 0.8946, 2.12, 0.326, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2938, 4inrG, 0.8946, 2.41, 0.349, 245, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2939, 3shjU, 0.8946, 1.96, 0.239, 243, 230, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2940, 3nzxG, 0.8946, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2941, 3hyeU, 0.8946, 1.88, 0.330, 250, 227, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2942, 3h4pF, 0.8946, 1.96, 0.239, 243, 230, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2943, 3gpwU, 0.8946, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2944, 4lqiG, 0.8945, 2.07, 0.338, 242, 231, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2945, 3shjG, 0.8945, 1.95, 0.239, 243, 230, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2946, 3hyeG, 0.8945, 1.95, 0.239, 243, 230, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2947, 3gpwG, 0.8945, 2.07, 0.338, 242, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2948, 3gpjU, 0.8945, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2949, 3gpjG, 0.8945, 1.97, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2950, 2fakU, 0.8945, 1.97, 0.239, 243, 230, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2951, 3mg8G, 0.8944, 2.15, 0.326, 244, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2952, 3gptU, 0.8944, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2953, 2fakG, 0.8944, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2954, 5dsvG, 0.8943, 1.46, 1.000, 250, 235, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2955, 3gptG, 0.8943, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2956, 3bdmU, 0.8943, 1.96, 0.239, 243, 230, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2957, 3bdmG, 0.8943, 2.11, 0.434, 232, 228, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2958, 1fntG, 0.8943, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2959, 4inuU, 0.8942, 1.97, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2960, 3nzwU, 0.8942, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2961, 1fntU, 0.8942, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2962, 5dsvK, 0.8941, 1.97, 0.239, 243, 230, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2963, 4ltcG, 0.8941, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2964, 4fzcU, 0.8941, 1.97, 0.239, 243, 230, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2965, 3nzwG, 0.8941, 1.97, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2966, 3e47U, 0.8941, 2.11, 0.434, 232, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2967, 4fzcG, 0.8940, 1.97, 0.239, 243, 230, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2968, 3sdiU, 0.8940, 1.97, 0.239, 243, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2969, 3mg4G, 0.8940, 1.97, 0.239, 243, 230, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2970, 3jcpJA, 0.8940, 1.97, 0.239, 243, 230, 
2971, 3jcpJ, 0.8940, 1.98, 0.239, 243, 230, 
2972, 3e47G, 0.8940, 1.98, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2973, 2gplU, 0.8940, 1.98, 0.239, 243, 230, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2974, 2f16U, 0.8940, 1.97, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2975, 1g65G, 0.8940, 1.97, 0.239, 243, 230, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2976, 5mpag, 0.8939, 1.98, 0.239, 243, 230, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2977, 5dsvI, 0.8939, 1.98, 0.239, 243, 230, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2978, 3okjU, 0.8939, 2.43, 0.349, 242, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2979, 2gplG, 0.8939, 1.98, 0.239, 243, 230, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2980, 2f16G, 0.8939, 1.98, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2981, 4intG, 0.8938, 1.98, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2982, 4fzgU, 0.8938, 2.21, 0.335, 240, 230, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2983, 3okjG, 0.8938, 1.97, 0.239, 243, 230, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2984, 3h4pG, 0.8938, 1.98, 0.239, 243, 230, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2985, 3h4pB, 0.8938, 2.22, 0.335, 240, 230, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2986, 4inuG, 0.8937, 2.36, 0.346, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2987, 4fzgG, 0.8937, 1.97, 0.239, 243, 230, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2988, 3h4pI, 0.8937, 1.97, 0.239, 243, 230, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2989, 3d29U, 0.8937, 1.98, 0.239, 243, 230, PROTEASOME INHIBITION BY FELLUTAMIDE B
2990, 3d29G, 0.8937, 1.97, 0.239, 243, 230, PROTEASOME INHIBITION BY FELLUTAMIDE B
2991, 5nifA, 0.8936, 1.97, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2992, 5m32S, 0.8936, 1.99, 0.248, 240, 230, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2993, 5m32Q, 0.8936, 1.98, 0.239, 243, 230, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2994, 3h4pK, 0.8934, 1.98, 0.239, 243, 230, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2995, 1g0uU, 0.8934, 1.98, 0.239, 243, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2996, 4zzgA, 0.8933, 1.98, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2997, 4gk7U, 0.8933, 1.97, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2998, 3dy3U, 0.8933, 1.98, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2999, 5t0iH, 0.8932, 1.98, 0.239, 243, 230, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3000, 5ln3C, 0.8932, 1.99, 0.239, 243, 230, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3001, 3dy3G, 0.8932, 2.23, 0.335, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3002, 2zcyU, 0.8932, 2.36, 0.346, 244, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3003, 2zcyG, 0.8932, 1.97, 0.239, 243, 230, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3004, 4gk7G, 0.8931, 1.98, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3005, 3dy4U, 0.8931, 1.98, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3006, 3dy4G, 0.8931, 1.97, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3007, 4q1sG, 0.8930, 1.97, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3008, 4x6zA, 0.8929, 1.98, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3009, 5m32C, 0.8927, 2.12, 0.434, 232, 228, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3010, 1g0uG, 0.8927, 2.13, 0.434, 232, 228, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3011, 5wviNA, 0.8925, 1.98, 0.239, 243, 230, 
3012, 4qv9U, 0.8925, 1.97, 0.239, 243, 230, YCP BETA5-C63F MUTANT
3013, 4qv9G, 0.8925, 1.87, 0.434, 232, 226, YCP BETA5-C63F MUTANT
3014, 5t0cV, 0.8924, 1.99, 0.239, 243, 230, 
3015, 5t0cBB, 0.8924, 1.99, 0.239, 243, 230, 
3016, 5l5bU, 0.8924, 1.92, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3017, 5l5bG, 0.8924, 1.78, 0.314, 238, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3018, 5d0wU, 0.8924, 1.94, 0.346, 235, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3019, 5d0wG, 0.8923, 2.13, 0.434, 232, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3020, 4ya4U, 0.8923, 2.00, 0.248, 240, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3021, 4ya4G, 0.8923, 1.93, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3022, 5fggU, 0.8922, 1.97, 0.239, 243, 230, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3023, 5fggG, 0.8922, 2.00, 0.239, 243, 230, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3024, 5czaU, 0.8922, 1.76, 0.311, 233, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3025, 5czaG, 0.8922, 2.14, 0.346, 261, 234, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3026, 3h4pM, 0.8922, 2.00, 0.239, 243, 230, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
3027, 4y8rU, 0.8921, 2.00, 0.239, 243, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3028, 4y8rG, 0.8921, 2.00, 0.239, 243, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3029, 4qv3U, 0.8921, 1.98, 0.239, 243, 230, YCP BETA5-M45V MUTANT
3030, 4qv3G, 0.8921, 2.00, 0.239, 243, 230, YCP BETA5-M45V MUTANT
3031, 4hrdG, 0.8920, 2.00, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3032, 4hnpG, 0.8920, 2.00, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3033, 5fg7U, 0.8919, 1.99, 0.239, 242, 230, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3034, 5fg7G, 0.8919, 1.93, 0.348, 234, 227, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3035, 5cgfU, 0.8919, 2.01, 0.248, 240, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3036, 5cgfG, 0.8919, 2.16, 0.358, 245, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3037, 5ahjU, 0.8919, 1.94, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3038, 1jd2G, 0.8919, 1.94, 0.240, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3039, 5vfom, 0.8918, 2.03, 0.342, 239, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3040, 5m32E, 0.8918, 2.03, 0.342, 239, 231, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3041, 5l55U, 0.8918, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3042, 5l55G, 0.8918, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3043, 5cggU, 0.8918, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3044, 5ahjG, 0.8918, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3045, 4ya1U, 0.8918, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3046, 4ya1G, 0.8918, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3047, 4quyU, 0.8918, 1.94, 0.240, 241, 229, YCP BETA5-A49S-MUTANT
3048, 4quyG, 0.8918, 1.94, 0.240, 241, 229, YCP BETA5-A49S-MUTANT
3049, 4no8U, 0.8918, 1.95, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3050, 4no8G, 0.8918, 1.95, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3051, 5vftM, 0.8917, 1.88, 0.434, 232, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3052, 5l5rU, 0.8917, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3053, 5l5rG, 0.8917, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3054, 5fgaU, 0.8917, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3055, 5cggG, 0.8917, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3056, 4qv7U, 0.8917, 2.00, 0.239, 243, 230, YCP BETA5-A50V MUTANT
3057, 4qv7G, 0.8917, 2.00, 0.239, 243, 230, YCP BETA5-A50V MUTANT
3058, 5vfuX, 0.8916, 1.95, 0.240, 241, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3059, 5l5uU, 0.8916, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3060, 5fgaG, 0.8916, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3061, 5d0sU, 0.8916, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3062, 5d0sG, 0.8916, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3063, 5bxlU, 0.8916, 2.00, 0.239, 243, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3064, 4qwlU, 0.8916, 2.32, 0.333, 240, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3065, 4qwlG, 0.8916, 1.73, 0.316, 234, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3066, 4no1U, 0.8916, 1.95, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3067, 4no1G, 0.8916, 1.95, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3068, 4nnnU, 0.8916, 1.95, 0.240, 241, 229, YCP IN COMPLEX WITH MG132
3069, 5l5uG, 0.8915, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3070, 5jhrU, 0.8915, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3071, 5bxlG, 0.8915, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3072, 4y8hU, 0.8915, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3073, 4y8hG, 0.8915, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3074, 4nnnG, 0.8915, 1.95, 0.240, 241, 229, YCP IN COMPLEX WITH MG132
3075, 3mg0G, 0.8915, 1.95, 0.240, 241, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3076, 5wvkV, 0.8914, 2.32, 0.333, 240, 231, 
3077, 5vfqG, 0.8914, 1.96, 0.240, 241, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3078, 5jhrG, 0.8914, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3079, 5bxnU, 0.8914, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3080, 4qv5U, 0.8914, 1.95, 0.240, 241, 229, YCP BETA5-M45I MUTANT
3081, 4qv5G, 0.8914, 1.96, 0.240, 241, 229, YCP BETA5-M45I MUTANT
3082, 4qv1U, 0.8914, 1.96, 0.240, 241, 229, YCP BETA5-M45A MUTANT
3083, 4qv1G, 0.8914, 2.32, 0.333, 240, 231, YCP BETA5-M45A MUTANT
3084, 4no9U, 0.8914, 1.96, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3085, 4no9G, 0.8914, 1.96, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3086, 4hrcG, 0.8914, 1.95, 0.240, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3087, 5l6aU, 0.8913, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3088, 5l6aG, 0.8913, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3089, 5l52U, 0.8913, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3090, 5l52G, 0.8913, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3091, 4y8tU, 0.8913, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3092, 4y8tG, 0.8913, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3093, 4qwuU, 0.8913, 1.95, 0.240, 241, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3094, 4qwuG, 0.8913, 1.96, 0.240, 241, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3095, 3sdiG, 0.8913, 1.95, 0.240, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3096, 5fgfU, 0.8912, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3097, 5fgfG, 0.8912, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3098, 5bxnG, 0.8912, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3099, 4z1lU, 0.8912, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3100, 4z1lG, 0.8912, 2.01, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3101, 4ya2U, 0.8912, 2.02, 0.235, 243, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3102, 4ya2G, 0.8912, 2.34, 0.333, 240, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3103, 4qv4U, 0.8912, 1.95, 0.240, 241, 229, YCP BETA5-M45T MUTANT
3104, 4qv4G, 0.8912, 1.96, 0.240, 241, 229, YCP BETA5-M45T MUTANT
3105, 5t0hL, 0.8911, 1.96, 0.240, 241, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3106, 4qz6U, 0.8911, 1.96, 0.240, 241, 229, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3107, 4qv8U, 0.8911, 1.96, 0.240, 241, 229, YCP BETA5-C52F MUTANT
3108, 4qv8G, 0.8911, 1.96, 0.240, 241, 229, YCP BETA5-C52F MUTANT
3109, 4qv0U, 0.8911, 1.95, 0.240, 241, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3110, 6gopU, 0.8910, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3111, 5wviCA, 0.8910, 2.00, 0.239, 243, 230, 
3112, 4ya7U, 0.8910, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3113, 4ya7G, 0.8910, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3114, 4y9yU, 0.8910, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3115, 4y9yG, 0.8910, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3116, 4y8mU, 0.8910, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3117, 4y8mG, 0.8910, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3118, 4qzzU, 0.8910, 1.96, 0.240, 241, 229, YCP IN COMPLEX WITH OMURALIDE
3119, 4qzzG, 0.8910, 1.96, 0.240, 241, 229, YCP IN COMPLEX WITH OMURALIDE
3120, 4qz6G, 0.8910, 2.03, 0.248, 240, 230, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3121, 4qvnU, 0.8910, 1.95, 0.240, 241, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3122, 4qvnG, 0.8910, 1.95, 0.240, 241, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3123, 4qv0G, 0.8910, 1.96, 0.240, 241, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3124, 3mg8T, 0.8910, 1.96, 0.240, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3125, 3jcoJA, 0.8910, 1.96, 0.240, 241, 229, 
3126, 6gopG, 0.8909, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3127, 5fg9U, 0.8909, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3128, 5fg9G, 0.8909, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3129, 5dsvH, 0.8909, 1.96, 0.240, 241, 229, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3130, 5d0zU, 0.8909, 1.92, 0.316, 238, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3131, 5d0zG, 0.8909, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3132, 4y8sU, 0.8909, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3133, 4y8pU, 0.8909, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3134, 4y8pG, 0.8909, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3135, 4r17U, 0.8909, 1.96, 0.240, 241, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3136, 4r17G, 0.8909, 2.17, 0.353, 245, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3137, 4r00U, 0.8909, 1.96, 0.240, 241, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3138, 4r00G, 0.8909, 1.96, 0.240, 241, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3139, 4qz0U, 0.8909, 1.96, 0.240, 241, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3140, 4qluU, 0.8909, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3141, 4qluG, 0.8909, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3142, 4cr2D, 0.8909, 1.97, 0.240, 241, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3143, 3jcoJ, 0.8909, 1.96, 0.240, 241, 229, 
3144, 5vfpEA, 0.8908, 1.96, 0.240, 241, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3145, 5lttU, 0.8908, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3146, 5lttG, 0.8908, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3147, 5cz9U, 0.8908, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3148, 5cz9G, 0.8908, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3149, 4y8sG, 0.8908, 2.09, 0.335, 237, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3150, 4y8kU, 0.8908, 2.02, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3151, 4y8kG, 0.8908, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3152, 4y8gU, 0.8908, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3153, 4qz0G, 0.8908, 1.97, 0.240, 241, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3154, 4qv6U, 0.8908, 2.09, 0.351, 239, 228, YCP BETA5-A49V MUTANT
3155, 5vfqFA, 0.8907, 1.96, 0.240, 241, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3156, 5vfoM, 0.8907, 1.96, 0.240, 241, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3157, 5nifO, 0.8907, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3158, 5l5hU, 0.8907, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3159, 5fhsU, 0.8907, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3160, 5fhsG, 0.8907, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3161, 4y8gG, 0.8907, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3162, 4r02U, 0.8907, 1.96, 0.240, 241, 229, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3163, 4qv6G, 0.8907, 1.96, 0.240, 241, 229, YCP BETA5-A49V MUTANT
3164, 4g4sA, 0.8907, 1.96, 0.240, 241, 229, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3165, 5vfsG, 0.8906, 1.96, 0.240, 241, 229, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3166, 5t0jL, 0.8906, 1.96, 0.240, 241, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3167, 5t0jK, 0.8906, 2.11, 0.342, 242, 231, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3168, 5l6bU, 0.8906, 2.02, 0.239, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3169, 5l6bG, 0.8906, 2.02, 0.239, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3170, 5l5hG, 0.8906, 2.33, 0.333, 240, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3171, 5l5aU, 0.8906, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3172, 5l5aG, 0.8906, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3173, 4zzgO, 0.8906, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3174, 4y9zU, 0.8906, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3175, 4y9zG, 0.8906, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3176, 4qltU, 0.8906, 1.96, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3177, 3oeuT, 0.8906, 1.96, 0.240, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3178, 3mg6T, 0.8906, 1.97, 0.240, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3179, 5l67U, 0.8905, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3180, 5l67G, 0.8905, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3181, 5d0vU, 0.8905, 2.34, 0.333, 240, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3182, 5d0vG, 0.8905, 2.25, 0.335, 240, 230, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3183, 5cz8U, 0.8905, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3184, 5cz8G, 0.8905, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3185, 5cz7U, 0.8905, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3186, 5cz7G, 0.8905, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3187, 5cghU, 0.8905, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3188, 4qz3U, 0.8905, 1.96, 0.240, 241, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3189, 4qw7U, 0.8905, 1.96, 0.240, 241, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3190, 4qvpU, 0.8905, 2.08, 0.239, 241, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3191, 4qvlU, 0.8905, 2.45, 0.332, 240, 232, YCP IN COMPLEX WITH BORTEZOMIB
3192, 4qvlG, 0.8905, 1.93, 0.316, 238, 228, YCP IN COMPLEX WITH BORTEZOMIB
3193, 4qltG, 0.8905, 1.82, 0.612, 228, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3194, 4no6U, 0.8905, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3195, 3oevT, 0.8905, 1.97, 0.240, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3196, 3mg7T, 0.8905, 1.97, 0.240, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3197, 5jhsU, 0.8904, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3198, 5jhsG, 0.8904, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3199, 5cghG, 0.8904, 1.98, 0.240, 242, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3200, 4qz5U, 0.8904, 1.96, 0.240, 241, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3201, 4qz3G, 0.8904, 1.96, 0.240, 241, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3202, 4qw7G, 0.8904, 1.97, 0.240, 241, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3203, 4qw6U, 0.8904, 2.10, 0.335, 237, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3204, 4qw5U, 0.8904, 2.09, 0.335, 237, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3205, 4qw5G, 0.8904, 1.97, 0.240, 241, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3206, 4qw1U, 0.8904, 1.97, 0.240, 241, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3207, 4qw1G, 0.8904, 1.96, 0.240, 241, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3208, 4qvyU, 0.8904, 1.96, 0.240, 241, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3209, 4qvpG, 0.8904, 1.96, 0.240, 241, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3210, 4qlsU, 0.8904, 1.96, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3211, 4qlsG, 0.8904, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3212, 4no6G, 0.8904, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3213, 5l64U, 0.8903, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3214, 5l63U, 0.8903, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3215, 5l63G, 0.8903, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3216, 5l61U, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3217, 5l5pU, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3218, 5l5pG, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3219, 5l5oU, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3220, 5l5oG, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3221, 5fgeU, 0.8903, 2.09, 0.335, 237, 227, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3222, 5fgeG, 0.8903, 2.10, 0.335, 237, 227, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3223, 5cz6U, 0.8903, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3224, 5cz6G, 0.8903, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3225, 4ya9U, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3226, 4ya9G, 0.8903, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3227, 4y8lU, 0.8903, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3228, 4y8lG, 0.8903, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3229, 4y75U, 0.8903, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3230, 4y75G, 0.8903, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3231, 4x6zO, 0.8903, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3232, 4r18U, 0.8903, 1.97, 0.240, 241, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3233, 4qz5G, 0.8903, 1.97, 0.240, 241, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3234, 4qw6G, 0.8903, 1.97, 0.240, 241, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3235, 4qvyG, 0.8903, 1.97, 0.240, 241, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3236, 4quxU, 0.8903, 1.97, 0.240, 241, 229, YCP BETA5-A49T-MUTANT
3237, 4eu2O, 0.8903, 1.97, 0.240, 241, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3238, 5vfpG, 0.8902, 1.97, 0.240, 241, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3239, 5l6cU, 0.8902, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3240, 5l6cG, 0.8902, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3241, 5l64G, 0.8902, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3242, 5l61G, 0.8902, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3243, 5l5fU, 0.8902, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3244, 5l5fG, 0.8902, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3245, 5l5dU, 0.8902, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3246, 5l54U, 0.8902, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3247, 4y8uU, 0.8902, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3248, 4y8uG, 0.8902, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3249, 4r18G, 0.8902, 1.97, 0.240, 241, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3250, 4quxG, 0.8902, 1.97, 0.240, 241, 229, YCP BETA5-A49T-MUTANT
3251, 4nnwU, 0.8902, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3252, 4nnwG, 0.8902, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3253, 5t0iL, 0.8901, 1.96, 0.240, 241, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3254, 5lajU, 0.8901, 1.96, 0.240, 241, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3255, 5lajG, 0.8901, 1.97, 0.240, 241, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3256, 5l66U, 0.8901, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3257, 5l65U, 0.8901, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3258, 5l65G, 0.8901, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3259, 5l62U, 0.8901, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3260, 5l62G, 0.8901, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3261, 5l5wU, 0.8901, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3262, 5l5dG, 0.8901, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3263, 5l54G, 0.8901, 1.90, 0.241, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3264, 5cgiU, 0.8901, 2.24, 0.335, 240, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3265, 4y77U, 0.8901, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3266, 4y77G, 0.8901, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3267, 4qz7U, 0.8901, 1.97, 0.240, 241, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3268, 4qz7G, 0.8901, 1.97, 0.240, 241, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3269, 4qz4U, 0.8901, 1.97, 0.240, 241, 229, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3270, 5t0cY, 0.8900, 1.97, 0.240, 241, 229, 
3271, 5t0cEB, 0.8900, 1.97, 0.240, 241, 229, 
3272, 5l66G, 0.8900, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3273, 5l5wG, 0.8900, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3274, 5cgiG, 0.8900, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3275, 4y70U, 0.8900, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3276, 4y70G, 0.8900, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3277, 4qzxU, 0.8900, 1.97, 0.240, 241, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3278, 4qzwU, 0.8900, 1.98, 0.240, 241, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3279, 4qzwG, 0.8900, 1.95, 0.320, 238, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3280, 4qz4G, 0.8900, 1.98, 0.240, 241, 229, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3281, 4qwrU, 0.8900, 1.98, 0.240, 241, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3282, 4qbyU, 0.8900, 1.98, 0.240, 241, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3283, 4qbyG, 0.8900, 1.98, 0.240, 241, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3284, 5vfsA, 0.8899, 1.98, 0.240, 241, 229, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3285, 5l5xU, 0.8899, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3286, 5l5qU, 0.8899, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3287, 5l5qG, 0.8899, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3288, 5l5eU, 0.8899, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3289, 5l5eG, 0.8899, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3290, 5d0tU, 0.8899, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3291, 5d0tG, 0.8899, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3292, 4y8qU, 0.8899, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3293, 4y7yU, 0.8899, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3294, 4y7yG, 0.8899, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3295, 4y7wU, 0.8899, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3296, 4y7wG, 0.8899, 2.29, 0.346, 240, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3297, 4qzxG, 0.8899, 1.99, 0.266, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3298, 4qwrG, 0.8899, 2.29, 0.346, 240, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3299, 4qvwU, 0.8899, 1.98, 0.240, 241, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3300, 5m2bU, 0.8898, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3301, 5m2bG, 0.8898, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3302, 5l5xG, 0.8898, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3303, 5l5vU, 0.8898, 1.97, 0.240, 241, 229,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3304, 5l5vG, 0.8898, 1.97, 0.240, 241, 229,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3305, 5l5sU, 0.8898, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3306, 5l5sG, 0.8898, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3307, 4y8qG, 0.8898, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3308, 4y6aU, 0.8898, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3309, 4y6aG, 0.8898, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3310, 4qwjU, 0.8898, 1.98, 0.240, 241, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3311, 4qwjG, 0.8898, 1.74, 0.310, 232, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3312, 4qvwG, 0.8898, 1.98, 0.262, 240, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3313, 3oevF, 0.8898, 1.98, 0.240, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3314, 3mg7F, 0.8898, 1.98, 0.240, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3315, 5mpaG, 0.8897, 1.98, 0.240, 241, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3316, 5l5tU, 0.8897, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3317, 5cz5U, 0.8897, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3318, 4y8jU, 0.8897, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3319, 4y8jG, 0.8897, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3320, 4y84U, 0.8897, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3321, 4y84G, 0.8897, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3322, 4y82U, 0.8897, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3323, 4y82G, 0.8897, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3324, 4y6vU, 0.8897, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3325, 4y6vG, 0.8897, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3326, 4qz2U, 0.8897, 1.97, 0.240, 241, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3327, 4qz2G, 0.8897, 1.98, 0.240, 241, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3328, 5vfrM, 0.8896, 1.98, 0.240, 241, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3329, 5l5zU, 0.8896, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3330, 5l5tG, 0.8896, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3331, 5fgiU, 0.8896, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3332, 5fgiG, 0.8896, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3333, 5fgdU, 0.8896, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3334, 5fgdG, 0.8896, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3335, 5cz5G, 0.8896, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3336, 4y80U, 0.8896, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3337, 4y7xU, 0.8896, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3338, 4y7xG, 0.8896, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3339, 4y74U, 0.8896, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3340, 4y69U, 0.8896, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3341, 4y69G, 0.8896, 2.08, 0.335, 237, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3342, 4qwxU, 0.8896, 2.08, 0.335, 237, 227, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3343, 4qwxG, 0.8896, 2.16, 0.332, 243, 229, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3344, 4qvqU, 0.8896, 1.98, 0.240, 241, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3345, 4qvqG, 0.8896, 1.97, 0.240, 241, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3346, 4qlvU, 0.8896, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3347, 4qlvG, 0.8896, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3348, 4qlqU, 0.8896, 1.99, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3349, 4qlqG, 0.8896, 1.99, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3350, 3oeuF, 0.8896, 1.97, 0.240, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3351, 6epfB, 0.8895, 1.97, 0.240, 241, 229, GROUND STATE 26S PROTEASOME (GS1)
3352, 5l5zG, 0.8895, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3353, 4y80G, 0.8895, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3354, 4y74G, 0.8895, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3355, 4qwiU, 0.8895, 1.97, 0.240, 241, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3356, 4qwiG, 0.8895, 2.25, 0.335, 240, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3357, 4cr2G, 0.8895, 1.98, 0.240, 241, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3358, 5vfsZ, 0.8894, 1.98, 0.240, 241, 229, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3359, 5vfoG, 0.8894, 1.97, 0.240, 241, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3360, 5l5iU, 0.8894, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3361, 5dkjU, 0.8894, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3362, 5bouU, 0.8894, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3363, 5bouG, 0.8894, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3364, 4y8nU, 0.8894, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3365, 4y8nG, 0.8894, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3366, 4qwfU, 0.8894, 1.98, 0.240, 241, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3367, 3mg8F, 0.8894, 1.98, 0.240, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3368, 5vfog, 0.8893, 1.98, 0.240, 241, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3369, 5t0cYA, 0.8893, 1.98, 0.240, 241, 229, 
3370, 5t0cS, 0.8893, 1.97, 0.240, 241, 229, 
3371, 5m32T, 0.8893, 1.97, 0.240, 241, 229, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3372, 5l5jU, 0.8893, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3373, 5l5iG, 0.8893, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3374, 5dkjG, 0.8893, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3375, 4rurU, 0.8893, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3376, 4rurG, 0.8893, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3377, 4qwfG, 0.8893, 1.99, 0.240, 241, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3378, 4cr4D, 0.8893, 2.08, 0.335, 237, 227, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3379, 5l68U, 0.8892, 1.80, 0.311, 234, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3380, 5l68G, 0.8892, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3381, 5l5jG, 0.8892, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3382, 4ya5U, 0.8892, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3383, 4ya5G, 0.8892, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3384, 4qwkU, 0.8892, 1.97, 0.240, 241, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3385, 4qw0U, 0.8892, 2.14, 0.332, 245, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3386, 5a0qS, 0.8891, 2.00, 0.266, 240, 229, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3387, 5a0qE, 0.8891, 1.96, 0.275, 239, 229, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3388, 4qwkG, 0.8891, 1.98, 0.240, 241, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3389, 4qw0G, 0.8891, 1.98, 0.240, 241, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3390, 3mg6F, 0.8891, 1.99, 0.240, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3391, 5vfrG, 0.8890, 1.99, 0.240, 241, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3392, 5l60U, 0.8890, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3393, 5l60G, 0.8890, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3394, 5l5yU, 0.8890, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3395, 5d0xU, 0.8890, 2.09, 0.335, 237, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3396, 4y8iU, 0.8890, 1.96, 0.266, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3397, 4y8iG, 0.8890, 1.99, 0.266, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3398, 4y6zU, 0.8890, 1.99, 0.266, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3399, 4qxjU, 0.8890, 2.34, 0.343, 240, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3400, 4qvvU, 0.8890, 1.98, 0.240, 241, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3401, 4qvvG, 0.8890, 1.98, 0.240, 241, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3402, 5l5yG, 0.8889, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3403, 5d0xG, 0.8889, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3404, 4y78U, 0.8889, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3405, 4y78G, 0.8889, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3406, 4y6zG, 0.8889, 2.19, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3407, 4qxjG, 0.8889, 1.98, 0.240, 241, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3408, 4intE, 0.8889, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3409, 4g4sF, 0.8889, 1.99, 0.240, 241, 229, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3410, 4ya3U, 0.8888, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3411, 4qw4U, 0.8888, 1.99, 0.240, 241, 229, YCP IN COMPLEX WITH CARFILZOMIB
3412, 4qw4G, 0.8888, 1.98, 0.240, 241, 229, YCP IN COMPLEX WITH CARFILZOMIB
3413, 5vfsFA, 0.8887, 1.99, 0.240, 241, 229, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3414, 5laiU, 0.8887, 0.99, 0.609, 215, 215, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3415, 5laiG, 0.8887, 0.99, 0.609, 215, 215, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3416, 4ya3G, 0.8887, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3417, 4intS, 0.8887, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3418, 3un8S, 0.8887, 2.10, 0.335, 237, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3419, 5l69U, 0.8886, 1.96, 0.275, 239, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3420, 5l69G, 0.8886, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3421, 5cz4U, 0.8886, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3422, 4r02G, 0.8886, 1.99, 0.240, 241, 229, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3423, 3un8E, 0.8886, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3424, 5cz4G, 0.8885, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3425, 4qvmU, 0.8885, 1.98, 0.240, 241, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3426, 4qvmG, 0.8885, 1.98, 0.240, 241, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3427, 4y81U, 0.8884, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3428, 5vfuR, 0.8883, 1.98, 0.240, 241, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3429, 5vfrg, 0.8883, 1.98, 0.240, 241, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3430, 5t0gM, 0.8883, 1.99, 0.240, 241, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3431, 5mpbD, 0.8883, 1.99, 0.240, 241, 229, 
3432, 4y81G, 0.8883, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3433, 4qz1U, 0.8883, 1.98, 0.240, 241, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3434, 4qz1G, 0.8883, 1.99, 0.240, 241, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3435, 4hnpE, 0.8883, 1.98, 0.240, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3436, 6avoN, 0.8882, 1.48, 0.344, 233, 221, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3437, 5vftG, 0.8882, 1.49, 0.344, 234, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3438, 5fghU, 0.8882, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3439, 5fghG, 0.8882, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3440, 4ya0U, 0.8882, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3441, 4ya0G, 0.8882, 2.47, 0.332, 240, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3442, 4qwsU, 0.8882, 2.00, 0.240, 241, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3443, 4hrdE, 0.8882, 2.00, 0.240, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3444, 3sdkE, 0.8882, 1.99, 0.240, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3445, 4qwsG, 0.8881, 1.48, 0.344, 233, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3446, 4jsqS, 0.8881, 1.49, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3447, 4jsqE, 0.8881, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3448, 5vfrm, 0.8880, 1.99, 0.240, 241, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3449, 4y8oU, 0.8880, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3450, 4y8oG, 0.8880, 2.01, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3451, 4inrS, 0.8880, 1.49, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3452, 4inrE, 0.8880, 2.00, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3453, 3jcoPA, 0.8880, 1.99, 0.240, 241, 229, 
3454, 5dsvJ, 0.8879, 1.99, 0.240, 241, 229, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3455, 4eu2A, 0.8879, 1.99, 0.240, 241, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3456, 3sdkS, 0.8879, 2.02, 0.266, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3457, 3jcoP, 0.8879, 1.97, 0.266, 240, 229, 
3458, 3dy3S, 0.8879, 2.31, 0.346, 240, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3459, 3dy3E, 0.8879, 1.95, 0.351, 240, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3460, 6epcE, 0.8878, 1.99, 0.240, 241, 229, GROUND STATE 26S PROTEASOME (GS2)
3461, 6avoI, 0.8878, 1.99, 0.240, 241, 229, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3462, 5mpbU, 0.8878, 1.99, 0.240, 241, 229, 
3463, 3sdkT, 0.8878, 1.49, 0.344, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3464, 3bdmS, 0.8878, 1.82, 0.356, 232, 225, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3465, 3bdmE, 0.8878, 2.02, 0.266, 240, 229, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3466, 5vfqZ, 0.8877, 2.00, 0.240, 241, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3467, 4ltcS, 0.8877, 2.00, 0.240, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3468, 4ltcE, 0.8877, 2.00, 0.240, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3469, 4hrdS, 0.8877, 2.00, 0.240, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3470, 4hnpS, 0.8877, 1.99, 0.240, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3471, 4eu2F, 0.8877, 1.49, 0.344, 233, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3472, 3nzjS, 0.8877, 1.49, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3473, 3nzjE, 0.8877, 1.99, 0.240, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3474, 3mg6S, 0.8877, 1.49, 0.344, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3475, 1z7qF, 0.8877, 1.49, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3476, 1rypF, 0.8877, 2.37, 0.333, 240, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3477, 1g65E, 0.8877, 1.99, 0.240, 241, 229, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3478, 5vfqA, 0.8876, 1.99, 0.240, 241, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3479, 4qw3U, 0.8876, 1.49, 0.344, 233, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3480, 4qw3G, 0.8876, 1.49, 0.344, 233, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3481, 3sdiE, 0.8876, 2.20, 0.326, 244, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3482, 3mg0S, 0.8876, 2.16, 0.355, 239, 228, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3483, 1z7qT, 0.8876, 1.96, 0.241, 241, 228, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3484, 5vfuLA, 0.8875, 1.49, 0.344, 233, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3485, 5vfuIA, 0.8875, 2.20, 0.326, 244, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3486, 5vftm, 0.8875, 2.20, 0.326, 244, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3487, 5vftj, 0.8875, 1.49, 0.344, 233, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3488, 4zzgT, 0.8875, 1.49, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3489, 4inuE, 0.8875, 1.78, 0.608, 233, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3490, 3d29S, 0.8875, 1.82, 0.356, 232, 225, PROTEASOME INHIBITION BY FELLUTAMIDE B
3491, 5vfpY, 0.8874, 2.18, 0.326, 243, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3492, 5dkiU, 0.8874, 2.07, 0.336, 236, 226, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3493, 5dkiG, 0.8874, 1.50, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3494, 4inuS, 0.8874, 1.50, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3495, 4fzgS, 0.8874, 1.98, 0.266, 240, 229, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3496, 4fzgE, 0.8874, 1.51, 0.344, 233, 221, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3497, 4fzcE, 0.8874, 1.51, 0.344, 233, 221, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3498, 3d29E, 0.8874, 1.49, 0.344, 233, 221, PROTEASOME INHIBITION BY FELLUTAMIDE B
3499, 5vfpA, 0.8873, 1.50, 0.344, 233, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3500, 5lajS, 0.8873, 1.51, 0.344, 232, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3501, 5lajE, 0.8873, 1.50, 0.344, 233, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3502, 4jt0S, 0.8873, 1.50, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3503, 4jt0E, 0.8873, 1.49, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3504, 4fzcS, 0.8873, 1.51, 0.344, 234, 221, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3505, 3un4S, 0.8873, 1.49, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3506, 3un4E, 0.8873, 1.50, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3507, 3nzwS, 0.8873, 1.75, 0.310, 232, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3508, 3nzwE, 0.8873, 1.97, 0.275, 239, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3509, 3mg8S, 0.8873, 2.00, 0.240, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3510, 3mg8E, 0.8873, 2.01, 0.240, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3511, 3gpjS, 0.8873, 1.50, 0.344, 230, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3512, 3gpjE, 0.8873, 1.50, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3513, 2fakE, 0.8873, 1.51, 0.344, 234, 221, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3514, 1z7qO, 0.8873, 2.45, 0.332, 240, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3515, 1z7qA, 0.8873, 2.11, 0.342, 239, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3516, 5vfoj, 0.8872, 2.45, 0.332, 240, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3517, 5mp9A, 0.8872, 2.11, 0.342, 239, 231, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3518, 4r18S, 0.8872, 1.50, 0.344, 232, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3519, 4r18E, 0.8872, 1.50, 0.344, 233, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3520, 4q1sE, 0.8872, 1.50, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3521, 3shjE, 0.8872, 2.02, 0.266, 240, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3522, 3oevE, 0.8872, 2.00, 0.240, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3523, 3nzxS, 0.8872, 2.00, 0.240, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3524, 3nzxE, 0.8872, 1.50, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3525, 3mg0E, 0.8872, 1.50, 0.344, 233, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3526, 3gpwE, 0.8872, 1.50, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3527, 2fakS, 0.8872, 1.50, 0.344, 233, 221, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3528, 5nifT, 0.8871, 1.50, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3529, 5ln3B, 0.8871, 1.96, 0.340, 250, 235, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3530, 4gk7E, 0.8871, 1.99, 0.275, 239, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3531, 4cr4G, 0.8871, 1.51, 0.344, 231, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3532, 3wxrU, 0.8871, 1.51, 0.344, 231, 221, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3533, 3wxrG, 0.8871, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3534, 3tddE, 0.8871, 1.50, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3535, 3shjS, 0.8871, 1.51, 0.344, 233, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3536, 3mg6E, 0.8871, 1.51, 0.344, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3537, 3gpwS, 0.8871, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3538, 3dy4E, 0.8871, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3539, 2gplS, 0.8871, 1.51, 0.344, 233, 221, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3540, 2gplE, 0.8871, 1.50, 0.344, 233, 221, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3541, 5mp9F, 0.8870, 1.51, 0.344, 233, 221, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3542, 5lttS, 0.8870, 1.50, 0.344, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3543, 5lttE, 0.8870, 1.50, 0.344, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3544, 5fg7S, 0.8870, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3545, 5fg7E, 0.8870, 2.03, 0.239, 243, 230, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3546, 4qzzS, 0.8870, 2.03, 0.239, 243, 230, YCP IN COMPLEX WITH OMURALIDE
3547, 4qzzE, 0.8870, 2.10, 0.342, 239, 231, YCP IN COMPLEX WITH OMURALIDE
3548, 4j70S, 0.8870, 2.00, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3549, 4j70E, 0.8870, 1.51, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3550, 4gk7S, 0.8870, 1.51, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3551, 3wxrF, 0.8870, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3552, 3tddS, 0.8870, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3553, 3mg7E, 0.8870, 1.51, 0.344, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3554, 3hyeS, 0.8870, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3555, 3hyeE, 0.8870, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3556, 3gptS, 0.8870, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3557, 3gptE, 0.8870, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3558, 3dy4S, 0.8870, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3559, 1g0uE, 0.8870, 1.51, 0.344, 232, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3560, 5mp9a, 0.8869, 1.82, 0.311, 234, 225, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3561, 5l6cS, 0.8869, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3562, 5l6cE, 0.8869, 2.35, 0.325, 245, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3563, 5l5uS, 0.8869, 2.20, 0.339, 237, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3564, 5l5uE, 0.8869, 2.11, 0.335, 237, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3565, 5l5pS, 0.8869, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3566, 5l5pE, 0.8869, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3567, 5l5bS, 0.8869, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3568, 5l5bE, 0.8869, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3569, 5fgaS, 0.8869, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3570, 5fgaE, 0.8869, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3571, 5fg9S, 0.8869, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3572, 5fg9E, 0.8869, 1.51, 0.348, 233, 221, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3573, 5dkjS, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3574, 5dkjE, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3575, 5czaS, 0.8869, 1.51, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3576, 5czaE, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3577, 5cz7S, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3578, 5cz7E, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3579, 5cgfS, 0.8869, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3580, 5cgfE, 0.8869, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3581, 4ya1S, 0.8869, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3582, 4ya1E, 0.8869, 1.50, 0.344, 232, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3583, 4qvyS, 0.8869, 1.51, 0.344, 233, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3584, 4qvyE, 0.8869, 1.51, 0.344, 233, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3585, 4qv8S, 0.8869, 1.51, 0.344, 233, 221, YCP BETA5-C52F MUTANT
3586, 4qv8E, 0.8869, 1.51, 0.344, 233, 221, YCP BETA5-C52F MUTANT
3587, 4qv7S, 0.8869, 1.51, 0.344, 233, 221, YCP BETA5-A50V MUTANT
3588, 4qv7E, 0.8869, 1.51, 0.344, 233, 221, YCP BETA5-A50V MUTANT
3589, 4quyS, 0.8869, 1.51, 0.344, 233, 221, YCP BETA5-A49S-MUTANT
3590, 4quyE, 0.8869, 1.50, 0.344, 230, 221, YCP BETA5-A49S-MUTANT
3591, 4lqiS, 0.8869, 2.01, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3592, 4lqiE, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3593, 4jsuS, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3594, 4jsuE, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3595, 3mg4S, 0.8869, 1.52, 0.344, 231, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3596, 3e47E, 0.8869, 1.52, 0.344, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3597, 2zcyS, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3598, 2f16S, 0.8869, 1.52, 0.344, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3599, 2f16E, 0.8869, 1.52, 0.344, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3600, 1rypT, 0.8869, 1.52, 0.344, 231, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3601, 1fntT, 0.8869, 1.52, 0.344, 231, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3602, 1fntF, 0.8869, 1.52, 0.344, 231, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3603, 5mpaf, 0.8868, 1.52, 0.344, 231, 221, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3604, 5m32F, 0.8868, 1.52, 0.344, 231, 221, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3605, 5l67S, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3606, 5l67E, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3607, 5l62S, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3608, 5l62E, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3609, 5l61S, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3610, 5l61E, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3611, 5l5vS, 0.8868, 1.52, 0.344, 231, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3612, 5l5vE, 0.8868, 1.52, 0.344, 231, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3613, 5l5qS, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3614, 5l5qE, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3615, 5l5hS, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3616, 5l5hE, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3617, 5l5aS, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3618, 5l5aE, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3619, 5bxlS, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3620, 5bxlE, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3621, 4z1lS, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3622, 4z1lE, 0.8868, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3623, 4y9yS, 0.8868, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3624, 4y9yE, 0.8868, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3625, 4y8rS, 0.8868, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3626, 4y8rE, 0.8868, 1.52, 0.344, 233, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3627, 4y8mS, 0.8868, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3628, 4y8mE, 0.8868, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3629, 4y69S, 0.8868, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3630, 4y69E, 0.8868, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3631, 4r00S, 0.8868, 1.50, 0.344, 233, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3632, 4r00E, 0.8868, 1.51, 0.344, 233, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3633, 4qvlS, 0.8868, 1.51, 0.344, 233, 221, YCP IN COMPLEX WITH BORTEZOMIB
3634, 4qvlE, 0.8868, 1.51, 0.344, 231, 221, YCP IN COMPLEX WITH BORTEZOMIB
3635, 4qv9S, 0.8868, 1.90, 0.350, 232, 226, YCP BETA5-C63F MUTANT
3636, 4qv9E, 0.8868, 1.52, 0.344, 231, 221, YCP BETA5-C63F MUTANT
3637, 4qv3S, 0.8868, 1.52, 0.344, 231, 221, YCP BETA5-M45V MUTANT
3638, 4qv3E, 0.8868, 1.52, 0.344, 231, 221, YCP BETA5-M45V MUTANT
3639, 4quxS, 0.8868, 1.52, 0.344, 231, 221, YCP BETA5-A49T-MUTANT
3640, 4quxE, 0.8868, 1.52, 0.344, 231, 221, YCP BETA5-A49T-MUTANT
3641, 3oeuE, 0.8868, 1.52, 0.344, 231, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3642, 3e47S, 0.8868, 1.52, 0.344, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3643, 2zcyE, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3644, 1g65S, 0.8868, 1.52, 0.344, 231, 221, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3645, 5wvkU, 0.8867, 1.52, 0.344, 231, 221, 
3646, 5l6aS, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3647, 5l6aE, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3648, 5l64S, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3649, 5l64E, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3650, 5l63S, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3651, 5l63E, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3652, 5l5zS, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3653, 5l5zE, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3654, 5l5tS, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3655, 5l5tE, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3656, 5l5sS, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3657, 5l5sE, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3658, 5l5rS, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3659, 5l5rE, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3660, 5l5oS, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3661, 5l5oE, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3662, 5l5fS, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3663, 5l5fE, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3664, 5fgfS, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3665, 5fgfE, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3666, 5d0wS, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3667, 5d0wE, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3668, 5cz6S, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3669, 5cz6E, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3670, 5cggS, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3671, 5cggE, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3672, 5bouS, 0.8867, 1.52, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3673, 5bouE, 0.8867, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3674, 4ya4S, 0.8867, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3675, 4ya4E, 0.8867, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3676, 4y6vS, 0.8867, 2.22, 0.336, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3677, 4y6vE, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3678, 4y6aS, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3679, 4y6aE, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3680, 4x6zT, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3681, 4qv1S, 0.8867, 1.52, 0.344, 231, 221, YCP BETA5-M45A MUTANT
3682, 4qv1E, 0.8867, 1.52, 0.344, 231, 221, YCP BETA5-M45A MUTANT
3683, 4qv0S, 0.8867, 1.52, 0.344, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3684, 4qv0E, 0.8867, 1.52, 0.344, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3685, 3mg4E, 0.8867, 1.52, 0.344, 231, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3686, 6gopS, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3687, 6gopE, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3688, 5l6bS, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3689, 5l6bE, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3690, 5l66S, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3691, 5l66E, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3692, 5l65S, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3693, 5l65E, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3694, 5l60S, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3695, 5l60E, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3696, 5l5xS, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3697, 5l5xE, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3698, 5l5wS, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3699, 5l5wE, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3700, 5l5jE, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3701, 5fgeS, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3702, 5d0xS, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3703, 5d0xE, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3704, 5d0tS, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3705, 5d0tE, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3706, 5cz9S, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3707, 5cz9E, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3708, 5bxnS, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3709, 5bxnE, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3710, 4ya5S, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3711, 4ya5E, 0.8866, 1.51, 0.344, 232, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3712, 4y8uS, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3713, 4y8uE, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3714, 4y8nS, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3715, 4y8nE, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3716, 4x6zF, 0.8866, 1.52, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3717, 4rurS, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3718, 4rurE, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3719, 4qvpS, 0.8866, 1.52, 0.344, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3720, 4qvpE, 0.8866, 1.52, 0.344, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3721, 4qv4S, 0.8866, 1.52, 0.344, 231, 221, YCP BETA5-M45T MUTANT
3722, 4qv4E, 0.8866, 1.52, 0.344, 231, 221, YCP BETA5-M45T MUTANT
3723, 4hrcS, 0.8866, 1.52, 0.344, 231, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3724, 4eu2T, 0.8866, 1.52, 0.344, 231, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3725, 3mg7S, 0.8866, 1.52, 0.344, 231, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3726, 5m2bS, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3727, 5m2bE, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3728, 5l69S, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3729, 5l69E, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3730, 5l5yS, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3731, 5l5yE, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3732, 5l5jS, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3733, 5l5iS, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3734, 5l5iE, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3735, 5l5eS, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3736, 5l5eE, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3737, 5jhsS, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3738, 5jhsE, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3739, 5fggS, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3740, 5fggE, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3741, 5fgeE, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3742, 5d0zS, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3743, 5d0zE, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3744, 5d0sS, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3745, 5d0sE, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3746, 5cghS, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3747, 5cghE, 0.8865, 1.51, 0.344, 232, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3748, 4zzgF, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3749, 4y8kS, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3750, 4y8kE, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3751, 4qwgU, 0.8865, 1.52, 0.344, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3752, 4qw0S, 0.8865, 1.52, 0.344, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3753, 4qw0E, 0.8865, 1.52, 0.344, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3754, 4qvwS, 0.8865, 1.51, 0.344, 233, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3755, 4qvwE, 0.8865, 1.52, 0.344, 232, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3756, 4qvnS, 0.8865, 1.51, 0.344, 233, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3757, 4qvnE, 0.8865, 1.52, 0.344, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3758, 4qv5S, 0.8865, 1.52, 0.344, 231, 221, YCP BETA5-M45I MUTANT
3759, 4qv5E, 0.8865, 1.52, 0.344, 231, 221, YCP BETA5-M45I MUTANT
3760, 4no8S, 0.8865, 1.52, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3761, 4no8E, 0.8865, 1.52, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3762, 3sdkF, 0.8865, 1.52, 0.344, 231, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3763, 3okjE, 0.8865, 1.52, 0.344, 231, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3764, 5l68S, 0.8864, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3765, 5l68E, 0.8864, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3766, 5l5dS, 0.8864, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3767, 5l5dE, 0.8864, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3768, 5fhsS, 0.8864, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3769, 5fhsE, 0.8864, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3770, 5fgiS, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3771, 5fgiE, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3772, 5fghS, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3773, 5fghE, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3774, 5fgdS, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3775, 5fgdE, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3776, 4qz6S, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3777, 4qz6E, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3778, 4qz3S, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3779, 4qz3E, 0.8864, 1.52, 0.344, 232, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3780, 4qwuS, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3781, 4qwuE, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3782, 4qwlS, 0.8864, 2.01, 0.240, 241, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3783, 4qwlE, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3784, 4qwgG, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3785, 4qw1S, 0.8864, 1.52, 0.344, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3786, 4qw1E, 0.8864, 1.52, 0.344, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3787, 4qvmS, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3788, 4qvmE, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3789, 3wxrT, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3790, 3okjS, 0.8864, 1.53, 0.344, 231, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3791, 3oevS, 0.8864, 1.53, 0.344, 231, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3792, 5nifF, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3793, 5l55S, 0.8863, 2.08, 0.336, 236, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3794, 5l55E, 0.8863, 1.52, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3795, 5l52S, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3796, 5l52E, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3797, 5jhrS, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3798, 5jhrE, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3799, 5dkiS, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3800, 5dkiE, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3801, 5d0vS, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3802, 5d0vE, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3803, 5cz8S, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3804, 5cz8E, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3805, 4y8pS, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3806, 4y8pE, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3807, 4y8lS, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3808, 4y8lE, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3809, 4r17S, 0.8863, 1.53, 0.344, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3810, 4r17E, 0.8863, 1.53, 0.344, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3811, 4qz7S, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3812, 4qz7E, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3813, 4qz5S, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3814, 4qz5E, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3815, 4qwrS, 0.8863, 2.01, 0.240, 241, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3816, 4qwrE, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3817, 4qw7S, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3818, 4qw7E, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3819, 4qw6S, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3820, 4qw6E, 0.8863, 1.50, 0.344, 232, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3821, 4qw5S, 0.8863, 1.52, 0.344, 233, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3822, 4qw5E, 0.8863, 1.52, 0.344, 233, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3823, 4qvvS, 0.8863, 1.52, 0.344, 232, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3824, 4qvvE, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3825, 4qvqS, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3826, 4qvqE, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3827, 4nnnS, 0.8863, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH MG132
3828, 5laiS, 0.8862, 1.53, 0.344, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3829, 5laiE, 0.8862, 1.53, 0.344, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3830, 5cz5S, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3831, 5cz5E, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3832, 5cz4S, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3833, 5cz4E, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3834, 5ahjS, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3835, 5ahjE, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3836, 4ya7S, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3837, 4ya7E, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3838, 4ya3S, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3839, 4ya3E, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3840, 4y9zS, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3841, 4y9zE, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3842, 4y8qS, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3843, 4y8qE, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3844, 4y8jS, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3845, 4y82S, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3846, 4y82E, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3847, 4y80E, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3848, 4y77S, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3849, 4y77E, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3850, 4r02S, 0.8862, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3851, 4qzwS, 0.8862, 1.53, 0.344, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3852, 4qzwE, 0.8862, 1.53, 0.344, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3853, 4qz0S, 0.8862, 1.53, 0.344, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3854, 4qz0E, 0.8862, 1.53, 0.344, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3855, 4qwiS, 0.8862, 1.53, 0.344, 231, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3856, 4qw4S, 0.8862, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH CARFILZOMIB
3857, 4qw4E, 0.8862, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH CARFILZOMIB
3858, 4qv6S, 0.8862, 1.53, 0.344, 231, 221, YCP BETA5-A49V MUTANT
3859, 4qv6E, 0.8862, 1.53, 0.344, 231, 221, YCP BETA5-A49V MUTANT
3860, 4nnnE, 0.8862, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH MG132
3861, 3oeuS, 0.8862, 1.53, 0.344, 231, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3862, 5cgiS, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3863, 5cgiE, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3864, 4ya9S, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3865, 4ya9E, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3866, 4y8jE, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3867, 4y8iS, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3868, 4y8iE, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3869, 4y80S, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3870, 4y7yS, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3871, 4y7yE, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3872, 4y7xS, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3873, 4y7xE, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3874, 4y7wS, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3875, 4y7wE, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3876, 4y75S, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3877, 4y75E, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3878, 4y70S, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3879, 4y70E, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3880, 4r02E, 0.8861, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3881, 4qz4S, 0.8861, 1.53, 0.344, 231, 221, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3882, 4qz4E, 0.8861, 1.53, 0.344, 231, 221, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3883, 4qwjS, 0.8861, 1.53, 0.344, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3884, 4qwjE, 0.8861, 1.53, 0.344, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3885, 4qwiE, 0.8861, 1.53, 0.344, 231, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3886, 4qwfS, 0.8861, 1.53, 0.344, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3887, 4qwfE, 0.8861, 1.53, 0.344, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3888, 4hrcE, 0.8861, 1.53, 0.344, 231, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3889, 4ya0S, 0.8860, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3890, 4ya0E, 0.8860, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3891, 4y81S, 0.8860, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3892, 4y81E, 0.8860, 1.52, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3893, 4y74S, 0.8860, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3894, 4y74E, 0.8860, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3895, 4y6zS, 0.8860, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3896, 4y6zE, 0.8860, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3897, 4qz2S, 0.8860, 1.53, 0.344, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3898, 4qz2E, 0.8860, 1.53, 0.344, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3899, 4qwxS, 0.8860, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3900, 4qwxE, 0.8860, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3901, 4qwkS, 0.8860, 1.53, 0.344, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3902, 4qwkE, 0.8860, 1.53, 0.344, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3903, 4qlsS, 0.8860, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3904, 4qlsE, 0.8860, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3905, 4q1sS, 0.8860, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3906, 4y8sS, 0.8859, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3907, 4y8sE, 0.8859, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3908, 4y8oS, 0.8859, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3909, 4y8oE, 0.8859, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3910, 4y78S, 0.8859, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3911, 4y78E, 0.8859, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3912, 4qzxS, 0.8859, 1.53, 0.344, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3913, 4qzxE, 0.8859, 1.53, 0.344, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3914, 4qw3S, 0.8859, 1.53, 0.344, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3915, 4qw3E, 0.8859, 1.53, 0.344, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3916, 3sdiS, 0.8859, 1.53, 0.344, 231, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3917, 5t0hH, 0.8858, 1.53, 0.344, 231, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3918, 4y8hS, 0.8858, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3919, 4y8hE, 0.8858, 1.52, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3920, 4qz1S, 0.8858, 1.53, 0.344, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3921, 4qz1E, 0.8858, 1.53, 0.344, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3922, 4qxjS, 0.8858, 1.53, 0.344, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3923, 4qxjE, 0.8858, 1.53, 0.344, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3924, 4qlqS, 0.8858, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3925, 4qlqE, 0.8858, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3926, 4no1S, 0.8858, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3927, 4no1E, 0.8858, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3928, 6epcF, 0.8857, 1.53, 0.344, 231, 221, GROUND STATE 26S PROTEASOME (GS2)
3929, 4y8gS, 0.8857, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3930, 4y8gE, 0.8857, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3931, 4y84E, 0.8857, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3932, 4nnwS, 0.8857, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3933, 4nnwE, 0.8857, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3934, 5l54S, 0.8856, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3935, 5l54E, 0.8856, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3936, 4y84S, 0.8856, 1.53, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3937, 4qwsS, 0.8856, 1.53, 0.344, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3938, 4qwsE, 0.8856, 1.53, 0.344, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3939, 1g0uS, 0.8856, 1.53, 0.344, 231, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3940, 4ya2E, 0.8855, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3941, 4ya2S, 0.8854, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3942, 4y8tS, 0.8854, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3943, 4y8tE, 0.8854, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3944, 4qltS, 0.8854, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3945, 4qltE, 0.8854, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3946, 4qwgS, 0.8853, 1.53, 0.344, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3947, 4qwgE, 0.8853, 1.52, 0.344, 230, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3948, 4no9S, 0.8853, 1.80, 0.311, 232, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3949, 4no9E, 0.8853, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3950, 5a5bG, 0.8852, 1.53, 0.344, 231, 221, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3951, 4qluS, 0.8852, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3952, 4qluE, 0.8852, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3953, 4no6S, 0.8852, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3954, 4no6E, 0.8852, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3955, 4cr3G, 0.8852, 1.54, 0.344, 231, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3956, 3jcpOA, 0.8852, 1.54, 0.344, 231, 221, 
3957, 3jcpO, 0.8852, 1.54, 0.344, 231, 221, 
3958, 5vfqCA, 0.8851, 1.53, 0.344, 231, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3959, 4qlvS, 0.8851, 1.80, 0.316, 238, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3960, 4qlvE, 0.8851, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3961, 4cr2A, 0.8850, 1.53, 0.344, 231, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3962, 6epcA, 0.8849, 1.53, 0.344, 231, 221, GROUND STATE 26S PROTEASOME (GS2)
3963, 5t0gG, 0.8849, 1.53, 0.344, 231, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3964, 4qbyS, 0.8848, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3965, 4qbyE, 0.8848, 1.54, 0.344, 231, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3966, 1jd2E, 0.8847, 1.54, 0.344, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3967, 5vfuFA, 0.8846, 1.53, 0.344, 231, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3968, 5vftg, 0.8846, 1.54, 0.344, 231, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3969, 5m32U, 0.8844, 1.54, 0.344, 231, 221, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3970, 5lexG, 0.8842, 1.53, 0.344, 230, 221, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3971, 6epfF, 0.8841, 1.54, 0.344, 231, 221, GROUND STATE 26S PROTEASOME (GS1)
3972, 5vfpBA, 0.8841, 1.54, 0.344, 231, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3973, 5mp9f, 0.8841, 1.54, 0.344, 231, 221, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3974, 5t0gJ, 0.8840, 1.54, 0.344, 231, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3975, 5lf0G, 0.8840, 1.54, 0.344, 231, 221, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3976, 5mpcU, 0.8839, 1.54, 0.344, 231, 221, 
3977, 6epfG, 0.8838, 1.54, 0.344, 231, 221, GROUND STATE 26S PROTEASOME (GS1)
3978, 5vfrj, 0.8838, 1.54, 0.344, 231, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3979, 5vfqD, 0.8838, 1.54, 0.344, 231, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3980, 5lf3G, 0.8838, 1.54, 0.344, 231, 221, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3981, 5lezG, 0.8838, 2.33, 0.326, 245, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3982, 5leyG, 0.8838, 1.55, 0.344, 231, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3983, 4v7oT, 0.8838, 1.55, 0.344, 231, 221, 
3984, 5m32G, 0.8837, 1.54, 0.344, 231, 221, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3985, 4v7oNA, 0.8837, 1.54, 0.344, 231, 221, 
3986, 4v7oF, 0.8837, 2.33, 0.326, 245, 230, 
3987, 4v7oBB, 0.8837, 1.52, 0.344, 233, 221, 
3988, 6epeC, 0.8836, 1.52, 0.344, 233, 221, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3989, 1ya7F, 0.8833, 1.52, 0.344, 233, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3990, 1jd2Z, 0.8833, 2.12, 0.342, 239, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3991, 5vfoJ, 0.8831, 1.55, 0.344, 231, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3992, 5le5G, 0.8831, 1.55, 0.344, 231, 221, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3993, 5wvkT, 0.8829, 2.05, 0.239, 243, 230, 
3994, 5lf7G, 0.8829, 2.11, 0.252, 246, 230, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3995, 5t0iK, 0.8828, 2.04, 0.266, 240, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3996, 5wvkO, 0.8827, 1.54, 0.344, 231, 221, 
3997, 5lf6G, 0.8827, 1.54, 0.344, 231, 221, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3998, 5lf4G, 0.8827, 1.54, 0.344, 233, 221, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3999, 5mpbG, 0.8826, 2.06, 0.266, 240, 229, 
4000, 5a5bB, 0.8826, 2.06, 0.266, 240, 229, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4001, 4cr3B, 0.8826, 1.86, 0.261, 241, 226, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4002, 3j9iU, 0.8826, 1.83, 0.267, 241, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4003, 3j9iT, 0.8826, 1.92, 0.314, 238, 226, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4004, 3j9iS, 0.8826, 2.13, 0.342, 239, 231, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4005, 3j9iR, 0.8826, 1.54, 0.344, 231, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4006, 3j9iQ, 0.8826, 2.23, 0.341, 239, 232, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4007, 3j9iP, 0.8826, 1.83, 0.267, 241, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4008, 3j9iO, 0.8826, 2.26, 0.335, 243, 230, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4009, 3j9iG, 0.8826, 2.26, 0.349, 245, 229, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4010, 3j9iF, 0.8826, 2.14, 0.342, 239, 231, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4011, 3j9iE, 0.8826, 1.30, 0.609, 228, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4012, 3j9iD, 0.8826, 2.17, 0.341, 239, 232, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4013, 3j9iC, 0.8826, 1.84, 0.267, 241, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4014, 3j9iB, 0.8826, 1.83, 0.267, 241, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4015, 3j9iA, 0.8826, 1.84, 0.267, 241, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4016, 5lf1G, 0.8825, 1.57, 0.344, 234, 221, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4017, 5t0jG, 0.8824, 2.01, 0.260, 233, 227, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4018, 1ya7C, 0.8824, 1.58, 0.344, 234, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4019, 1ya7G, 0.8822, 1.58, 0.344, 234, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4020, 5t0hM, 0.8818, 1.58, 0.344, 234, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4021, 1ya7A, 0.8817, 2.37, 0.325, 249, 234, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4022, 5mpcG, 0.8814, 1.61, 0.407, 227, 221, 
4023, 5mpaa, 0.8812, 1.56, 0.344, 233, 221, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4024, 2ku1F, 0.8812, 2.19, 0.336, 239, 232, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4025, 5vfpD, 0.8811, 1.85, 0.267, 241, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4026, 1fntO, 0.8811, 1.54, 0.348, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4027, 5vfrJ, 0.8810, 1.85, 0.267, 241, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4028, 5mpcR, 0.8810, 1.96, 0.612, 228, 227, 
4029, 1fntA, 0.8810, 2.08, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4030, 5le5Q, 0.8806, 1.86, 0.267, 241, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4031, 5mpbF, 0.8805, 1.85, 0.267, 241, 225, 
4032, 3jseG, 0.8805, 2.31, 0.335, 243, 230, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4033, 2ku2F, 0.8805, 2.02, 0.326, 250, 227, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4034, 1ya7B, 0.8805, 2.02, 0.326, 250, 227, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4035, 3jseF, 0.8804, 1.51, 0.400, 224, 220, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4036, 3jseE, 0.8804, 1.51, 0.400, 224, 220, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4037, 2ku2G, 0.8804, 1.51, 0.400, 224, 220, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4038, 2ku1E, 0.8804, 1.51, 0.400, 224, 220, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4039, 3jseB, 0.8803, 1.51, 0.400, 224, 220, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4040, 3jseA, 0.8803, 1.51, 0.400, 224, 220, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4041, 1ya7D, 0.8803, 1.51, 0.400, 224, 220, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4042, 3jseC, 0.8802, 1.51, 0.400, 224, 220, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4043, 5m32B, 0.8801, 1.51, 0.400, 224, 220, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4044, 3jseD, 0.8801, 1.51, 0.400, 224, 220, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4045, 6epeA, 0.8799, 1.51, 0.400, 224, 220, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4046, 5mpaF, 0.8799, 1.51, 0.400, 224, 220, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4047, 5wviX, 0.8798, 1.51, 0.400, 224, 220, 
4048, 5mpcD, 0.8798, 1.51, 0.400, 224, 220, 
4049, 5lexQ, 0.8798, 1.86, 0.267, 241, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4050, 4cr4A, 0.8797, 2.09, 0.265, 240, 230, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4051, 2ku1C, 0.8797, 1.62, 0.407, 227, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4052, 2ku2D, 0.8796, 1.62, 0.407, 227, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4053, 2ku2E, 0.8793, 2.42, 0.346, 240, 231, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4054, 5ln3G, 0.8790, 1.62, 0.407, 227, 221, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4055, 3jrmC, 0.8790, 2.33, 0.335, 243, 230, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4056, 3jrmA, 0.8790, 2.07, 0.240, 241, 229, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4057, 3jrmG, 0.8789, 1.60, 0.407, 237, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4058, 3jrmF, 0.8788, 1.78, 0.316, 238, 228, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4059, 3jrmE, 0.8788, 2.21, 0.336, 239, 232, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4060, 3jrmD, 0.8788, 2.02, 0.224, 238, 228, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4061, 3jrmB, 0.8788, 2.20, 0.336, 239, 232, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4062, 5lezQ, 0.8786, 2.19, 0.351, 240, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4063, 6epfA, 0.8785, 2.02, 0.224, 238, 228, GROUND STATE 26S PROTEASOME (GS1)
4064, 2ku1D, 0.8783, 1.95, 0.356, 233, 225, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4065, 2ku1G, 0.8781, 1.73, 0.342, 231, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4066, 1ya7E, 0.8781, 1.63, 0.407, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4067, 3jcoOA, 0.8779, 1.62, 0.403, 237, 221, 
4068, 3jcoO, 0.8779, 1.63, 0.407, 227, 221, 
4069, 5t0jM, 0.8774, 1.63, 0.407, 227, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4070, 5dsvM, 0.8774, 1.63, 0.407, 227, 221, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4071, 1yauA, 0.8770, 1.61, 0.403, 237, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4072, 5mpaA, 0.8769, 1.61, 0.403, 237, 221, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4073, 3c92U, 0.8768, 1.63, 0.407, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4074, 3c92T, 0.8768, 1.63, 0.407, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4075, 3c92S, 0.8768, 1.65, 0.407, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4076, 3c92R, 0.8768, 1.63, 0.407, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4077, 3c92Q, 0.8768, 1.94, 0.339, 234, 224, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4078, 3c92P, 0.8768, 1.64, 0.407, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4079, 3c92O, 0.8768, 2.11, 0.264, 246, 231, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4080, 3c92G, 0.8768, 1.62, 0.348, 233, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4081, 3c92F, 0.8768, 2.31, 0.335, 245, 230, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4082, 3c92E, 0.8768, 2.20, 0.348, 240, 230, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4083, 3c92D, 0.8768, 1.96, 0.356, 233, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4084, 3c92C, 0.8768, 2.14, 0.235, 243, 230, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4085, 3c92B, 0.8768, 1.63, 0.407, 237, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4086, 3c92A, 0.8768, 1.62, 0.403, 237, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4087, 6epdE, 0.8767, 1.64, 0.403, 237, 221, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4088, 5t0hJ, 0.8765, 2.25, 0.343, 242, 230, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4089, 5a5bF, 0.8763, 1.64, 0.407, 227, 221, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4090, 4cr3F, 0.8763, 1.64, 0.407, 227, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4091, 2ku2A, 0.8763, 1.64, 0.407, 227, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4092, 3jtlC, 0.8760, 1.65, 0.407, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4093, 6epeF, 0.8759, 1.65, 0.407, 227, 221, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4094, 3jtlD, 0.8759, 1.65, 0.407, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4095, 3jtlB, 0.8759, 1.65, 0.407, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4096, 3jtlA, 0.8759, 1.99, 0.356, 234, 225, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4097, 1yauF, 0.8759, 2.18, 0.260, 246, 231, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4098, 4cr2F, 0.8758, 1.65, 0.407, 237, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4099, 3jtlG, 0.8758, 1.66, 0.407, 237, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4100, 3jtlF, 0.8757, 1.70, 0.407, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4101, 3jtlE, 0.8757, 1.63, 0.344, 233, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4102, 5wvkAA, 0.8756, 1.63, 0.344, 233, 221, 
4103, 2ku1A, 0.8755, 1.63, 0.344, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4104, 2ku1B, 0.8754, 2.45, 0.333, 240, 231, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4105, 1yauG, 0.8753, 2.27, 0.350, 239, 226, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4106, 5mpbT, 0.8752, 1.47, 0.408, 222, 218, 
4107, 5t0hG, 0.8751, 2.11, 0.240, 241, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4108, 1yauC, 0.8751, 1.60, 0.400, 224, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4109, 3c91U, 0.8750, 1.60, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4110, 3c91T, 0.8750, 1.60, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4111, 3c91S, 0.8750, 1.60, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4112, 3c91R, 0.8750, 1.60, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4113, 3c91Q, 0.8750, 1.60, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4114, 3c91P, 0.8750, 1.60, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4115, 3c91O, 0.8750, 1.60, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4116, 3c91G, 0.8750, 1.60, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4117, 3c91F, 0.8750, 1.60, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4118, 3c91E, 0.8750, 1.60, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4119, 3c91D, 0.8750, 1.60, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4120, 3c91C, 0.8750, 1.60, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4121, 3c91B, 0.8750, 1.60, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4122, 3c91A, 0.8750, 1.91, 0.593, 233, 226, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4123, 6epeE, 0.8749, 2.28, 0.336, 239, 232, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4124, 2ku2C, 0.8749, 1.62, 0.344, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4125, 6epeB, 0.8747, 1.62, 0.344, 233, 221, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4126, 5mpbR, 0.8747, 1.77, 0.403, 237, 221, 
4127, 6epfD, 0.8746, 1.73, 0.412, 227, 221, GROUND STATE 26S PROTEASOME (GS1)
4128, 6epcG, 0.8746, 2.00, 0.314, 238, 226, GROUND STATE 26S PROTEASOME (GS2)
4129, 2ku2B, 0.8745, 1.73, 0.412, 227, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4130, 6epdB, 0.8742, 1.73, 0.412, 227, 221, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4131, 5lf0U, 0.8742, 1.73, 0.412, 227, 221, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4132, 5wviF, 0.8740, 1.48, 0.408, 222, 218, 
4133, 5lexU, 0.8740, 1.72, 0.342, 233, 222, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4134, 5lezU, 0.8736, 1.73, 0.412, 227, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4135, 1yauB, 0.8736, 1.73, 0.412, 227, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4136, 5lf7U, 0.8735, 1.73, 0.412, 227, 221, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4137, 5leyU, 0.8735, 1.65, 0.348, 233, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4138, 5lf3U, 0.8734, 1.80, 0.407, 237, 221, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4139, 1yauE, 0.8730, 1.85, 0.407, 237, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4140, 5lf1U, 0.8729, 1.50, 0.408, 222, 218, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4141, 5lf6U, 0.8727, 1.66, 0.344, 233, 221, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4142, 5lf4U, 0.8726, 2.12, 0.266, 240, 229, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4143, 1yauD, 0.8726, 1.50, 0.408, 222, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4144, 5mpbA, 0.8724, 1.76, 0.403, 227, 221, 
4145, 1yarG, 0.8724, 1.76, 0.403, 227, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4146, 1yarC, 0.8722, 1.76, 0.403, 227, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4147, 1yarD, 0.8719, 1.76, 0.403, 227, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4148, 6epeG, 0.8718, 1.76, 0.403, 227, 221, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4149, 5wviI, 0.8717, 1.76, 0.403, 227, 221, 
4150, 1yarF, 0.8717, 1.76, 0.403, 227, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4151, 5mpcO, 0.8715, 1.76, 0.403, 227, 221, 
4152, 1yarA, 0.8715, 1.76, 0.403, 227, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4153, 1yarB, 0.8712, 1.76, 0.403, 227, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4154, 5mpbO, 0.8710, 1.76, 0.403, 227, 221, 
4155, 5ln3A, 0.8708, 1.76, 0.403, 227, 221, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4156, 5t0jJ, 0.8704, 1.76, 0.403, 227, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4157, 4v7oP, 0.8700, 1.76, 0.403, 227, 221, 
4158, 4v7oB, 0.8700, 2.06, 0.608, 233, 227, 
4159, 5fmgS, 0.8699, 1.69, 0.405, 237, 220, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4160, 5fmgE, 0.8699, 1.98, 0.304, 234, 224, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4161, 5dsvC, 0.8699, 2.16, 0.355, 240, 228, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4162, 4v7oXA, 0.8698, 2.38, 0.323, 246, 232, 
4163, 4v7oJA, 0.8698, 2.40, 0.345, 245, 232, 
4164, 6bdfY, 0.8696, 1.70, 0.405, 237, 220, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4165, 6bdfW, 0.8696, 2.09, 0.310, 234, 226, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4166, 6bdfU, 0.8696, 1.95, 0.269, 235, 223, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4167, 6bdfS, 0.8696, 2.37, 0.335, 245, 230, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4168, 6bdfQ, 0.8696, 1.97, 0.269, 235, 223, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4169, 6bdfO, 0.8696, 1.96, 0.269, 235, 223, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4170, 6bdfM, 0.8696, 1.52, 0.408, 222, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4171, 6bdfK, 0.8696, 1.97, 0.269, 235, 223, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4172, 6bdfI, 0.8696, 1.97, 0.269, 235, 223, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4173, 6bdfG, 0.8696, 1.97, 0.269, 235, 223, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4174, 6bdfE, 0.8696, 1.54, 0.408, 222, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4175, 6bdfC, 0.8696, 1.97, 0.269, 235, 223, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4176, 6bdfA, 0.8696, 1.98, 0.269, 235, 223, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4177, 6bdf0, 0.8696, 1.98, 0.269, 235, 223, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4178, 5vy3Y, 0.8694, 1.54, 0.408, 222, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4179, 5vy3W, 0.8694, 2.19, 0.240, 241, 229, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4180, 5vy3U, 0.8694, 1.48, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4181, 5vy3S, 0.8694, 1.48, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4182, 5vy3Q, 0.8694, 1.48, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4183, 5vy3O, 0.8694, 2.44, 0.339, 245, 230, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4184, 5vy3M, 0.8694, 2.11, 0.354, 242, 226, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4185, 5vy3K, 0.8694, 1.52, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4186, 5vy3I, 0.8694, 2.23, 0.223, 241, 229, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4187, 5vy3G, 0.8694, 1.50, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4188, 5vy3E, 0.8694, 1.50, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4189, 5vy3C, 0.8694, 2.15, 0.224, 241, 228, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4190, 5vy3A, 0.8694, 2.23, 0.273, 239, 231, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4191, 5vy30, 0.8694, 2.29, 0.341, 239, 232, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4192, 1yarE, 0.8693, 1.24, 0.324, 231, 213, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4193, 5vy4Y, 0.8687, 1.58, 0.344, 234, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4194, 5vy4W, 0.8687, 1.24, 0.324, 231, 213, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4195, 5vy4U, 0.8687, 1.45, 0.495, 217, 216, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4196, 5vy4S, 0.8687, 1.45, 0.495, 217, 216, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4197, 5vy4Q, 0.8687, 2.10, 0.359, 234, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4198, 5vy4O, 0.8687, 1.24, 0.324, 231, 213, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4199, 5vy4M, 0.8687, 1.24, 0.324, 231, 213, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4200, 5vy4K, 0.8687, 1.52, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4201, 5vy4I, 0.8687, 1.52, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4202, 5vy4G, 0.8687, 1.52, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4203, 5vy4E, 0.8687, 1.52, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4204, 5vy4C, 0.8687, 1.52, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4205, 5vy4AA, 0.8687, 1.52, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4206, 5vy4A, 0.8687, 1.52, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4207, 5vy40, 0.8687, 1.52, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4208, 5mpcF, 0.8687, 1.52, 0.410, 221, 217, 
4209, 4v7oR, 0.8685, 1.52, 0.410, 221, 217, 
4210, 4v7oLA, 0.8685, 1.52, 0.410, 221, 217, 
4211, 4v7oD, 0.8685, 1.52, 0.410, 221, 217, 
4212, 4v7oZA, 0.8684, 1.52, 0.410, 221, 217, 
4213, 5wviD, 0.8683, 1.52, 0.410, 221, 217, 
4214, 5mpcT, 0.8682, 1.53, 0.410, 221, 217, 
4215, 4cr4F, 0.8681, 1.53, 0.410, 221, 217, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4216, 5wviY, 0.8669, 1.53, 0.410, 221, 217, 
4217, 6epdF, 0.8665, 1.53, 0.410, 221, 217, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4218, 5le5U, 0.8664, 1.53, 0.410, 221, 217, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4219, 1pmaO, 0.8664, 1.53, 0.410, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4220, 1pmaN, 0.8664, 1.53, 0.410, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4221, 1pmaL, 0.8662, 1.53, 0.410, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4222, 1pmaG, 0.8662, 1.53, 0.410, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4223, 1pmaF, 0.8662, 1.53, 0.410, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4224, 1pmaD, 0.8662, 1.53, 0.410, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4225, 1pmaH, 0.8660, 1.53, 0.410, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4226, 1pmaM, 0.8659, 1.53, 0.410, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4227, 1pmaK, 0.8659, 1.53, 0.410, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4228, 1pmaI, 0.8659, 1.53, 0.410, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4229, 6epdA, 0.8657, 1.53, 0.410, 221, 217, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4230, 1pmaA, 0.8657, 1.53, 0.410, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4231, 1pmaJ, 0.8656, 1.53, 0.410, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4232, 1pmaC, 0.8656, 1.53, 0.410, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4233, 1pmaE, 0.8655, 1.53, 0.410, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4234, 5ln3F, 0.8653, 1.53, 0.410, 221, 217, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4235, 5t0iG, 0.8652, 1.53, 0.410, 221, 217, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4236, 5fmgQ, 0.8651, 1.53, 0.410, 221, 217, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4237, 5fmgC, 0.8651, 1.53, 0.410, 221, 217, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4238, 5mpcA, 0.8645, 1.53, 0.410, 221, 217, 
4239, 5wviAA, 0.8644, 1.53, 0.410, 221, 217, 
4240, 6epcB, 0.8638, 1.53, 0.410, 221, 217, GROUND STATE 26S PROTEASOME (GS2)
4241, 5t0iM, 0.8620, 1.53, 0.410, 221, 217, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4242, 5wviG, 0.8611, 1.53, 0.410, 221, 217, 
4243, 5wviZ, 0.8592, 1.53, 0.410, 221, 217, 
4244, 3ipmF, 0.8592, 1.53, 0.410, 221, 217, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4245, 3ipmE, 0.8592, 1.74, 0.339, 231, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4246, 3ipmD, 0.8592, 1.90, 0.326, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4247, 3ipmC, 0.8592, 1.90, 0.326, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4248, 3ipmA, 0.8592, 1.90, 0.326, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4249, 5ln3D, 0.8591, 1.90, 0.326, 227, 221, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4250, 3ipmG, 0.8591, 1.86, 0.326, 250, 227, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4251, 3ipmB, 0.8591, 2.21, 0.235, 243, 230, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4252, 5fmgT, 0.8589, 1.74, 0.344, 233, 221, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4253, 5fmgF, 0.8589, 1.83, 0.342, 233, 222, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4254, 6epeD, 0.8572, 2.23, 0.235, 243, 230, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4255, 5t0iJ, 0.8552, 2.10, 0.319, 238, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4256, 5a5bA, 0.8549, 1.83, 0.273, 232, 220, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4257, 4cr3A, 0.8549, 1.58, 0.406, 221, 217, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4258, 4g4sD, 0.8522, 1.58, 0.406, 221, 217, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
4259, 6epdG, 0.8515, 1.59, 0.406, 221, 217, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4260, 6epcD, 0.8503, 1.58, 0.406, 221, 217, GROUND STATE 26S PROTEASOME (GS2)
4261, 5t0jH, 0.8475, 1.59, 0.406, 221, 217, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4262, 5a0qP, 0.8459, 1.58, 0.406, 221, 217, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4263, 5a0qB, 0.8459, 1.59, 0.406, 221, 217, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4264, 5a0qR, 0.8386, 1.59, 0.406, 221, 217, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4265, 5a0qD, 0.8386, 1.59, 0.406, 221, 217, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4266, 5fmgO, 0.8380, 1.59, 0.406, 221, 217, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4267, 5fmgA, 0.8380, 2.30, 0.265, 246, 230, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4268, 5fmgP, 0.8325, 1.59, 0.406, 221, 217, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4269, 5fmgB, 0.8325, 1.59, 0.406, 221, 217, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4270, 5fmgR, 0.8291, 1.59, 0.406, 221, 217, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4271, 5fmgD, 0.8291, 1.60, 0.406, 221, 217, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4272, 5fmgU, 0.8250, 1.78, 0.317, 233, 221, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4273, 5fmgG, 0.8250, 2.23, 0.266, 240, 229, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4274, 6epdD, 0.8231, 1.76, 0.406, 220, 217, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4275, 5a0qU, 0.8173, 1.76, 0.406, 220, 217, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4276, 5a0qG, 0.8173, 2.22, 0.220, 241, 227, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4277, 5ts0G, 0.8137, 2.19, 0.350, 242, 226, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4278, 3mkaA, 0.8136, 2.15, 0.304, 234, 224, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4279, 5trgP, 0.8134, 2.51, 0.348, 240, 230, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4280, 3mi0F, 0.8115, 1.91, 0.342, 233, 222, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4281, 3mkaF, 0.8105, 1.92, 0.342, 233, 222, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4282, 5thoS, 0.8103, 1.91, 0.400, 227, 220, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4283, 2fhgW, 0.8099, 1.91, 0.400, 227, 220, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4284, 2fhgD, 0.8099, 1.91, 0.400, 227, 220, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4285, 2fhgA, 0.8099, 1.91, 0.400, 227, 220, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4286, 5trsA, 0.8098, 1.91, 0.400, 227, 220, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4287, 2fhgU, 0.8098, 2.50, 0.329, 248, 231, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4288, 2fhgQ, 0.8098, 1.91, 0.400, 227, 220, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4289, 2fhgM, 0.8098, 1.91, 0.400, 227, 220, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4290, 2fhgI, 0.8098, 1.55, 0.353, 219, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4291, 2fhgF, 0.8098, 1.55, 0.353, 219, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4292, 2fhgB, 0.8098, 2.69, 0.328, 246, 232, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4293, 2fhgY, 0.8097, 2.50, 0.343, 239, 233, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4294, 2fhgS, 0.8097, 2.38, 0.218, 243, 229, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4295, 2fhgO, 0.8097, 2.38, 0.218, 243, 229, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4296, 2fhgK, 0.8097, 1.61, 0.347, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4297, 2fhg1, 0.8097, 2.64, 0.341, 245, 229, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4298, 5thoG, 0.8088, 2.66, 0.312, 246, 231, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4299, 2fhhW, 0.8088, 2.20, 0.306, 232, 222, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4300, 2fhhD, 0.8088, 1.71, 0.322, 214, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4301, 2fhhA, 0.8088, 1.71, 0.322, 214, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4302, 2fhhU, 0.8087, 1.75, 0.363, 214, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4303, 2fhhO, 0.8087, 1.75, 0.363, 214, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4304, 2fhhM, 0.8087, 1.88, 0.248, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4305, 5trrA, 0.8086, 1.88, 0.248, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4306, 5trgA, 0.8086, 1.88, 0.314, 212, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4307, 2fhhY, 0.8086, 1.88, 0.314, 212, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4308, 2fhhS, 0.8086, 1.96, 0.311, 215, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4309, 2fhhQ, 0.8086, 1.96, 0.311, 215, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4310, 2fhhF, 0.8086, 2.08, 0.252, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4311, 2fhhB, 0.8086, 2.08, 0.252, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4312, 2fhhK, 0.8085, 3.01, 0.345, 246, 232, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4313, 2fhhI, 0.8085, 1.66, 0.356, 209, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4314, 5trsP, 0.8084, 1.66, 0.356, 209, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4315, 2fhh1, 0.8084, 2.24, 0.160, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4316, 5tryA, 0.8079, 2.31, 0.164, 222, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4317, 5thoA, 0.8079, 2.18, 0.161, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4318, 5ts0A, 0.8077, 2.29, 0.165, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4319, 3mkaK, 0.8073, 2.37, 0.164, 221, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4320, 2h6jB, 0.8068, 2.38, 0.160, 221, 213, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4321, 3mkaU, 0.8065, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4322, 3mkaQ, 0.8064, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4323, 5ts0T, 0.8063, 2.26, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4324, 3h6iQ, 0.8063, 2.23, 0.161, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4325, 2h6jG, 0.8062, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4326, 2h6jF, 0.8062, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4327, 2h6jA, 0.8062, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4328, 5trsD, 0.8061, 2.26, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4329, 2h6jE, 0.8060, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4330, 2h6jD, 0.8060, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4331, 5tryS, 0.8059, 2.26, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4332, 5thoO, 0.8058, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4333, 2h6jC, 0.8058, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4334, 5tryF, 0.8057, 2.26, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4335, 5trsC, 0.8057, 2.26, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4336, 5thoE, 0.8056, 2.21, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4337, 3mfeI, 0.8056, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4338, 5ts0Q, 0.8055, 2.28, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4339, 5trrP, 0.8055, 2.28, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4340, 3mka1, 0.8055, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4341, 5tryQ, 0.8053, 2.28, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4342, 1q5rD, 0.8053, 2.28, 0.156, 220, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4343, 1q5rG, 0.8052, 2.19, 0.162, 218, 210, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4344, 1q5rF, 0.8052, 2.19, 0.162, 218, 210, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4345, 1q5rE, 0.8052, 2.28, 0.156, 220, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4346, 1q5rC, 0.8052, 2.28, 0.156, 220, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4347, 1q5rB, 0.8052, 2.28, 0.156, 220, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4348, 1q5rA, 0.8051, 2.28, 0.156, 220, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4349, 5ts0P, 0.8050, 2.28, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4350, 5ts0U, 0.8049, 2.28, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4351, 5tryP, 0.8049, 2.28, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4352, 3mkaM, 0.8048, 2.28, 0.161, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4353, 1q5qD, 0.8048, 2.29, 0.156, 220, 212, THE RHODOCOCCUS 20S PROTEASOME
4354, 1q5qC, 0.8048, 2.20, 0.162, 218, 210, THE RHODOCOCCUS 20S PROTEASOME
4355, 1q5qA, 0.8048, 2.20, 0.162, 218, 210, THE RHODOCOCCUS 20S PROTEASOME
4356, 5ts0E, 0.8047, 2.21, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4357, 5trgS, 0.8047, 2.34, 0.160, 221, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4358, 5trgO, 0.8047, 2.22, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4359, 1q5qG, 0.8047, 2.39, 0.165, 221, 212, THE RHODOCOCCUS 20S PROTEASOME
4360, 1q5qF, 0.8047, 2.37, 0.160, 222, 212, THE RHODOCOCCUS 20S PROTEASOME
4361, 1q5qE, 0.8047, 2.25, 0.162, 218, 210, THE RHODOCOCCUS 20S PROTEASOME
4362, 1q5qB, 0.8047, 2.22, 0.162, 218, 210, THE RHODOCOCCUS 20S PROTEASOME
4363, 5trgE, 0.8045, 2.22, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4364, 3mkaB, 0.8044, 2.22, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4365, 5trrT, 0.8042, 2.22, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4366, 5trrE, 0.8042, 2.24, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4367, 5trrS, 0.8040, 2.23, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4368, 3mkaS, 0.8039, 2.22, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4369, 5ts0B, 0.8038, 2.30, 0.161, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4370, 5thoT, 0.8038, 2.25, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4371, 3mfeK, 0.8037, 2.22, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4372, 5trsE, 0.8034, 2.23, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4373, 3mfeB, 0.8034, 2.26, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4374, 5ts0C, 0.8033, 2.25, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4375, 5trsS, 0.8032, 2.14, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4376, 5trgT, 0.8032, 2.26, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4377, 3mkaD, 0.8031, 2.19, 0.162, 219, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4378, 5trrC, 0.8030, 2.34, 0.166, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4379, 3mkaW, 0.8030, 2.27, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4380, 3h6iF, 0.8029, 2.23, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4381, 3mkaO, 0.8028, 2.23, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4382, 5tryE, 0.8026, 2.23, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4383, 5trsU, 0.8026, 2.23, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4384, 5trrU, 0.8026, 2.23, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4385, 5thoC, 0.8026, 2.23, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4386, 5ts0D, 0.8024, 2.23, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4387, 5trgU, 0.8024, 2.28, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4388, 5thoR, 0.8024, 2.20, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4389, 3mkaY, 0.8024, 2.25, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4390, 5ts0S, 0.8023, 2.41, 0.165, 224, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4391, 5trsT, 0.8023, 2.29, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4392, 5thoF, 0.8023, 2.29, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4393, 5lzpD, 0.8023, 2.29, 0.156, 219, 211, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4394, 5tryR, 0.8022, 2.27, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4395, 3h6fQ, 0.8022, 2.27, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4396, 5trsB, 0.8020, 2.27, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4397, 5thoP, 0.8019, 2.30, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4398, 5tryU, 0.8018, 2.30, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4399, 5thoU, 0.8018, 2.30, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4400, 5ts0R, 0.8017, 2.30, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4401, 3h6fW, 0.8015, 2.26, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4402, 5trgQ, 0.8013, 2.36, 0.161, 220, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4403, 5tryD, 0.8011, 2.20, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4404, 5trgD, 0.8011, 2.22, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4405, 3h6iW, 0.8011, 2.27, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4406, 3h6iK, 0.8011, 2.36, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4407, 5tryC, 0.8008, 2.17, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4408, 5trrO, 0.8004, 2.22, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4409, 3h6iA, 0.8002, 2.14, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4410, 5trsO, 0.8001, 2.23, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4411, 5trrD, 0.8001, 2.15, 0.159, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4412, 5trgG, 0.8001, 2.23, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4413, 3hfaB, 0.8001, 2.29, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4414, 5trrG, 0.8000, 2.24, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4415, 5thoQ, 0.7999, 2.37, 0.166, 222, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4416, 5trsQ, 0.7998, 2.21, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4417, 3mi0K, 0.7997, 2.34, 0.162, 221, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4418, 3h6fF, 0.7997, 2.21, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4419, 5trgB, 0.7996, 2.30, 0.157, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4420, 5tryT, 0.7994, 2.24, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4421, 5tryG, 0.7991, 2.17, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4422, 5trsG, 0.7991, 2.16, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4423, 5ts0O, 0.7990, 2.25, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4424, 3krdF, 0.7989, 2.24, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4425, 5thoB, 0.7988, 2.18, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4426, 3mi0S, 0.7988, 2.26, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4427, 3mi0O, 0.7987, 2.48, 0.160, 224, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4428, 5thoD, 0.7986, 2.31, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4429, 3mi0I, 0.7986, 2.23, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4430, 5trrB, 0.7985, 2.25, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4431, 3mi0Y, 0.7980, 2.22, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4432, 3mi0U, 0.7980, 2.25, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4433, 3mfeS, 0.7980, 2.21, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4434, 3h6iM, 0.7980, 2.19, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4435, 3h6fK, 0.7980, 2.27, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4436, 5tryB, 0.7979, 2.18, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4437, 3mi0M, 0.7978, 2.19, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4438, 3krdY, 0.7976, 2.27, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4439, 3h6i1, 0.7976, 2.21, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4440, 3h6iI, 0.7975, 2.28, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4441, 5trsR, 0.7973, 2.26, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4442, 3h6fA, 0.7971, 2.59, 0.156, 223, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4443, 3h6f1, 0.7971, 2.24, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4444, 5trgC, 0.7970, 2.23, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4445, 5trgF, 0.7969, 2.18, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4446, 3h6iU, 0.7968, 2.26, 0.158, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4447, 5trsF, 0.7967, 2.18, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4448, 3mi01, 0.7965, 2.26, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4449, 3krdI, 0.7965, 2.22, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4450, 5trrQ, 0.7963, 2.22, 0.159, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4451, 3hfaA, 0.7962, 2.10, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4452, 3mkaI, 0.7960, 2.21, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4453, 3h6fS, 0.7959, 2.24, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4454, 5lzpH, 0.7955, 2.24, 0.163, 216, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4455, 3hfaW, 0.7955, 2.22, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4456, 3hfaM, 0.7955, 2.19, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4457, 3h6fO, 0.7955, 2.16, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4458, 5lzp2, 0.7954, 2.22, 0.163, 216, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4459, 3mi0W, 0.7954, 2.22, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4460, 3hfaQ, 0.7954, 2.22, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4461, 3h6iO, 0.7954, 2.25, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4462, 5lzp4, 0.7953, 2.21, 0.159, 216, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4463, 5lzp0, 0.7953, 2.18, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4464, 3mi0Q, 0.7953, 2.23, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4465, 3h6iS, 0.7953, 2.24, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4466, 5lzp6, 0.7951, 2.24, 0.163, 216, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4467, 3hfaO, 0.7951, 2.24, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4468, 3hfaK, 0.7951, 2.18, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4469, 5lzpY, 0.7950, 2.23, 0.163, 216, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4470, 3hfaS, 0.7950, 2.24, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4471, 5lzpW, 0.7949, 2.17, 0.159, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4472, 5lzp8, 0.7949, 2.22, 0.159, 216, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4473, 3hfaI, 0.7948, 2.14, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4474, 3hfa1, 0.7948, 2.19, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4475, 5ts0F, 0.7947, 2.25, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4476, 3hfaF, 0.7947, 2.24, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4477, 5lzpJ, 0.7946, 2.16, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4478, 5trrR, 0.7945, 2.16, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4479, 3h6fI, 0.7945, 2.28, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4480, 3krdS, 0.7944, 2.16, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4481, 5tryO, 0.7942, 2.16, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4482, 5trgR, 0.7941, 2.27, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4483, 3krd1, 0.7941, 2.22, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4484, 3krdW, 0.7939, 2.18, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4485, 3h6fM, 0.7939, 2.26, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4486, 5lzpS, 0.7938, 2.21, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4487, 3mi0A, 0.7938, 2.21, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4488, 3hfaY, 0.7938, 2.24, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4489, 3krdK, 0.7937, 2.15, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4490, 5trrF, 0.7936, 2.35, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4491, 3hfaU, 0.7936, 2.18, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4492, 3mfeA, 0.7931, 2.21, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4493, 3h6fB, 0.7929, 2.17, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4494, 3mi0D, 0.7926, 2.17, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4495, 3h6fD, 0.7925, 2.19, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4496, 6bgoN, 0.7921, 2.21, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4497, 3krdQ, 0.7920, 2.35, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4498, 3krdO, 0.7920, 2.17, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4499, 3h6iB, 0.7920, 2.20, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4500, 6bgoJ, 0.7919, 2.21, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4501, 3mfeY, 0.7919, 2.21, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4502, 3hfaD, 0.7918, 2.23, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4503, 6bgoO, 0.7917, 2.19, 0.159, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4504, 3h6fU, 0.7917, 2.21, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4505, 3h6iD, 0.7916, 2.17, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4506, 6bgoM, 0.7914, 2.17, 0.165, 214, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4507, 6bgoA, 0.7913, 2.21, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4508, 5lzpQ, 0.7911, 2.19, 0.165, 214, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4509, 5lzpB, 0.7911, 2.21, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4510, 5lzpM, 0.7909, 2.21, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4511, 2z5cF, 0.7909, 2.18, 0.165, 214, 206, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4512, 2z5cC, 0.7909, 2.19, 0.165, 214, 206, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4513, 6bgoL, 0.7908, 2.23, 0.159, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4514, 6bgoK, 0.7907, 2.18, 0.165, 214, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4515, 3krdA, 0.7905, 2.23, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4516, 3h6fY, 0.7898, 2.25, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4517, 3mfeO, 0.7894, 2.14, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4518, 3krdU, 0.7894, 2.23, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4519, 3mfe1, 0.7887, 2.29, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4520, 3hf9I, 0.7884, 2.25, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4521, 3krdM, 0.7882, 2.23, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4522, 6bgoI, 0.7876, 2.24, 0.159, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4523, 6bgoH, 0.7876, 2.22, 0.159, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4524, 6bgoG, 0.7876, 2.24, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4525, 6bgoF, 0.7876, 2.24, 0.159, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4526, 6bgoE, 0.7876, 2.21, 0.165, 214, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4527, 6bgoD, 0.7876, 2.24, 0.159, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4528, 6bgoC, 0.7876, 2.23, 0.159, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4529, 6bglO, 0.7876, 2.20, 0.165, 214, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4530, 6bglN, 0.7876, 2.17, 0.160, 214, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4531, 6bglM, 0.7876, 2.18, 0.160, 214, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4532, 6bglL, 0.7876, 2.21, 0.160, 214, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4533, 6bglK, 0.7876, 2.17, 0.160, 214, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4534, 6bglJ, 0.7876, 2.48, 0.167, 219, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4535, 6bglI, 0.7876, 2.21, 0.160, 214, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4536, 6bglH, 0.7876, 2.22, 0.160, 214, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4537, 6bglG, 0.7876, 2.19, 0.160, 214, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4538, 6bglF, 0.7876, 2.65, 0.166, 219, 211, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4539, 6bglE, 0.7876, 2.15, 0.161, 213, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4540, 6bglD, 0.7876, 2.17, 0.161, 213, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4541, 6bglC, 0.7876, 2.35, 0.163, 217, 209, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4542, 6bglA, 0.7876, 2.19, 0.160, 214, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4543, 3mfeD, 0.7875, 2.13, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4544, 3krdD, 0.7875, 2.52, 0.162, 219, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4545, 3mfeQ, 0.7871, 2.36, 0.163, 218, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4546, 3mi0B, 0.7870, 2.22, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4547, 3krdB, 0.7870, 2.22, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4548, 3hf9y, 0.7859, 2.22, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4549, 3h6iY, 0.7853, 0.76, 1.000, 189, 189, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4550, 3hf9s, 0.7848, 0.76, 1.000, 189, 189, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4551, 3hf9i, 0.7846, 2.38, 0.163, 218, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4552, 3hf9d, 0.7844, 2.55, 0.167, 219, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4553, 3hf9B, 0.7844, 2.24, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4554, 3hf9f, 0.7843, 2.16, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4555, 3hf9b, 0.7842, 2.20, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4556, 3hf9w, 0.7839, 2.26, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4557, 3hf9u, 0.7839, 2.15, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4558, 3hf9S, 0.7838, 2.13, 0.162, 212, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4559, 3hf9K, 0.7838, 2.27, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4560, 3hf91, 0.7837, 2.28, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4561, 3mfeU, 0.7834, 2.28, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4562, 3hf9A, 0.7834, 2.28, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4563, 3hf9k, 0.7833, 2.28, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4564, 3hf9a, 0.7832, 2.28, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4565, 3hf9U, 0.7829, 2.28, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4566, 3hf9O, 0.7828, 2.28, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4567, 3hf9o, 0.7827, 2.28, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4568, 3hf9q, 0.7823, 2.28, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4569, 3hf9Q, 0.7820, 2.28, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4570, 3hf9Y, 0.7810, 2.28, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4571, 3hf93, 0.7803, 2.28, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4572, 3mfeW, 0.7787, 2.28, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4573, 3hf9D, 0.7764, 2.28, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4574, 5a0qT, 0.7733, 2.28, 0.164, 215, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4575, 5a0qF, 0.7727, 2.28, 0.164, 215, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4576, 3hf9m, 0.7725, 2.28, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4577, 5a0qO, 0.7673, 2.28, 0.164, 215, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4578, 5a0qA, 0.7673, 2.28, 0.164, 215, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4579, 3hf9M, 0.7651, 2.28, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4580, 6bdfZ, 0.7548, 2.28, 0.164, 215, 207, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4581, 6bdfX, 0.7548, 2.21, 0.161, 213, 205, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4582, 6bdfV, 0.7548, 2.23, 0.161, 213, 205, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4583, 6bdfT, 0.7548, 2.20, 0.161, 213, 205, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4584, 6bdfR, 0.7548, 2.23, 0.161, 213, 205, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4585, 6bdfP, 0.7548, 2.23, 0.161, 213, 205, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4586, 6bdfN, 0.7548, 2.11, 0.163, 211, 203, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4587, 6bdfL, 0.7548, 2.24, 0.161, 213, 205, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4588, 6bdfJ, 0.7548, 2.16, 0.163, 211, 203, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4589, 6bdfH, 0.7548, 2.12, 0.163, 211, 203, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4590, 6bdfF, 0.7548, 2.11, 0.163, 211, 203, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4591, 6bdfD, 0.7548, 2.08, 0.163, 211, 203, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4592, 6bdfB, 0.7548, 2.15, 0.163, 211, 203, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4593, 6bdf1, 0.7548, 2.09, 0.163, 211, 203, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4594, 3j9iZ, 0.7540, 2.12, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4595, 3j9iY, 0.7540, 2.15, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4596, 3j9iX, 0.7540, 2.14, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4597, 3j9iW, 0.7540, 2.11, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4598, 3j9iV, 0.7540, 2.13, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4599, 3j9iN, 0.7540, 2.22, 0.162, 212, 204, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4600, 3j9iM, 0.7540, 2.15, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4601, 3j9iL, 0.7540, 2.16, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4602, 3j9iK, 0.7540, 2.14, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4603, 3j9iJ, 0.7540, 2.16, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4604, 3j9iI, 0.7540, 2.14, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4605, 3j9iH, 0.7540, 2.13, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4606, 3j9i2, 0.7540, 2.15, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4607, 3j9i1, 0.7540, 2.16, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4608, 5vy3Z, 0.7537, 2.12, 0.163, 210, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4609, 5vy3X, 0.7537, 2.13, 0.163, 210, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4610, 5vy3V, 0.7537, 2.03, 0.164, 209, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4611, 5vy3T, 0.7537, 2.20, 0.163, 210, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4612, 5vy3R, 0.7537, 1.50, 0.333, 195, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4613, 5vy3P, 0.7537, 1.52, 0.333, 195, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4614, 5vy3N, 0.7537, 2.14, 0.160, 208, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4615, 5vy3L, 0.7537, 1.56, 0.293, 195, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4616, 5vy3J, 0.7537, 1.56, 0.293, 195, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4617, 5vy3H, 0.7537, 2.00, 0.162, 205, 197, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4618, 5vy3F, 0.7537, 2.23, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4619, 5vy3D, 0.7537, 2.23, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4620, 5vy3B, 0.7537, 2.23, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4621, 5vy31, 0.7537, 2.23, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4622, 3h4pf, 0.7537, 2.23, 0.210, 201, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4623, 3h4pe, 0.7534, 2.23, 0.210, 201, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4624, 5vy4Z, 0.7533, 2.23, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4625, 5vy4X, 0.7533, 2.23, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4626, 5vy4V, 0.7533, 2.23, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4627, 5vy4T, 0.7533, 2.23, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4628, 5vy4R, 0.7533, 2.23, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4629, 5vy4P, 0.7533, 2.23, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4630, 5vy4N, 0.7533, 2.23, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4631, 5vy4L, 0.7533, 2.23, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4632, 5vy4J, 0.7533, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4633, 5vy4H, 0.7533, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4634, 5vy4F, 0.7533, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4635, 5vy4D, 0.7533, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4636, 5vy4BA, 0.7533, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4637, 5vy4B, 0.7533, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4638, 5vy41, 0.7533, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4639, 3h4pl, 0.7533, 2.38, 0.209, 203, 196, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4640, 3h4pj, 0.7532, 2.38, 0.209, 203, 196, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4641, 3h4pc, 0.7532, 2.38, 0.209, 203, 196, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4642, 3h4pn, 0.7531, 2.38, 0.209, 203, 196, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4643, 3h4pk, 0.7531, 2.38, 0.209, 203, 196, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4644, 3h4pg, 0.7531, 2.38, 0.209, 203, 196, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4645, 3h4pa, 0.7531, 2.38, 0.209, 203, 196, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4646, 1yauM, 0.7531, 2.24, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4647, 3h4pi, 0.7526, 2.24, 0.210, 203, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4648, 3h4pd, 0.7526, 2.24, 0.210, 203, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4649, 3h4pb, 0.7526, 2.24, 0.210, 203, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4650, 3h4ph, 0.7525, 2.24, 0.210, 203, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4651, 1yarM, 0.7525, 2.24, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4652, 1ya7M, 0.7522, 2.24, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4653, 3jrmM, 0.7518, 2.24, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4654, 3jseM, 0.7517, 2.24, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4655, 3h4pm, 0.7517, 2.24, 0.210, 203, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4656, 1yauJ, 0.7517, 2.24, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4657, 1pmaX, 0.7516, 2.24, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4658, 3jrmK, 0.7515, 2.24, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4659, 3jrmJ, 0.7515, 2.24, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4660, 3jrmI, 0.7515, 2.28, 0.246, 202, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4661, 3jrmH, 0.7515, 2.29, 0.246, 202, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4662, 1ya7K, 0.7515, 2.24, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4663, 3jseK, 0.7514, 2.24, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4664, 3jrmL, 0.7514, 2.24, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4665, 3c92W, 0.7514, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4666, 3c92I, 0.7514, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4667, 3c91W, 0.7514, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4668, 3c91I, 0.7514, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4669, 1pmaP, 0.7514, 2.24, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4670, 3jrmN, 0.7513, 2.24, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4671, 3c92X, 0.7513, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4672, 3c92N, 0.7513, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4673, 3c92J, 0.7513, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4674, 3c922, 0.7513, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4675, 3c91X, 0.7513, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4676, 3c91N, 0.7513, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4677, 3c91J, 0.7513, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4678, 3c912, 0.7513, 2.27, 0.246, 202, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4679, 1ya7J, 0.7513, 2.27, 0.246, 202, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4680, 1pmaU, 0.7513, 2.28, 0.246, 202, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4681, 1pmaQ, 0.7513, 2.28, 0.246, 202, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4682, 3jseL, 0.7512, 2.28, 0.246, 202, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4683, 3jseJ, 0.7512, 2.27, 0.246, 202, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4684, 3c92M, 0.7512, 2.28, 0.246, 202, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4685, 3c921, 0.7512, 2.26, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4686, 3c91M, 0.7512, 2.29, 0.246, 202, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4687, 3c911, 0.7512, 2.29, 0.246, 202, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4688, 1ya7I, 0.7512, 2.28, 0.246, 202, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4689, 1pmaY, 0.7512, 2.30, 0.246, 202, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4690, 1pmaT, 0.7512, 2.26, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4691, 3jseI, 0.7511, 2.27, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4692, 3jseH, 0.7511, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4693, 1yauK, 0.7511, 2.28, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4694, 1pmaV, 0.7511, 2.29, 0.246, 202, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4695, 1pma2, 0.7511, 2.28, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4696, 1pma1, 0.7511, 2.28, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4697, 3jseN, 0.7510, 2.29, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4698, 1yauI, 0.7510, 2.29, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4699, 1yauH, 0.7510, 2.29, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4700, 1yarK, 0.7510, 2.29, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4701, 2h6jK, 0.7509, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4702, 1ya7L, 0.7509, 2.28, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4703, 1pmaZ, 0.7509, 2.29, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4704, 2h6jN, 0.7508, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4705, 2h6jM, 0.7508, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4706, 1ya7H, 0.7508, 2.28, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4707, 3jtlM, 0.7507, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4708, 3c92Z, 0.7507, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4709, 3c92L, 0.7507, 2.29, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4710, 3c91Z, 0.7507, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4711, 3c91L, 0.7507, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4712, 1yauL, 0.7507, 2.28, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4713, 1yarJ, 0.7507, 2.28, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4714, 1pmaS, 0.7507, 2.28, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4715, 3jtlN, 0.7506, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4716, 3jtlK, 0.7506, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4717, 3jtlI, 0.7506, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4718, 3c92V, 0.7506, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4719, 3c92H, 0.7506, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4720, 3c91V, 0.7506, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4721, 3c91H, 0.7506, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4722, 2h6jI, 0.7506, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4723, 1yarL, 0.7506, 2.28, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4724, 1yarI, 0.7506, 2.28, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4725, 1pmaW, 0.7506, 2.28, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4726, 1pmaB, 0.7506, 2.28, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4727, 3jtlL, 0.7505, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4728, 3jtlJ, 0.7505, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4729, 3jtlH, 0.7505, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4730, 1ya7N, 0.7505, 2.28, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4731, 3c92Y, 0.7504, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4732, 3c92K, 0.7504, 2.29, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4733, 3c91Y, 0.7504, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4734, 3c91K, 0.7504, 2.27, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4735, 2h6jH, 0.7504, 2.29, 0.210, 203, 195, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4736, 1pmaR, 0.7504, 2.29, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4737, 1yarH, 0.7502, 2.29, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4738, 1yarN, 0.7501, 2.29, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4739, 1yauN, 0.7500, 2.28, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4740, 2h6jL, 0.7495, 2.72, 0.198, 242, 202, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4741, 2h6jJ, 0.7493, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4742, 1q5rN, 0.7478, 2.28, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4743, 1q5rM, 0.7478, 2.72, 0.193, 242, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4744, 1q5rL, 0.7478, 2.72, 0.198, 242, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4745, 1q5rK, 0.7477, 2.29, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4746, 1q5rJ, 0.7477, 2.29, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4747, 1q5rI, 0.7477, 2.28, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4748, 1q5rH, 0.7477, 2.28, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4749, 5fgeY, 0.7448, 2.28, 0.210, 203, 195, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4750, 5fgeK, 0.7446, 2.28, 0.210, 203, 195, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4751, 5fgdY, 0.7446, 2.29, 0.210, 203, 195, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4752, 3hfaV, 0.7443, 2.29, 0.210, 203, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4753, 5ts0K, 0.7442, 2.28, 0.210, 203, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4754, 1j2qN, 0.7441, 2.30, 0.210, 203, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4755, 3ipmM, 0.7440, 2.30, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4756, 3ipmL, 0.7440, 2.30, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4757, 3ipmK, 0.7440, 2.29, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4758, 3ipmJ, 0.7440, 2.29, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4759, 3ipmH, 0.7440, 2.29, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4760, 1j2qJ, 0.7440, 2.29, 0.210, 203, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4761, 3ipmN, 0.7439, 2.74, 0.193, 242, 202, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4762, 3ipmI, 0.7439, 2.29, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4763, 1j2qM, 0.7439, 2.29, 0.210, 203, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4764, 1j2qL, 0.7439, 2.29, 0.210, 203, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4765, 1j2qK, 0.7439, 2.29, 0.210, 203, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4766, 1j2qI, 0.7439, 2.30, 0.210, 203, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4767, 1j2qH, 0.7439, 2.30, 0.210, 203, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4768, 5trsK, 0.7437, 2.30, 0.210, 203, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4769, 5fgdK, 0.7437, 2.30, 0.210, 203, 195, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4770, 5cz7Y, 0.7434, 2.29, 0.210, 203, 195, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4771, 3mkaL, 0.7434, 2.29, 0.210, 203, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4772, 5cz7K, 0.7433, 2.29, 0.210, 203, 195, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4773, 5trgK, 0.7430, 2.29, 0.210, 203, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4774, 3mkaV, 0.7428, 2.75, 0.193, 242, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4775, 5trgL, 0.7427, 2.29, 0.210, 203, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4776, 3mkaN, 0.7426, 2.30, 0.210, 203, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4777, 5thoL, 0.7425, 2.31, 0.210, 203, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4778, 3hfaZ, 0.7425, 2.32, 0.210, 203, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4779, 5trrL, 0.7424, 2.63, 0.194, 242, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4780, 1q5qN, 0.7424, 2.47, 0.200, 242, 200, THE RHODOCOCCUS 20S PROTEASOME
4781, 1q5qM, 0.7424, 2.75, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME
4782, 1q5qL, 0.7423, 2.75, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME
4783, 1q5qK, 0.7423, 2.75, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME
4784, 1q5qJ, 0.7423, 2.75, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME
4785, 1q5qH, 0.7423, 2.75, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME
4786, 5tryK, 0.7422, 2.75, 0.193, 251, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4787, 3mkaP, 0.7422, 2.75, 0.193, 251, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4788, 3mi0L, 0.7422, 2.99, 0.206, 218, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4789, 1q5qI, 0.7422, 3.00, 0.206, 218, 204, THE RHODOCOCCUS 20S PROTEASOME
4790, 5trsL, 0.7420, 2.97, 0.211, 216, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4791, 5fgfK, 0.7420, 2.76, 0.147, 226, 204, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4792, 3hfaX, 0.7420, 2.72, 0.148, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4793, 3mka2, 0.7419, 2.58, 0.230, 202, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4794, 5trsY, 0.7418, 2.41, 0.210, 203, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4795, 5lzpN, 0.7418, 2.42, 0.210, 203, 195, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4796, 5fgfY, 0.7418, 2.41, 0.210, 203, 195, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4797, 3mkaJ, 0.7418, 2.41, 0.210, 203, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4798, 5trgV, 0.7417, 2.42, 0.210, 203, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4799, 5lzpP, 0.7417, 2.58, 0.224, 202, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4800, 3mkaT, 0.7417, 2.42, 0.210, 203, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4801, 3mkaC, 0.7417, 2.42, 0.210, 203, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4802, 5ts0W, 0.7416, 2.58, 0.224, 202, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4803, 5trgY, 0.7416, 2.58, 0.224, 202, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4804, 5thoK, 0.7416, 2.58, 0.230, 202, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4805, 3mkaR, 0.7416, 2.58, 0.224, 202, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4806, 5trrW, 0.7415, 2.58, 0.230, 202, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4807, 5trrV, 0.7415, 2.66, 0.149, 223, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4808, 5trrK, 0.7415, 2.93, 0.217, 215, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4809, 5lzpI, 0.7415, 3.09, 0.206, 217, 204, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4810, 5trrY, 0.7413, 3.08, 0.150, 251, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4811, 5trsW, 0.7412, 3.10, 0.206, 217, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4812, 5trrb, 0.7412, 2.72, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4813, 5thoV, 0.7412, 2.91, 0.151, 249, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4814, 3mi0V, 0.7412, 2.79, 0.148, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4815, 3hfaE, 0.7412, 2.91, 0.151, 252, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4816, 5trsV, 0.7411, 2.78, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4817, 5trrI, 0.7411, 2.81, 0.147, 224, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4818, 5thoW, 0.7411, 2.72, 0.148, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4819, 3mkaE, 0.7411, 2.80, 0.186, 224, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4820, 3hfaT, 0.7411, 2.80, 0.186, 224, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4821, 3hfaH, 0.7411, 2.80, 0.186, 224, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4822, 5trra, 0.7410, 2.80, 0.186, 224, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4823, 3mkaG, 0.7410, 2.81, 0.186, 224, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4824, 3mi0R, 0.7409, 2.80, 0.186, 224, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4825, 3mkaH, 0.7408, 2.75, 0.148, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4826, 5trgI, 0.7407, 3.02, 0.151, 250, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4827, 5lzpO, 0.7407, 2.73, 0.153, 223, 203, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4828, 5ts0L, 0.7406, 2.81, 0.186, 224, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4829, 5thoY, 0.7406, 2.77, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4830, 5tryV, 0.7405, 2.89, 0.208, 214, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4831, 5trga, 0.7405, 2.84, 0.147, 224, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4832, 5lzpU, 0.7404, 2.98, 0.151, 246, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4833, 5ts0a, 0.7403, 2.75, 0.153, 223, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4834, 5tryL, 0.7403, 2.78, 0.157, 234, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4835, 5trya, 0.7403, 2.90, 0.208, 214, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4836, 3hfaG, 0.7403, 2.87, 0.152, 252, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4837, 5tryb, 0.7402, 2.73, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4838, 5thoI, 0.7402, 2.76, 0.153, 234, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4839, 3mi0X, 0.7402, 3.02, 0.151, 250, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4840, 5ts0V, 0.7401, 2.97, 0.151, 250, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4841, 5tryW, 0.7401, 2.74, 0.149, 223, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4842, 5thoa, 0.7401, 2.79, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4843, 5lzpC, 0.7401, 2.74, 0.153, 223, 203, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4844, 5trrZ, 0.7400, 2.86, 0.152, 246, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4845, 5lzpR, 0.7400, 2.74, 0.153, 223, 203, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4846, 5lzpG, 0.7400, 2.80, 0.148, 223, 203, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4847, 3mi0T, 0.7400, 2.75, 0.148, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4848, 3mi0E, 0.7400, 2.74, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4849, 3mi02, 0.7400, 2.72, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4850, 3hfaC, 0.7400, 2.75, 0.149, 223, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4851, 5trsa, 0.7399, 2.75, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4852, 3hfaL, 0.7399, 2.80, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4853, 3hfa2, 0.7399, 2.80, 0.157, 239, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4854, 5thob, 0.7398, 2.79, 0.148, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4855, 3hfaN, 0.7398, 2.82, 0.148, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4856, 3hfaJ, 0.7398, 2.74, 0.149, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4857, 5ts0I, 0.7397, 2.80, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4858, 5tryY, 0.7397, 3.05, 0.150, 248, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4859, 5trgX, 0.7397, 2.76, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4860, 3mi0J, 0.7397, 2.76, 0.148, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4861, 3hfaR, 0.7397, 2.75, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4862, 3hfaP, 0.7397, 2.87, 0.152, 251, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4863, 5ts0Y, 0.7396, 2.80, 0.157, 239, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4864, 5ts0b, 0.7396, 2.87, 0.152, 249, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4865, 5trsN, 0.7395, 2.74, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4866, 5lzpT, 0.7395, 2.77, 0.149, 223, 202, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4867, 5trsb, 0.7394, 2.74, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4868, 5lzpK, 0.7394, 2.74, 0.153, 223, 203, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4869, 3mi0N, 0.7394, 2.75, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4870, 5tryI, 0.7392, 2.77, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4871, 5trgN, 0.7390, 2.76, 0.153, 223, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4872, 5lzpE, 0.7390, 2.77, 0.153, 223, 202, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4873, 5lzpA, 0.7390, 2.73, 0.153, 223, 203, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4874, 5trsI, 0.7389, 2.77, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4875, 5lzpF, 0.7389, 2.76, 0.149, 222, 202, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4876, 3mi0Z, 0.7389, 2.77, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4877, 3krdV, 0.7389, 2.76, 0.149, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4878, 3krdR, 0.7389, 2.81, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4879, 6bgoZ, 0.7388, 2.82, 0.148, 223, 203, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4880, 6bgoY, 0.7388, 2.77, 0.148, 223, 203, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4881, 6bgoX, 0.7388, 2.76, 0.153, 223, 203, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4882, 6bgoW, 0.7388, 2.77, 0.153, 223, 203, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4883, 6bgoV, 0.7388, 2.75, 0.149, 222, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4884, 6bgoU, 0.7388, 2.81, 0.153, 223, 203, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4885, 6bgoT, 0.7388, 2.70, 0.149, 222, 201, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4886, 6bgoS, 0.7388, 2.75, 0.153, 223, 203, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4887, 6bgoR, 0.7388, 2.71, 0.153, 223, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4888, 6bgoQ, 0.7388, 2.76, 0.153, 223, 203, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4889, 6bgoP, 0.7388, 2.76, 0.149, 222, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4890, 6bgoc, 0.7388, 2.84, 0.148, 223, 203, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4891, 6bgob, 0.7388, 2.76, 0.149, 222, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4892, 6bgoa, 0.7388, 2.76, 0.149, 222, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4893, 6bglZ, 0.7388, 2.83, 0.153, 223, 203, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4894, 6bglY, 0.7388, 2.77, 0.149, 223, 202, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4895, 6bglX, 0.7388, 2.77, 0.149, 222, 202, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4896, 6bglW, 0.7388, 2.76, 0.153, 222, 202, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4897, 6bglV, 0.7388, 2.76, 0.153, 223, 203, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4898, 6bglU, 0.7388, 2.75, 0.153, 222, 202, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4899, 6bglT, 0.7388, 2.74, 0.153, 222, 202, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4900, 6bglS, 0.7388, 2.76, 0.149, 222, 202, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4901, 6bglR, 0.7388, 2.77, 0.149, 222, 202, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4902, 6bglQ, 0.7388, 2.69, 0.153, 223, 202, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4903, 6bglP, 0.7388, 2.84, 0.148, 223, 203, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4904, 6bglc, 0.7388, 2.84, 0.148, 223, 203, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4905, 6bglb, 0.7388, 2.82, 0.153, 223, 203, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4906, 6bgla, 0.7388, 2.84, 0.153, 223, 203, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4907, 5ts0Z, 0.7388, 2.74, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4908, 5trrN, 0.7388, 2.74, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4909, 5thoZ, 0.7388, 2.77, 0.149, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4910, 3krdL, 0.7388, 2.83, 0.148, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4911, 5trgW, 0.7387, 2.75, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4912, 5lzpL, 0.7387, 2.71, 0.149, 222, 201, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4913, 3mi0G, 0.7387, 2.76, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4914, 3mi0H, 0.7386, 2.72, 0.149, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4915, 5ts0N, 0.7385, 2.83, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4916, 5tryZ, 0.7385, 2.79, 0.158, 229, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4917, 5trsZ, 0.7385, 2.79, 0.158, 229, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4918, 5thoM, 0.7385, 2.72, 0.149, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4919, 5thoJ, 0.7384, 2.72, 0.149, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4920, 5trgZ, 0.7383, 2.72, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4921, 5trgH, 0.7382, 2.72, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4922, 5trgb, 0.7382, 2.72, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4923, 5trrM, 0.7381, 2.72, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4924, 5thoN, 0.7381, 2.72, 0.149, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4925, 3mi0C, 0.7381, 2.72, 0.149, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4926, 5tryH, 0.7380, 2.72, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4927, 5trsH, 0.7380, 2.72, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4928, 5trrH, 0.7380, 2.72, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4929, 5thoH, 0.7380, 2.72, 0.149, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4930, 5tryN, 0.7379, 2.72, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4931, 3mi0P, 0.7379, 2.72, 0.149, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4932, 5ts0M, 0.7376, 2.72, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4933, 5trrJ, 0.7376, 2.72, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4934, 5trsM, 0.7375, 2.72, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4935, 5trgM, 0.7373, 2.72, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4936, 5trsJ, 0.7372, 2.72, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4937, 5d0vK, 0.7372, 2.72, 0.149, 222, 201, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4938, 5ts0J, 0.7371, 2.72, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4939, 5ts0H, 0.7370, 2.72, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4940, 5thoX, 0.7367, 2.72, 0.149, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4941, 3wxrZ, 0.7367, 2.72, 0.149, 222, 201, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4942, 3krdN, 0.7367, 2.72, 0.149, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4943, 5tryM, 0.7366, 2.72, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4944, 3krd2, 0.7366, 2.72, 0.149, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4945, 5trgJ, 0.7365, 2.72, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4946, 3mfeP, 0.7365, 2.70, 0.149, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4947, 3krdJ, 0.7365, 2.78, 0.148, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4948, 5trrX, 0.7364, 2.76, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4949, 3wxrL, 0.7364, 2.74, 0.149, 222, 201, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4950, 3krdC, 0.7364, 2.84, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4951, 5l5rY, 0.7363, 2.72, 0.149, 222, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4952, 5l5rK, 0.7363, 2.75, 0.153, 222, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4953, 5l5bY, 0.7362, 2.70, 0.154, 222, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4954, 5l5bK, 0.7361, 2.80, 0.148, 223, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4955, 3krdT, 0.7361, 2.75, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4956, 3krdE, 0.7360, 2.69, 0.154, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4957, 5trsX, 0.7359, 2.87, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4958, 3krdX, 0.7359, 2.77, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4959, 3krdG, 0.7359, 2.77, 0.149, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4960, 5ts0X, 0.7358, 2.78, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4961, 5tryJ, 0.7358, 2.86, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4962, 4ya0K, 0.7358, 2.79, 0.149, 222, 202, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4963, 4y8uY, 0.7358, 2.76, 0.153, 222, 202, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4964, 4y8uK, 0.7358, 2.77, 0.153, 222, 202, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4965, 4y69Y, 0.7358, 2.78, 0.149, 222, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4966, 4y69K, 0.7358, 2.78, 0.149, 222, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4967, 5tryX, 0.7357, 2.78, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4968, 5cgfY, 0.7357, 2.77, 0.153, 222, 202, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4969, 5cgfK, 0.7357, 2.86, 0.153, 223, 203, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4970, 5bouY, 0.7357, 2.77, 0.153, 222, 202, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4971, 5bouK, 0.7357, 2.74, 0.149, 222, 201, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4972, 4ya5Y, 0.7357, 2.78, 0.153, 222, 202, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4973, 4ya5K, 0.7357, 2.75, 0.149, 222, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4974, 4ya3Y, 0.7357, 2.80, 0.149, 222, 202, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4975, 4ya3K, 0.7357, 2.79, 0.153, 222, 202, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4976, 4ya0Y, 0.7357, 3.05, 0.208, 218, 202, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4977, 4q1sK, 0.7357, 2.79, 0.153, 222, 202, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4978, 4j70K, 0.7357, 2.79, 0.153, 222, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4979, 3mkaX, 0.7357, 2.80, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4980, 5m2bY, 0.7356, 3.00, 0.203, 212, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4981, 5m2bK, 0.7356, 2.74, 0.154, 222, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4982, 4y6vK, 0.7356, 2.80, 0.153, 222, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4983, 4y6aY, 0.7356, 2.76, 0.149, 222, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4984, 4y6aK, 0.7356, 2.80, 0.149, 222, 202, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4985, 4quxK, 0.7356, 2.69, 0.150, 221, 200, YCP BETA5-A49T-MUTANT
4986, 5cz4K, 0.7355, 2.81, 0.153, 222, 202, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4987, 4y8tY, 0.7355, 2.80, 0.153, 222, 202, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4988, 4y8tK, 0.7355, 2.94, 0.204, 212, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4989, 4qv4Y, 0.7355, 2.75, 0.154, 222, 201, YCP BETA5-M45T MUTANT
4990, 4qv4K, 0.7355, 2.84, 0.216, 211, 199, YCP BETA5-M45T MUTANT
4991, 4quxY, 0.7355, 2.84, 0.216, 211, 199, YCP BETA5-A49T-MUTANT
4992, 4j70Y, 0.7355, 2.85, 0.216, 211, 199, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4993, 5cz4Y, 0.7354, 2.85, 0.216, 211, 199, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4994, 4ya1Y, 0.7354, 2.74, 0.154, 222, 201, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4995, 4ya1K, 0.7354, 2.76, 0.154, 222, 201, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4996, 4y8nY, 0.7354, 2.82, 0.153, 222, 202, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4997, 4y8nK, 0.7354, 2.76, 0.154, 222, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4998, 4y6vY, 0.7354, 2.76, 0.154, 222, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4999, 4qv9Y, 0.7354, 2.82, 0.153, 222, 202, YCP BETA5-C63F MUTANT
5000, 4qv9K, 0.7354, 2.80, 0.153, 222, 202, YCP BETA5-C63F MUTANT
